PDB ID	GPCR Name	Family	Subfamily	UniProt ID	Species	Description	Method	Resolution	Date Released	Reference	PMID	Ligand ID	Ligand Name	InChI ID	InChI Key	Mutations	Fusion Protein(s)	Associated Protein(s)
4DJH	Kappa-type opioid receptor	Class A	Opioid peptides receptors	P41145	Homo sapiens (Human)	Structure of the human kappa opioid receptor in complex with JDTic	X-Ray Diffraction	2.9	2012-03-21	Wu et al. Structure of the human kappa-opioid receptor in complex with JDTic. Nature. 2012, 485, 327.	22437504	JDC	(3R)-7-hydroxy-N-{(2S)-1-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]-3-methylbutan-2-yl}-1,2,3,4-tetrahydroisoquinoline-3-carboxamide	InChI=1S/C28H39N3O3/c1-18(2)26(30-27(34)25-13-20-8-9-24(33)12-21(20)15-29-25)17-31-11-10-28(4,19(3)16-31)22-6-5-7-23(32)14-22/h5-9,12,14,18-19,25-26,29,32-33H,10-11,13,15-17H2,1-4H3,(H,30,34)/t19-,25+,26+,28+/m0/s1	ZLVXBBHTMQJRSX-VMGNSXQWSA-N	I135L	Lysozyme (P00720)	N/A
5NJ6	Proteinase-activated receptor 2	Class A	Proteinase-activated receptors	P55085	Homo sapiens (Human)	Crystal structure of a thermostabilised human protease-activated receptor-2 (PAR2) in ternary complex with Fab3949 and AZ7188 at 4.0 angstrom resolution	X-Ray Diffraction	4.0	2017-05-03	Cheng et al. Structural insight into allosteric modulation of protease-activated receptor 2. Nature. 2017, 545, 112.	28445455	N/A	N/A	N/A	N/A	N/A	Soluble cytochrome b562 (P0ABE7)	Fab3949 H, Fab3949 L
4XT3	G-protein coupled receptor homolog US28	Class A	Viral receptors	P69332	Human cytomegalovirus (strain AD169) (HHV-5)	Structure of a viral GPCR bound to human chemokine CX3CL1	X-Ray Diffraction	3.8	2015-03-04	Burg et al. Structural biology Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor. Science. 2015, 347, 1113.	25745166	N/A	N/A	N/A	N/A	N/A	N/A	Fractalkine (P78423)
5GLI	Endothelin receptor type B	Class A	Endothelin receptors	P24530	Homo sapiens (Human)	Human endothelin receptor type-B in the ligand-free form	X-Ray Diffraction	2.5	2016-09-07	Shihoya et al. Activation mechanism of endothelin ETB receptor by endothelin-1. Nature. 2016, 537, 363.	27595334	N/A	N/A	N/A	N/A	N/A	Lysozyme (P00720)	N/A
4NTJ	P2Y purinoceptor 12	Class A	Adenosine and adenine nucleotide receptors	Q9H244	Homo sapiens (Human)	Structure of the human P2Y12 receptor in complex with an antithrombotic drug	X-Ray Diffraction	2.62	2014-03-26	Zhang et al. Structure of the human P2Y12 receptor in complex with an antithrombotic drug. Nature. 2014, 509, 115.	24670650	AZJ	ethyl 6-{4-[(benzylsulfonyl)carbamoyl]piperidin-1-yl}-5-cyano-2-methylpyridine-3-carboxylate	InChI=1S/C23H26N4O5S/c1-3-32-23(29)20-13-19(14-24)21(25-16(20)2)27-11-9-18(10-12-27)22(28)26-33(30,31)15-17-7-5-4-6-8-17/h4-8,13,18H,3,9-12,15H2,1-2H3,(H,26,28)	NEMHKCNXXRQYRF-UHFFFAOYSA-N	D294N	Soluble cytochrome b562 (P0ABE7)	N/A
5YC8	Muscarinic acetylcholine receptor M2	Class A	Acetylcholine (muscarinic) receptors	P08172	Homo sapiens (Human)	Crystal structure of rationally thermostabilized M2 muscarinic acetylcholine receptor bound with NMS (Hg-derivative)	X-Ray Diffraction	2.5	2018-11-21	Suno et al. Structural insights into the subtype-selective antagonist binding to the M2muscarinic receptor. Nat. Chem. Biol. 2018, 14, 1150.	30420692	3C0	N-methyl scopolamine	InChI=1S/C18H24NO4/c1-19(2)14-8-12(9-15(19)17-16(14)23-17)22-18(21)13(10-20)11-6-4-3-5-7-11/h3-7,12-17,20H,8-10H2,1-2H3/q+1/t12-,13-,14-,15+,16-,17+/m1/s1	LZCOQTDXKCNBEE-IKIFYQGPSA-N	S110R	N/A	N/A
3OE0	C-X-C chemokine receptor type 4	Class A	Chemokines and chemotactic factors receptors	P61073	Homo sapiens (Human)	Crystal structure of the CXCR4 chemokine receptor in complex with a cyclic peptide antagonist CVX15	X-Ray Diffraction	2.9	2010-10-27	Wu et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science. 2010, 330, 1066.	20929726	N/A	N/A	N/A	N/A	N/A	Lysozyme (P00720)	N/A
3AYN	Rhodopsin	Class A	Opsins	P31356	Todarodes pacificus (Japanese flying squid)	Crystal structure of squid isorhodopsin	X-Ray Diffraction	2.7	2011-08-17	Murakami et al. Crystallographic Analysis of the Primary Photochemical Reaction of Squid Rhodopsin. J.Mol.Biol. 2011, 413, 615.	21906602	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
4L6R	Glucagon receptor	Class B	N/A	P47871	Homo sapiens (Human)	Structure of the class B human glucagon G protein coupled receptor	X-Ray Diffraction	3.3	2013-07-24	Siu et al. Structure of the human glucagon class B G-protein-coupled receptor. Nature. 2013, 499, 444.	23863937	N/A	N/A	N/A	N/A	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
6HLO	Substance-P receptor	Class A	Tachykinin receptors	P25103	Homo sapiens (Human)	Crystal structure of the Neurokinin 1 receptor in complex with the small molecule antagonist Aprepitant	X-Ray Diffraction	2.4	2019-01-16	Schoppe et al. Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists. Nat Commun. 2019, 10, 17.	30604743	GBQ	5-[[(2~{R},3~{S})-2-[(1~{R})-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one	InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1	ATALOFNDEOCMKK-OITMNORJSA-N	L74A, V116I, A144L, M181K, A215L, W224R, K243A	GlgA glycogen synthase (Q9V2J8)	N/A
6FK6	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of N2C/D282C stabilized opsin bound to RS01	X-Ray Diffraction	2.36	2018-04-04	Mattle et al. Ligand channel in pharmacologically stabilized rhodopsin. Proc. Natl. Acad. Sci. U.S.A. 2018, 115, 3640.	29555765	DOK	(2~{S})-2-(4-chlorophenyl)-3-methyl-1-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl-butan-1-one	InChI=1S/C22H24ClNO3/c1-15(2)20(16-7-9-17(23)10-8-16)21(25)24-13-11-22(12-14-24)26-18-5-3-4-6-19(18)27-22/h3-10,15,20H,11-14H2,1-2H3/t20-/m0/s1	UDAMUOKENMUCKG-FQEVSTJZSA-N	N/A	N/A	N/A
3OE8	C-X-C chemokine receptor type 4	Class A	Chemokines and chemotactic factors receptors	P61073	Homo sapiens (Human)	Crystal structure of the CXCR4 chemokine receptor in complex with a small molecule antagonist IT1t in P1 spacegroup	X-Ray Diffraction	3.1	2010-10-27	Wu et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science. 2010, 330, 1066.	20929726	ITD	(6,6-dimethyl-5,6-dihydroimidazo[2,1-b][1,3]thiazol-3-yl)methyl N,N'-dicyclohexylimidothiocarbamate	InChI=1S/C21H34N4S2/c1-21(2)15-25-18(14-27-20(25)24-21)13-26-19(22-16-9-5-3-6-10-16)23-17-11-7-4-8-12-17/h14,16-17H,3-13,15H2,1-2H3,(H,22,23)	OOSUDWRRWZVFEB-UHFFFAOYSA-N	N/A	Lysozyme (P00720)	N/A
3NY8	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	Crystal structure of the human beta2 adrenergic receptor in complex with the inverse agonist ICI 118,551	X-Ray Diffraction	2.84	2010-08-11	Wacker et al. Conserved Binding Mode of Human beta(2) Adrenergic Receptor Inverse Agonists and Antagonist Revealed by X-ray Crystallography. J.Am.Chem.Soc. 2010, 132, 11443.	20669948	JRZ	(2S,3S)-1-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]butan-2-ol	InChI=1S/C17H27NO2/c1-11(2)18-13(4)16(19)10-20-17-9-8-12(3)14-6-5-7-15(14)17/h8-9,11,13,16,18-19H,5-7,10H2,1-4H3/t13-,16+/m0/s1	VFIDUCMKNJIJTO-XJKSGUPXSA-N	E122W, N187E	Lysozyme (P00720)	N/A
6D9H	Adenosine receptor A1	Class A	Adenosine and adenine nucleotide receptors	P30542	Homo sapiens (Human)	Cryo-EM structure of the human adenosine A1 receptor-Gi2-protein complex bound to its endogenous agonist	Electron Microscopy	3.6	2018-06-20	Draper-Joyce et al. Structure of the adenosine-bound human adenosine A1receptor-Gicomplex. Nature. 2018.	29925945	ADN	ADENOSINE	InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1	OIRDTQYFTABQOQ-KQYNXXCUSA-N	N/A	Muscarinic acetylcholine receptor M4 (P08173)	Guanine nucleotide-binding protein G(i) subunit alpha-2 (P04899), Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (P62873), Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 (P59768)
3UZC	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Thermostabilised Adenosine A2A receptor in complex with 4-(3-amino-5-phenyl-1,2,4-triazin-6-yl)-2-chlorophenol	X-Ray Diffraction	3.34	2012-03-21	Congreve et al. Discovery of 1,2,4-Triazine Derivatives as Adenosine A(2A) Antagonists using Structure Based Drug Design. J.Med.Chem. 2012, 55, 1898.	22220592	T4E	4-(3-amino-5-phenyl-1,2,4-triazin-6-yl)-2-chlorophenol	InChI=1S/C15H11ClN4O/c16-11-8-10(6-7-12(11)21)14-13(18-15(17)20-19-14)9-4-2-1-3-5-9/h1-8,21H,(H2,17,18,20)	ZHUZHTHIEMXLRA-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, L202A, L235A, V239A, S277A	N/A	N/A
3P0G	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	Structure of a nanobody-stabilized active state of the beta2 adrenoceptor	X-Ray Diffraction	3.5	2011-01-19	Rasmussen et al. Structure of a nanobody-stabilized active state of the b2 adrenoceptor. Nature. 2011, 469, 175.	21228869	P0G	8-[(1R)-2-{[1,1-dimethyl-2-(2-methylphenyl)ethyl]amino}-1-hydroxyethyl]-5-hydroxy-2H-1,4-benzoxazin-3(4H)-one	InChI=1S/C21H26N2O4/c1-13-6-4-5-7-14(13)10-21(2,3)22-11-17(25)15-8-9-16(24)19-20(15)27-12-18(26)23-19/h4-9,17,22,24-25H,10-12H2,1-3H3,(H,23,26)/t17-/m0/s1	NWQXBEWHTDRJIP-KRWDZBQOSA-N	N187E	Lysozyme (P00720)	Camelid Antibody Fragment
5OLG	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Structure of the A2A-StaR2-bRIL562-ZM241385 complex at 1.86A obtained from in meso soaking experiments.	X-Ray Diffraction	1.87	2018-01-17	Rucktooa et al. Towards high throughput GPCR crystallography: In Meso soaking of Adenosine A2A Receptor crystals. Sci Rep. 2018, 8, 41.	29311713	ZMA	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, N154A, L202A, L235A, V239A, S277A	Soluble cytochrome b562 (P0ABE7)	N/A
6DRY	5-hydroxytryptamine receptor 2B	Class A	Serotonin receptors	P41595	Homo sapiens (Human)	Structural Determinants of Activation and Biased Agonism at the 5-HT2B Receptor	X-Ray Diffraction	2.92	2018-08-29	McCorvy et al. Structural determinants of 5-HT2Breceptor activation and biased agonism. Nat. Struct. Mol. Biol. 2018.	30127358	H8D	(8beta)-N-[(2S)-1-hydroxybutan-2-yl]-6-methyl-9,10-didehydroergoline-8-carboxamide	InChI=1S/C20H25N3O2/c1-3-14(11-24)22-20(25)13-7-16-15-5-4-6-17-19(15)12(9-21-17)8-18(16)23(2)10-13/h4-7,9,13-14,18,21,24H,3,8,10-11H2,1-2H3,(H,22,25)/t13-,14+,18-/m1/s1	UNBRKDKAWYKMIV-QWQRMKEZSA-N	M144W	Soluble cytochrome b562 (P0ABE7)	N/A
4MBS	C-C chemokine receptor type 5	Class A	Chemokines and chemotactic factors receptors	P51681	Homo sapiens (Human)	Crystal Structure of the CCR5 Chemokine Receptor	X-Ray Diffraction	2.71	2013-09-11	Tan et al. Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex. Science. 2013, 341, 1387.	24030490	MRV	4,4-difluoro-N-[(1S)-3-{(3-exo)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl}-1-phenylpropyl]cyclohexanecarboxamide	InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25-,26-/m0/s1	GSNHKUDZZFZSJB-QYOOZWMWSA-N	C58Y, G163N, A233D, K303E	Rubredoxin (P00268)	N/A
5XR8	Cannabinoid receptor 1	Class A	Cannabinoids receptors	P21554	Homo sapiens (Human)	Crystal structure of the human CB1 in complex with agonist AM841	X-Ray Diffraction	2.95	2017-07-12	Hua et al. Crystal structures of agonist-bound human cannabinoid receptor CB1. Nature. 2017, 547, 468.	28678776	8D0	(6aR,9R,10aR)-3-(8-azanyl-2-methyl-octan-2-yl)-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol	InChI=1S/C25H41NO3/c1-24(2,11-7-5-6-8-12-26)18-14-21(28)23-19-13-17(16-27)9-10-20(19)25(3,4)29-22(23)15-18/h14-15,17,19-20,27-28H,5-13,16,26H2,1-4H3/t17-,19-,20-/m1/s1	IMRFQPBRZWXESL-MISYRCLQSA-N	T210A, E273K, T283V, R340E	Flavodoxin (P00323)	N/A
5UIW	C-C chemokine receptor type 5	Class A	Chemokines and chemotactic factors receptors	P51681	Homo sapiens (Human)	Crystal Structure of CC Chemokine Receptor 5 (CCR5) in complex with high potency HIV entry inhibitor 5P7-CCL5	X-Ray Diffraction	2.2	2017-06-28	Zheng et al. Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV. Immunity. 2017, 46, 1005.	28636951	N/A	N/A	N/A	N/A	C58Y, G163N, A233D, K303E	Rubredoxin (P00268)	C-C motif chemokine 5 (P13501)
4XEE	Neurotensin receptor type 1	Class A	Neurotensin receptors	P20789	Rattus norvegicus (Rat)	Structure of active-like neurotensin receptor	X-Ray Diffraction	2.9	2015-07-29	Krumm et al. Structural prerequisites for G-protein activation by the neurotensin receptor. Nat Commun. 2015, 6, 7895.	26205105	N/A	N/A	N/A	N/A	A86L, G215A, V360A	Lysozyme (P00720)	N/A
6N51	Metabotropic glutamate receptor 5	Class C	N/A	P41594	Homo sapiens (Human)	Metabotropic Glutamate Receptor 5 bound to L-quisqualate and Nb43	Electron Microscopy	4.0	2019-01-23	Koehl et al. Structural insights into the activation of metabotropic glutamate receptors. Nature. 2019.	30675062	QUS	(S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID	InChI=1S/C5H7N3O5/c6-2(3(9)10)1-8-4(11)7-5(12)13-8/h2H,1,6H2,(H,9,10)(H,7,11,12)/t2-/m0/s1	ASNFTDCKZKHJSW-REOHCLBHSA-N	N/A	N/A	Nanobody 43
4BEZ	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Night blindness causing G90D rhodopsin in the active conformation	X-Ray Diffraction	3.3	2013-04-24	Singhal et al. Insights Into Congenital Stationary Night Blindness Based on the Structure of G90D Rhodopsin. Embo Rep. 2013, 14, 520.	23579341	N/A	N/A	N/A	N/A	N2C, G90D, D282C	N/A	N/A
6HLP	Substance-P receptor	Class A	Tachykinin receptors	P25103	Homo sapiens (Human)	Crystal structure of the Neurokinin 1 receptor in complex with the small molecule antagonist Netupitant	X-Ray Diffraction	2.2	2019-01-16	Schoppe et al. Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists. Nat Commun. 2019, 10, 17.	30604743	GAW	2-[3,5-bis(trifluoromethyl)phenyl]-~{N},2-dimethyl-~{N}-[4-(2-methylphenyl)-6-(4-methylpiperazin-1-yl)pyridin-3-yl]propanamide	InChI=1S/C30H32F6N4O/c1-19-8-6-7-9-23(19)24-17-26(40-12-10-38(4)11-13-40)37-18-25(24)39(5)27(41)28(2,3)20-14-21(29(31,32)33)16-22(15-20)30(34,35)36/h6-9,14-18H,10-13H2,1-5H3	WAXQNWCZJDTGBU-UHFFFAOYSA-N	L74A, V116I, A144L, M181K, A215L, W224R, K243A	GlgA glycogen synthase (Q9V2J8)	N/A
2R4R	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	Crystal structure of the human beta2 adrenoceptor	X-Ray Diffraction	3.4	2007-11-06	Rasmussen et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature. 2007, 450, 383.	17952055	N/A	N/A	N/A	N/A	N/A	N/A	Antibody For Beta2 Adrenoceptor, Heavy Chain, Antibody For Beta2 Adrenoceptor, Light Chain
6C1Q	C5a anaphylatoxin chemotactic receptor 1	Class A	Chemokines and chemotactic factors receptors	P21730	Homo sapiens (Human)	Crystal structure of human C5a receptor in complex with an orthosteric antagonist PMX53 and an allosteric antagonist NDT9513727	X-Ray Diffraction	2.9	2018-05-30	Liu et al. Orthosteric and allosteric action of the C5a receptor antagonists. Nat. Struct. Mol. Biol. 2018, 25, 472.	29867214	9P2	1-(1,3-benzodioxol-5-yl)-~{N}-(1,3-benzodioxol-5-ylmethyl)-~{N}-[(3-butyl-2,5-diphenyl-imidazol-4-yl)methyl]methanamine	InChI=1S/C36H35N3O4/c1-2-3-18-39-30(35(28-10-6-4-7-11-28)37-36(39)29-12-8-5-9-13-29)23-38(21-26-14-16-31-33(19-26)42-24-40-31)22-27-15-17-32-34(20-27)43-25-41-32/h4-17,19-20H,2-3,18,21-25H2,1H3	ITACCRHKSPSKKL-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
5D5B	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	In meso X-ray crystallography structure of the Beta2-adrenergic receptor at 100 K	X-Ray Diffraction	3.8	2016-01-13	Huang et al. In meso in situ serial X-ray crystallography of soluble and membrane proteins at cryogenic temperatures. Acta Crystallogr D Struct Biol. 2016, 72, 93.	26894538	CAU	(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol	InChI=1S/C18H22N2O2/c1-12(2)19-10-13(21)11-22-17-9-5-8-16-18(17)14-6-3-4-7-15(14)20-16/h3-9,12-13,19-21H,10-11H2,1-2H3/t13-/m0/s1	BQXQGZPYHWWCEB-ZDUSSCGKSA-N	N/A	Lysozyme (P00720)	N/A
5V57	Smoothened homolog	Class F	N/A	Q99835	Homo sapiens (Human)	3.0A SYN structure of the multi-domain human smoothened receptor in complex with TC114	X-Ray Diffraction	3.0	2017-05-24	Zhang et al. Crystal structure of a multi-domain human smoothened receptor in complex with a super stabilizing ligand. Nat Commun. 2017, 8, 15383.	28513578	836	N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-4-nitro-2-(trifluoromethyl)benzamide	InChI=1S/C26H24F3N7O3/c1-33(25(37)20-8-7-17(36(38)39)15-21(20)26(27,28)29)16-10-13-35(14-11-16)24-19-6-4-3-5-18(19)23(31-32-24)22-9-12-30-34(22)2/h3-9,12,15-16H,10-11,13-14H2,1-2H3	ZDEZQXNVPSUJHK-UHFFFAOYSA-N	N/A	Flavodoxin (P00323)	N/A
3PDS	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	Irreversible Agonist-Beta2 Adrenoceptor Complex	X-Ray Diffraction	3.5	2011-01-12	Rosenbaum et al. Structure and function of an irreversible agonist-beta(2) adrenoceptor complex. Nature. 2011, 469, 236.	21228876	ERC	8-hydroxy-5-[(1R)-1-hydroxy-2-({2-[3-methoxy-4-(3-sulfanylpropoxy)phenyl]ethyl}amino)ethyl]quinolin-2(1H)-one	InChI=1S/C23H28N2O5S/c1-29-21-13-15(3-7-20(21)30-11-2-12-31)9-10-24-14-19(27)16-4-6-18(26)23-17(16)5-8-22(28)25-23/h3-8,13,19,24,26-27,31H,2,9-12,14H2,1H3,(H,25,28)/t19-/m0/s1	WAQRESHSGHIXBV-IBGZPJMESA-N	H93C, N187E	Lysozyme (P00720)	N/A
5WKT	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	3.2-Angstrom In situ Mylar structure of bovine opsin at 100 K	X-Ray Diffraction	3.2	2017-12-13	Broecker et al. High-throughput in situ X-ray screening of and data collection from protein crystals at room temperature and under cryogenic conditions. Nat Protoc. 2018, 13, 260.	29300389	N/A	N/A	N/A	N/A	N/A	N/A	N/A
5IUA	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with compound 12b at 2.2A resolution	X-Ray Diffraction	2.2	2016-06-29	Segala et al. Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength. J.Med.Chem. 2016, 59, 6470.	27312113	6DX	2-(furan-2-yl)-N~5~-[3-(4-phenylpiperazin-1-yl)propyl][1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine	InChI=1S/C21H25N9O/c22-19-25-20(26-21-24-18(27-30(19)21)17-8-4-15-31-17)23-9-5-10-28-11-13-29(14-12-28)16-6-2-1-3-7-16/h1-4,6-8,15H,5,9-14H2,(H3,22,23,24,25,26,27)	ATLUGIZVRICDDK-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, N154A, L202A, L235A, V239A, S277A	Soluble cytochrome b562 (P0ABE7)	N/A
6H7O	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND WEAK PARTIAL AGONIST CYANOPINDOLOL AND NANOBODY Nb6B9	X-Ray Diffraction	2.8	2018-10-17	Warne et al. Molecular basis for high affinity agonist binding in GPCRs. Biorxiv. 2018.	N/A	P32	4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile	InChI=1S/C16H21N3O2/c1-16(2,3)18-9-12(20)10-21-15-6-4-5-14-13(15)7-11(8-17)19-14/h4-6,12,18,20H,7,9-10H2,1-3H3/t12-/m0/s1	CQEFAUFOQSCRMZ-LBPRGKRZSA-N	R68S, M90V, C116L, F327A, F338M, C358A	N/A	Camelid Antibody Fragment Nb6b9, Thioredoxin 1 (P0AA25)
4QKX	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	Structure of beta2 adrenoceptor bound to a covalent agonist and an engineered nanobody	X-Ray Diffraction	3.3	2014-07-23	Weichert et al. Covalent agonists for studying G protein-coupled receptor activation. Proc.Natl.Acad.Sci.USA. 2014, 111, 10744.	25006259	35V	4-[(1R)-1-hydroxy-2-({2-[3-methoxy-4-(2-sulfanylethoxy)phenyl]ethyl}amino)ethyl]benzene-1,2-diol	InChI=1S/C19H25NO5S/c1-24-19-10-13(2-5-18(19)25-8-9-26)6-7-20-12-17(23)14-3-4-15(21)16(22)11-14/h2-5,10-11,17,20-23,26H,6-9,12H2,1H3/t17-/m0/s1	ABMSPPLJHILUDP-KRWDZBQOSA-N	H1093C, M1096T, M1098T, N1187E, C1265A	Lysozyme (P00720)	R9 Protein
6DDF	Mu-type opioid receptor	Class A	Opioid peptides receptors	P42866	Mus musculus (Mouse)	Mu Opioid Receptor-Gi Protein Complex	Electron Microscopy	3.5	2018-06-13	Koehl et al. Structure of the &#956;-opioid receptor-Giprotein complex. Nature. 2018.	29899455	N/A	N/A	N/A	N/A	N/A	N/A	Guanine nucleotide-binding protein G(i) subunit alpha-1 (P63096), Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (P62873), Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 (P59768)
3REY	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Thermostabilised adenosine A2A receptor in complex with XAC	X-Ray Diffraction	3.31	2011-09-07	Dore et al. Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. Structure. 2011, 19, 1283.	21885291	XAC	N-(2-aminoethyl)-2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy]acetamide	InChI=1S/C21H28N6O4/c1-3-11-26-19-17(20(29)27(12-4-2)21(26)30)24-18(25-19)14-5-7-15(8-6-14)31-13-16(28)23-10-9-22/h5-8H,3-4,9-13,22H2,1-2H3,(H,23,28)(H,24,25)	FIQGIOAELHTLHM-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, L202A, L235A, V239A, S277A	N/A	N/A
5V54	5-hydroxytryptamine receptor 1B	Class A	Serotonin receptors	P28222	Homo sapiens (Human)	Crystal structure of 5-HT1B receptor in complex with methiothepin	X-Ray Diffraction	3.9	2018-02-07	Yin et al. A common antagonistic mechanism for class A GPCRs revealed by the structure of the human 5-HT1B serotonin receptor bound to an antagonist. Cell Discov. 2018.	N/A	89F	1-methyl-4-[(5~{S})-3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-5-yl]piperazine	InChI=1S/C20H24N2S2/c1-21-9-11-22(12-10-21)18-13-15-5-3-4-6-19(15)24-20-8-7-16(23-2)14-17(18)20/h3-8,14,18H,9-13H2,1-2H3/t18-/m0/s1	RLJFTICUTYVZDG-SFHVURJKSA-N	L138W	N/A	N/A
2YCZ	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND ANTAGONIST IODOCYANOPINDOLOL	X-Ray Diffraction	3.65	2011-06-01	Moukhametzianov et al. Two Distinct Conformations of Helix 6 Observed in Antagonist-Bound Structures of a {Beta}1- Adrenergic Receptor. Proc.Natl.Acad.Sci.USA. 2011, 108, 8228.	21540331	I32	4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3-iodo-1H-indole-2-carbonitrile	InChI=1S/C16H20IN3O2/c1-16(2,3)19-8-10(21)9-22-13-6-4-5-11-14(13)15(17)12(7-18)20-11/h4-6,10,19-21H,8-9H2,1-3H3/t10-/m0/s1	JBLUMBNIBNHRSO-JTQLQIEISA-N	R68S, M90V, C116L, Y227A, A282L, F327A, F338M	N/A	N/A
5WF6	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Agonist bound human A2a adenosine receptor with S91A mutation at 2.90 A resolution	X-Ray Diffraction	2.9	2018-02-21	White et al. Structural Connection between Activation Microswitch and Allosteric Sodium Site in GPCR Signaling. Structure. 2018, 26, 259.	29395784	UKA	6-(2,2-diphenylethylamino)-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]-N-[2-[(1-pyridin-2-ylpiperidin-4-yl)carbamoylamino]ethyl]purine-2-carboxamide	InChI=1S/C40H47N11O6/c1-2-41-37(54)33-31(52)32(53)39(57-33)51-24-46-30-34(45-23-28(25-11-5-3-6-12-25)26-13-7-4-8-14-26)48-35(49-36(30)51)38(55)43-19-20-44-40(56)47-27-16-21-50(22-17-27)29-15-9-10-18-42-29/h3-15,18,24,27-28,31-33,39,52-53H,2,16-17,19-23H2,1H3,(H,41,54)(H,43,55)(H2,44,47,56)(H,45,48,49)/t31-,32+,33-,39+/m0/s1	ZOTHAEBAWXWVID-HXEFRTELSA-N	S91A	Lysozyme (P00720)	N/A
3VG9	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Crystal structure of human adenosine A2A receptor with an allosteric inverse-agonist antibody at 2.7 A resolution	X-Ray Diffraction	2.7	2012-02-01	Hino et al. G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody. Nature. 2012, 482, 237.	22286059	ZMA	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N	N154Q	N/A	Antibody Fab Fragment Light Chain, Antibody Fab Fragment Heavy Chain
4OR2	Metabotropic glutamate receptor 1	Class C	N/A	Q13255	Homo sapiens (Human)	Human class C G protein-coupled metabotropic glutamate receptor 1 in complex with a negative allosteric modulator	X-Ray Diffraction	2.8	2014-03-19	Wu et al. Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator. Science. 2014, 344, 58.	24603153	FM9	4-fluoro-N-methyl-N-{4-[6-(propan-2-ylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl}benzamide	InChI=1S/C18H18FN5OS/c1-11(2)22-16-8-14(20-10-21-16)15-9-26-18(23-15)24(3)17(25)12-4-6-13(19)7-5-12/h4-11H,1-3H3,(H,20,21,22)	WIVGIKIKQHUFOD-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
5C1M	Mu-type opioid receptor	Class A	Opioid peptides receptors	P42866	Mus musculus (Mouse)	Crystal structure of active mu-opioid receptor bound to the agonist BU72	X-Ray Diffraction	2.1	2015-08-05	Huang et al. Structural insights into mu-opioid receptor activation. Nature. 2015, 524, 315.	26245379	4VO	(2S,3S,3aR,5aR,6R,11bR,11cS)-3a-methoxy-3,14-dimethyl-2-phenyl-2,3,3a,6,7,11c-hexahydro-1H-6,11b-(epiminoethano)-3,5a-methanonaphtho[2,1-g]indol-10-ol	InChI=1S/C28H32N2O2/c1-25-17-26-11-12-28(25,32-3)24(29-23(25)18-7-5-4-6-8-18)27(26)13-14-30(2)22(26)15-19-9-10-20(31)16-21(19)27/h4-12,16,22-24,29,31H,13-15,17H2,1-3H3/t22-,23+,24+,25+,26-,27+,28+/m1/s1	RGJHUVJQGAAZLK-CLYKQLRXSA-N	N/A	N/A	Nanobody 39
6FK7	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of N2C/D282C stabilized opsin bound to RS06	X-Ray Diffraction	2.62	2018-04-04	Mattle et al. Ligand channel in pharmacologically stabilized rhodopsin. Proc. Natl. Acad. Sci. U.S.A. 2018, 115, 3640.	29555765	DO5	(2~{R},3~{R})-2-(4-chlorophenyl)-3-oxidanyl-1-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl-butan-1-one	InChI=1S/C21H22ClNO4/c1-14(24)19(15-6-8-16(22)9-7-15)20(25)23-12-10-21(11-13-23)26-17-4-2-3-5-18(17)27-21/h2-9,14,19,24H,10-13H2,1H3/t14-,19+/m1/s1	GYIGPNZLXGKQBD-KUHUBIRLSA-N	N/A	N/A	N/A
2KSA	Substance-P receptor	Class A	Tachykinin receptors	P25103	Homo sapiens (Human)	Substance P in DMPC/CHAPS isotropic q=0.25 bicelles as a ligand for NK1R	Solution NMR	N/A	2010-11-03	Gayen et al. NMR evidence of GM1-induced conformational change of Substance P using isotropic bicelles. Biochim.Biophys.Acta. 2010.	20937248	N/A	N/A	N/A	N/A	N/A	N/A	N/A
5K2D	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	1.9A angstrom A2a adenosine receptor structure with MR phasing using XFEL data	X-Ray Diffraction	1.9	2016-09-21	Batyuk et al. Native phasing of x-ray free-electron laser data for a G protein-coupled receptor. Sci Adv. 2016, 2, e1600292.	27679816	ZMA	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
4EJ4	Delta-type opioid receptor	Class A	Opioid peptides receptors	P32300	Mus musculus (Mouse)	Structure of the delta opioid receptor bound to naltrindole	X-Ray Diffraction	3.4	2012-05-16	Granier et al. Structure of the delta opioid receptor bound to naltrindole. Nature. 2012, 485, 400.	22596164	EJ4	(4bS,8R,8aS,14bR)-7-(cyclopropylmethyl)-5,6,7,8,14,14b-hexahydro-4,8-methano[1]benzofuro[2,3-a]pyrido[4,3-b]carbazole-1,8a(9H)-diol	InChI=1S/C26H26N2O3/c29-19-8-7-15-11-20-26(30)12-17-16-3-1-2-4-18(16)27-22(17)24-25(26,21(15)23(19)31-24)9-10-28(20)13-14-5-6-14/h1-4,7-8,14,20,24,27,29-30H,5-6,9-13H2/t20-,24+,25+,26-/m1/s1	WIYUZYBFCWCCQJ-IFKAHUTRSA-N	N/A	Lysozyme (P00720)	N/A
2J4Y	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of a rhodopsin stabilizing mutant expressed in mammalian cells	X-Ray Diffraction	3.4	2007-09-25	Standfuss et al. Crystal Structure of a Thermally Stable Rhodopsin Mutant. J.Mol.Biol. 2007, 372, 1179.	17825322	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N2C, D282C	N/A	N/A
6BD4	Frizzled-4	Class F	N/A	Q9ULV1	Homo sapiens (Human)	Crystal structure of human apo-Frizzled4 receptor	X-Ray Diffraction	2.4	2018-08-22	Yang et al. Crystal structure of the Frizzled 4 receptor in a ligand-free state. Nature. 2018.	30135577	N/A	N/A	N/A	N/A	M309L, C450I, C507F, S508Y	Rubredoxin (P00268)	N/A
6G79	5-hydroxytryptamine receptor 1B	Class A	Serotonin receptors	P28222	Homo sapiens (Human)	Coupling specificity of heterotrimeric Go to the serotonin 5-HT1B receptor	Electron Microscopy	3.78	2018-06-20	Garcia-Nafria et al. Cryo-EM structure of the serotonin 5-HT1Breceptor coupled to heterotrimeric Go. Nature. 2018, 558, 620.	29925951	EP5	2-[5-[2-[4-(4-cyanophenyl)piperazin-1-yl]-2-oxidanylidene-ethoxy]-1~{H}-indol-3-yl]ethylazanium	InChI=1S/C23H25N5O2/c24-8-7-18-15-26-22-6-5-20(13-21(18)22)30-16-23(29)28-11-9-27(10-12-28)19-3-1-17(14-25)2-4-19/h1-6,13,15,26H,7-12,16,24H2/p+1	SOHCKWZVTCTQBG-UHFFFAOYSA-O	N/A	N/A	Guanine nucleotide-binding protein G(o) subunit alpha (A0A0P7), Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (P62873), Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 (P59768)
4BEY	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Night blindness causing G90D rhodopsin in complex with GaCT2 peptide	X-Ray Diffraction	2.9	2013-05-08	Singhal et al. Insights Into Congenital Stationary Night Blindness Based on the Structure of G90D Rhodopsin. Embo Rep. 2013, 14, 520.	23579341	N/A	N/A	N/A	N/A	N2C, G90D, D282C	N/A	N/A
4Z9G	Corticotropin-releasing factor receptor 1	Class B	N/A	P34998	Homo sapiens (Human)	Crystal structure of human corticotropin-releasing factor receptor 1 (CRF1R) in complex with the antagonist CP-376395 in a hexagonal setting with translational non-crystallographic symmetry	X-Ray Diffraction	3.18	2016-06-29	Dore et al. Decoding Corticotropin-Releasing Factor Receptor Type 1 Crystal Structures. Curr Mol Pharmacol. 2017, 10, 334.	28183242	1Q5	3,6-dimethyl-N-(pentan-3-yl)-2-(2,4,6-trimethylphenoxy)pyridin-4-amine	InChI=1S/C21H30N2O/c1-8-18(9-2)23-19-12-16(6)22-21(17(19)7)24-20-14(4)10-13(3)11-15(20)5/h10-12,18H,8-9H2,1-7H3,(H,22,23)	VIZBSVDBNLAVAW-UHFFFAOYSA-N	V120A, L144A, W156A, S160A, K228A, F260A, I277A, Y309A, F330A, S349A, Y363A	Lysozyme (C3V2B5)	N/A
5MZJ	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with theophylline at 2.0A resolution	X-Ray Diffraction	2.0	2017-07-26	Cheng et al. Structures of Human A1 and A2A Adenosine Receptors with Xanthines Reveal Determinants of Selectivity. Structure. 2017, 25, 1275.	28712806	TEP	THEOPHYLLINE	InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)	ZFXYFBGIUFBOJW-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, N154A, L202A, L235A, V239A, S277A, G318A	Soluble cytochrome b562 (P0ABE7)	N/A
5O9H	C5a anaphylatoxin chemotactic receptor 1	Class A	Chemokines and chemotactic factors receptors	P21730	Homo sapiens (Human)	Crystal structure of thermostabilised human C5a anaphylatoxin chemotactic receptor 1 (C5aR) in complex with NDT9513727	X-Ray Diffraction	2.7	2018-01-10	Robertson et al. Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727. Nature. 2018, 553, 111.	29300009	9P2	1-(1,3-benzodioxol-5-yl)-~{N}-(1,3-benzodioxol-5-ylmethyl)-~{N}-[(3-butyl-2,5-diphenyl-imidazol-4-yl)methyl]methanamine	InChI=1S/C36H35N3O4/c1-2-3-18-39-30(35(28-10-6-4-7-11-28)37-36(39)29-12-8-5-9-13-29)23-38(21-26-14-16-31-33(19-26)42-24-40-31)22-27-15-17-32-34(20-27)43-25-41-32/h4-17,19-20H,2-3,18,21-25H2,1H3	ITACCRHKSPSKKL-UHFFFAOYSA-N	S85A, I91A, I142A, N146R, A156L, F172A, R232A, A234E, L311E, S317E, N321E	N/A	N/A
4RWS	C-X-C chemokine receptor type 4	Class A	Chemokines and chemotactic factors receptors	P61073	Homo sapiens (Human)	Crystal structure of CXCR4 and viral chemokine antagonist vMIP-II complex (PSI Community Target)	X-Ray Diffraction	3.1	2015-02-11	Qin et al. Structural biology Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine. Science. 2015, 347, 1117.	25612609	N/A	N/A	N/A	N/A	L125W, D187C, T240P	Lysozyme (P00720)	Viral macrophage inflammatory protein 2 (Q98157)
4O9R	Smoothened homolog	Class F	N/A	Q99835	Homo sapiens (Human)	Human Smoothened Receptor structure in complex with cyclopamine	X-Ray Diffraction	3.2	2014-03-05	Weierstall et al. Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography. Nat Commun. 2014, 5, 3309.	24525480	CY8	Cyclopamine	InChI=1S/C27H41NO2/c1-15-11-24-25(28-14-15)17(3)27(30-24)10-8-20-21-6-5-18-12-19(29)7-9-26(18,4)23(21)13-22(20)16(27)2/h5,15,17,19-21,23-25,28-29H,6-14H2,1-4H3/t15-,17+,19-,20-,21-,23-,24+,25-,26-,27-/m0/s1	QASFUMOKHFSJGL-LAFRSMQTSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
5NLX	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	A2A Adenosine receptor room-temperature structure determined by serial millisecond crystallography	X-Ray Diffraction	2.14	2017-09-27	Weinert et al. Serial millisecond crystallography for routine room-temperature structure determination at synchrotrons. Nat Commun. 2017, 8, 542.	28912485	ZMA	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N	A63L, T97A, R116A, K131A, N163A, L211A, L340A, V344A, S382A	Soluble cytochrome b562 (P0ABE7)	N/A
3RFM	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Thermostabilised adenosine A2A receptor in complex with caffeine	X-Ray Diffraction	3.6	2011-09-07	Dore et al. Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. Structure. 2011, 19, 1283.	21885291	CFF	CAFFEINE	InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3	RYYVLZVUVIJVGH-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, L202A, L235A, V239A, S277A	N/A	N/A
6IGL	Endothelin receptor type B	Class A	Endothelin receptors	P24530	Homo sapiens (Human)	Crystal Structure of human ETB receptor in complex with IRL1620	X-Ray Diffraction	2.7	2018-11-21	Shihoya et al. Crystal structures of human ETBreceptor provide mechanistic insight into receptor activation and partial activation. Nat Commun. 2018, 9, 4711.	30413709	N/A	N/A	N/A	N/A	R124Y, D154A, K270A, S342A, I381A, C396A, C400A, C405A	Thymosin beta {ECO:0000256|PIRNR:PIRNR001828} (A0A097)	N/A
5A8E	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	thermostabilised beta1-adrenoceptor with rationally designed inverse agonist 7-methylcyanopindolol bound	X-Ray Diffraction	2.4	2015-09-30	Sato et al. Pharmacological Analysis and Structure Determination of 7-Methylcyanopindolol-Bound Beta1-Adrenergic Receptor. Mol.Pharmacol. 2015, 88, 1024.	26385885	XTK	4-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-7-methyl-1H-indole-2-carbonitrile	InChI=1S/C17H23N3O2/c1-11-5-6-15(14-7-12(8-18)20-16(11)14)22-10-13(21)9-19-17(2,3)4/h5-7,13,19-21H,9-10H2,1-4H3/t13-/m0/s1	NDCOGBYMSDLXAU-ZDUSSCGKSA-N	R68S, M90V, C116L, I129V, E130W, Y227A, A282L, F327A, F338M, Y343L, C358A	N/A	N/A
6DDE	Mu-type opioid receptor	Class A	Opioid peptides receptors	P42866	Mus musculus (Mouse)	Mu Opioid Receptor-Gi Protein Complex	Electron Microscopy	3.5	2018-06-13	Koehl et al. Structure of the &#956;-opioid receptor-Giprotein complex. Nature. 2018.	29899455	N/A	N/A	N/A	N/A	N/A	N/A	Guanine nucleotide-binding protein G(i) subunit alpha-1 (P63096), Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (P62873), Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 (P59768), Scfv16
6AK3	Prostaglandin E2 receptor EP3 subtype	Class A	Prostanoids receptors	P43115	Homo sapiens (Human)	Crystal structure of the human prostaglandin E receptor EP3 bound to prostaglandin E2	X-Ray Diffraction	2.9	2018-12-05	Toyoda et al. Ligand binding to human prostaglandin E receptor EP4at the lipid-bilayer interface. Nat. Chem. Biol. 2019, 15, 18.	30510193	P2E	(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopentyl]hept-5-enoic acid	InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1	XEYBRNLFEZDVAW-ARSRFYASSA-N	A173I, V185S, N217Q, S258D, C289L, N308Q	Soluble cytochrome b562 (P0ABE7)	N/A
6FUF	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of the rhodopsin-mini-Go complex	X-Ray Diffraction	3.12	2018-10-03	Tsai et al. Crystal structure of rhodopsin in complex with a mini-Gosheds light on the principles of G protein selectivity. Sci Adv. 2018, 4, eaat7052.	30255144	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N2C, M257Y, D282C	N/A	Guanine nucleotide-binding protein G(o) subunit alpha (P09471)
5KW2	Free fatty acid receptor 1	Class A	Free fatty acid receptors	O14842	Homo sapiens (Human)	The extra-helical binding site of GPR40 and the structural basis for allosteric agonism and incretin stimulation	X-Ray Diffraction	2.76	2018-05-02	Ho et al. Structural basis for GPR40 allosteric agonism and incretin stimulation. Nat Commun. 2018, 9, 1645.	29695780	6XQ	(3~{S})-3-cyclopropyl-3-[2-[1-[2-[2,2-dimethylpropyl-(6-methylpyridin-2-yl)carbamoyl]-5-methoxy-phenyl]piperidin-4-yl]-1-benzofuran-6-yl]propanoic acid	InChI=1S/C38H45N3O5/c1-24-7-6-8-35(39-24)41(23-38(2,3)4)37(44)30-14-13-29(45-5)21-32(30)40-17-15-26(16-18-40)33-20-28-12-11-27(19-34(28)46-33)31(22-36(42)43)25-9-10-25/h6-8,11-14,19-21,25-26,31H,9-10,15-18,22-23H2,1-5H3,(H,42,43)/t31-/m0/s1	RJZJYKXHTPUHAO-HKBQPEDESA-N	L42A, F88A, G103A, Y202F	N/A	N/A
4PXF	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of the active G-protein-coupled receptor opsin in complex with the finger-loop peptide derived from the full-length arrestin-1	X-Ray Diffraction	2.75	2014-09-17	Szczepek et al. Crystal structure of a common GPCR-binding interface for G protein and arrestin. Nat Commun. 2014, 5, 4801.	25205354	N/A	N/A	N/A	N/A	N/A	N/A	N/A
6B73	Kappa-type opioid receptor	Class A	Opioid peptides receptors	P41145	Homo sapiens (Human)	Crystal Structure of a nanobody-stabilized active state of the kappa-opioid receptor	X-Ray Diffraction	3.1	2018-01-17	Che et al. Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor. Cell. 2018, 172, 55.	29307491	CVV	N-[(5alpha,6beta)-17-(cyclopropylmethyl)-3-hydroxy-7,8-didehydro-4,5-epoxymorphinan-6-yl]-3-iodobenzamide	InChI=1S/C27H27IN2O3/c28-18-3-1-2-17(12-18)26(32)29-20-8-7-19-21-13-16-6-9-22(31)24-23(16)27(19,25(20)33-24)10-11-30(21)14-15-4-5-15/h1-3,6-9,12,15,19-21,25,31H,4-5,10-11,13-14H2,(H,29,32)/t19-,20+,21+,25-,27-/m0/s1	WTIFKSFIQUZRRN-JXGKSYOJSA-N	I135L	Soluble cytochrome b562 (P0ABE7)	Nanobody
6DRX	5-hydroxytryptamine receptor 2B	Class A	Serotonin receptors	P41595	Homo sapiens (Human)	Structural Determinants of Activation and Biased Agonism at the 5-HT2B Receptor	X-Ray Diffraction	3.1	2018-08-29	McCorvy et al. Structural determinants of 5-HT2Breceptor activation and biased agonism. Nat. Struct. Mol. Biol. 2018.	30127358	H8G	N,N-diethyl-N'-[(8alpha)-6-methyl-9,10-didehydroergolin-8-yl]urea	InChI=1S/C20H26N4O/c1-4-24(5-2)20(25)22-14-10-16-15-7-6-8-17-19(15)13(11-21-17)9-18(16)23(3)12-14/h6-8,10-11,14,18,21H,4-5,9,12H2,1-3H3,(H,22,25)/t14-,18+/m0/s1	BKRGVLQUQGGVSM-KBXCAEBGSA-N	M144W	Soluble cytochrome b562 (P0ABE7)	N/A
5VRA	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	2.35-Angstrom In situ Mylar structure of human A2A adenosine receptor at 100 K	X-Ray Diffraction	2.35	2017-12-13	Broecker et al. High-throughput in situ X-ray screening of and data collection from protein crystals at room temperature and under cryogenic conditions. Nat Protoc. 2018, 13, 260.	29300389	ZMA	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
4LDO	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	Structure of beta2 adrenoceptor bound to adrenaline and an engineered nanobody	X-Ray Diffraction	3.2	2013-09-25	Ring et al. Adrenaline-activated structure of beta 2-adrenoceptor stabilized by an engineered nanobody. Nature. 2013, 502, 575.	24056936	ALE	L-EPINEPHRINE	InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1	UCTWMZQNUQWSLP-VIFPVBQESA-N	M1096T, M1098T, N1187E, C1265A	Lysozyme (P00720)	Camelid Antibody Fragment
6DO1	Type-1 angiotensin II receptor	Class A	Angiotensin receptors	P30556	Homo sapiens (Human)	Structure of nanobody-stabilized angiotensin II type 1 receptor bound to S1I8	X-Ray Diffraction	2.9	2019-01-30	Wingler et al. Distinctive Activation Mechanism for Angiotensin Receptor Revealed by a Synthetic Nanobody. Cell. 2019.	30639100	N/A	N/A	N/A	N/A	N/A	Soluble cytochrome b562 (P0ABE7)	Nanobody Nb.at110i1
5TE3	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of Bos taurus opsin at 2.7 Angstrom	X-Ray Diffraction	2.7	2017-03-15	Gulati et al. Photocyclic behavior of rhodopsin induced by an atypical isomerization mechanism. Proc. Natl. Acad. Sci. U.S.A. 2017, 114, E2608.	28289214	N/A	N/A	N/A	N/A	N/A	N/A	N/A
6H7M	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND PARTIAL AGONIST SALBUTAMOL AND NANOBODY Nb6B9	X-Ray Diffraction	2.76	2018-10-17	Warne et al. Molecular basis for high affinity agonist binding in GPCRs. Biorxiv. 2018.	N/A	68H	SALBUTAMOL	InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3/t12-/m0/s1	NDAUXUAQIAJITI-LBPRGKRZSA-N	R68S, M90V, C116L, F327A, F338M, C358A	N/A	Camelid Antibody Fragment Nb6b9, Thioredoxin 1 (P0AA25)
2HPY	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystallographic model of lumirhodopsin	X-Ray Diffraction	2.8	2006-08-22	Nakamichi et al. Local peptide movement in the photoreaction intermediate of rhodopsin. Proc.Natl.Acad.Sci.Usa. 2006, 103, 12729.	16908857	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
5CGC	Metabotropic glutamate receptor 5	Class C	N/A	P41594	Homo sapiens (Human)	Structure of the human class C GPCR metabotropic glutamate receptor 5 transmembrane domain in complex with the negative allosteric modulator 3-chloro-4-fluoro-5-[6-(1H-pyrazol-1-yl)pyrimidin-4-yl]benzonitrile	X-Ray Diffraction	3.1	2015-08-12	Christopher et al. Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile). J.Med.Chem. 2015, 58, 6653.	26225459	51D	3-chloro-4-fluoro-5-[6-(1H-pyrazol-1-yl)pyrimidin-4-yl]benzonitrile	InChI=1S/C14H7ClFN5/c15-11-5-9(7-17)4-10(14(11)16)12-6-13(19-8-18-12)21-3-1-2-20-21/h1-6,8H	UPDNOLJVPHHECL-UHFFFAOYSA-N	E579A, N667Y, I669A, G675M, T742A, S753A	Lysozyme (P00720)	N/A
5OLZ	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Structure of the A2A-StaR2-bRIL562-Compound 4e complex at 1.9A obtained from bespoke co-crystallisation experiments.	X-Ray Diffraction	1.9	2018-01-17	Rucktooa et al. Towards high throughput GPCR crystallography: In Meso soaking of Adenosine A2A Receptor crystals. Sci Rep. 2018, 8, 41.	29311713	T4E	4-(3-amino-5-phenyl-1,2,4-triazin-6-yl)-2-chlorophenol	InChI=1S/C15H11ClN4O/c16-11-8-10(6-7-12(11)21)14-13(18-15(17)20-19-14)9-4-2-1-3-5-9/h1-8,21H,(H2,17,18,20)	ZHUZHTHIEMXLRA-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, N154A, L202A, L235A, V239A, S277A	Soluble cytochrome b562 (P0ABE7)	N/A
1JFP	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Structure of bovine rhodopsin (dark adapted)	Solution NMR	N/A	2001-10-05	Yeagle et al. Studies on the structure of the G-protein-coupled receptor rhodopsin including the putative G-protein binding site in unactivated and activated forms. Biochemistry. 2001, 40, 11932.	11570894	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
6A93	5-hydroxytryptamine receptor 2A	Class A	Serotonin receptors	P28223	Homo sapiens (Human)	Crystal structure of 5-HT2AR in complex with risperidone	X-Ray Diffraction	3.0	2019-02-13	Kimura et al. Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepin. Nat.Struct.Mol.Biol. 2019, 26, 121.	N/A	8NU	3-[2-[4-(6-fluoranyl-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one	InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3	RAPZEAPATHNIPO-UHFFFAOYSA-N	S162K, M164W	Soluble cytochrome b562 (P0ABE7)	N/A
5EN0	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal Structure of T94I rhodopsin mutant	X-Ray Diffraction	2.81	2016-08-10	Singhal et al. Structural role of the T94I rhodopsin mutation in congenital stationary night blindness. Embo Rep. 2016, 17, 1431.	27458239	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N2C, T94I, D282C	N/A	N/A
2VT4	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND CYANOPINDOLOL	X-Ray Diffraction	2.7	2008-06-24	Warne et al. Structure of a Beta1-Adrenergic G-Protein-Coupled Receptor. Nature. 2008, 454, 486.	18594507	P32	4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile	InChI=1S/C16H21N3O2/c1-16(2,3)18-9-12(20)10-21-15-6-4-5-14-13(15)7-11(8-17)19-14/h4-6,12,18,20H,7,9-10H2,1-3H3/t12-/m0/s1	CQEFAUFOQSCRMZ-LBPRGKRZSA-N	R68S, M90V, C116L, Y227A, A282L, F327A, F338M, C358A	N/A	N/A
6IBL	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST FORMOTEROL AND NANOBODY Nb80	X-Ray Diffraction	2.7	2019-01-09	Warne et al. Molecular basis for high affinity agonist binding in GPCRs. To Be Published.	N/A	H98	~{N}-[5-[(1~{R})-2-[[(2~{R})-1-(4-methoxyphenyl)propan-2-yl]amino]-1-oxidanyl-ethyl]-2-oxidanyl-phenyl]methanamide	InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t13-,19+/m1/s1	BPZSYCZIITTYBL-YJYMSZOUSA-N	R284K, F327A, F338M, C358A	Thioredoxin 1 (P0AA25)	Camelid Antibody Fragment Nb80
5UZ7	Calcitonin receptor	Class B	N/A	P30988	Homo sapiens (Human)	Volta phase plate cryo-electron microscopy structure of a calcitonin receptor-heterotrimeric Gs protein complex	Electron Microscopy	4.1	2017-05-03	Liang et al. Phase-plate cryo-EM structure of a class B GPCR-G-protein complex. Nature. 2017, 546, 118.	28437792	N/A	N/A	N/A	N/A	N/A	N/A	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (P63092), Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (P62873), Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 (P59768), Nanobody 35
4AMJ	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	Turkey beta1 adrenergic receptor with stabilising mutations and bound biased agonist carvedilol	X-Ray Diffraction	2.3	2012-05-23	Warne et al. Crystal Structures of a Stabilized Beta1-Adrenoceptor Bound to the Biased Agonists Bucindolol and Carvedilol. Structure. 2012, 20, 841.	22579251	CVD	(2S)-1-(8H-CARBAZOL-4-YLOXY)-3-[2-(2-METHOXYPHENOXY)ETHYLAMINO]PROPAN-2-OL	InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3/t17-/m0/s1	OGHNVEJMJSYVRP-KRWDZBQOSA-N	R68S, M90V, C116L, Y227A, A282L, F327A, F338M, C358A	N/A	N/A
5D6L	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	beta2AR-T4L - CIM	X-Ray Diffraction	3.2	2016-08-17	Ma et al. The cubicon method for concentrating membrane proteins in the cubic mesophase. Nat Protoc. 2017, 12, 1745.	28771236	CAU	(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol	InChI=1S/C18H22N2O2/c1-12(2)19-10-13(21)11-22-17-9-5-8-16-18(17)14-6-3-4-7-15(14)20-16/h3-9,12-13,19-21H,10-11H2,1-2H3/t13-/m0/s1	BQXQGZPYHWWCEB-ZDUSSCGKSA-N	E27Q	Lysozyme (P00720)	N/A
4GBR	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	N-Terminal T4 Lysozyme Fusion Facilitates Crystallization of a G Protein Coupled Receptor	X-Ray Diffraction	3.99	2012-10-24	Zou et al. N-terminal t4 lysozyme fusion facilitates crystallization of a g protein coupled receptor. Plos One. 2012, 7, e46039.	23056231	CAU	(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol	InChI=1S/C18H22N2O2/c1-12(2)19-10-13(21)11-22-17-9-5-8-16-18(17)14-6-3-4-7-15(14)20-16/h3-9,12-13,19-21H,10-11H2,1-2H3/t13-/m0/s1	BQXQGZPYHWWCEB-ZDUSSCGKSA-N	M96T, M98T, N187E	N/A	Lysozyme (P00720)
5T04	Neurotensin receptor type 1	Class A	Neurotensin receptors	P20789	Rattus norvegicus (Rat)	STRUCTURE OF CONSTITUTIVELY ACTIVE NEUROTENSIN RECEPTOR	X-Ray Diffraction	3.3	2016-12-21	Krumm et al. Structure and dynamics of a constitutively active neurotensin receptor. Sci Rep. 2016, 6, 38564.	27924846	N/A	N/A	N/A	N/A	A86L, G215A, F358A, V360A	Lysozyme (P00720)	N/A
4IB4	5-hydroxytryptamine receptor 2B	Class A	Serotonin receptors	P41595	Homo sapiens (Human)	Crystal structure of the chimeric protein of 5-HT2B-BRIL in complex with ergotamine	X-Ray Diffraction	2.7	2013-03-13	Wacker et al. Structural features for functional selectivity at serotonin receptors. Science. 2013, 340, 615.	23519215	ERM	Ergotamine	InChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1	XCGSFFUVFURLIX-VFGNJEKYSA-N	M144W	Soluble cytochrome b562 (P0ABE7)	N/A
5XJM	Type-2 angiotensin II receptor	Class A	Angiotensin receptors	P50052	Homo sapiens (Human)	Complex structure of angiotensin II type 2 receptor with Fab	X-Ray Diffraction	3.2	2018-07-11	Asada et al. Crystal structure of the human angiotensin II type 2 receptor bound to an angiotensin II analog. Nat. Struct. Mol. Biol. 2018.	29967536	N/A	N/A	N/A	N/A	N/A	Soluble cytochrome b562 (P0ABE7)	Fabh, Fabl
2Y04	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND PARTIAL AGONIST SALBUTAMOL	X-Ray Diffraction	3.05	2011-01-12	Warne et al. The Structural Basis for Agonist and Partial Agonist Action on a Beta1-Adrenergic Receptor. Nature. 2011, 469, 241.	21228877	68H	SALBUTAMOL	InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3/t12-/m0/s1	NDAUXUAQIAJITI-LBPRGKRZSA-N	R68S, M90V, C116L, Y227A, A282L, F327A, F338M, C358A	N/A	N/A
4XT1	G-protein coupled receptor homolog US28	Class A	Viral receptors	P69332	Human cytomegalovirus (strain AD169) (HHV-5)	Structure of a nanobody-bound viral GPCR bound to human chemokine CX3CL1	X-Ray Diffraction	2.89	2015-03-04	Burg et al. Structural biology Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor. Science. 2015, 347, 1113.	25745166	N/A	N/A	N/A	N/A	N/A	N/A	Fractalkine (P78423), Nanobody 7
4BVN	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	Ultra-thermostable beta1-adrenoceptor with cyanopindolol bound	X-Ray Diffraction	2.1	2014-04-02	Miller-Gallacher et al. The 21 A Resolution Structure of Cyanopindolol-Bound Beta1- Adrenoceptor Identifies an Intramembrane Na+ Ion that Stabilises the Ligand-Free Receptor. Plos One. 2014, 9, 92727.	24663151	P32	4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile	InChI=1S/C16H21N3O2/c1-16(2,3)18-9-12(20)10-21-15-6-4-5-14-13(15)7-11(8-17)19-14/h4-6,12,18,20H,7,9-10H2,1-3H3/t12-/m0/s1	CQEFAUFOQSCRMZ-LBPRGKRZSA-N	R68S, M90V, C116L, I129V, Y227A, A282L, D322K, F327A, F338M, Y343L, C358A	N/A	N/A
3OE9	C-X-C chemokine receptor type 4	Class A	Chemokines and chemotactic factors receptors	P61073	Homo sapiens (Human)	Crystal structure of the chemokine CXCR4 receptor in complex with a small molecule antagonist IT1t in P1 spacegroup	X-Ray Diffraction	3.1	2010-10-27	Wu et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science. 2010, 330, 1066.	20929726	ITD	(6,6-dimethyl-5,6-dihydroimidazo[2,1-b][1,3]thiazol-3-yl)methyl N,N'-dicyclohexylimidothiocarbamate	InChI=1S/C21H34N4S2/c1-21(2)15-25-18(14-27-20(25)24-21)13-26-19(22-16-9-5-3-6-10-16)23-17-11-7-4-8-12-17/h14,16-17H,3-13,15H2,1-2H3,(H,22,23)	OOSUDWRRWZVFEB-UHFFFAOYSA-N	N/A	Lysozyme (P00720)	N/A
5OLH	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Structure of the A2A-StaR2-bRIL562-Vipadenant complex at 2.6A obtained from in meso soaking experiments.	X-Ray Diffraction	2.6	2018-01-17	Rucktooa et al. Towards high throughput GPCR crystallography: In Meso soaking of Adenosine A2A Receptor crystals. Sci Rep. 2018, 8, 41.	29311713	9XT	3-[(4-azanyl-3-methyl-phenyl)methyl]-7-(furan-2-yl)-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine	InChI=1S/C16H15N7O/c1-9-7-10(4-5-11(9)17)8-23-15-14(21-22-23)13(19-16(18)20-15)12-3-2-6-24-12/h2-7H,8,17H2,1H3,(H2,18,19,20)	HQSBCDPYXDGTCL-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, N154A, L202A, L235A, V239A, S277A	Soluble cytochrome b562 (P0ABE7)	N/A
5UVI	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Serial Millisecond Crystallography of Membrane and Soluble Protein Micro-crystals using Synchrotron Radiation	X-Ray Diffraction	3.2	2017-05-24	Martin-Garcia et al. Serial millisecond crystallography of membrane and soluble protein microcrystals using synchrotron radiation. IUCrJ. 2017, 4, 439.	28875031	ZMA	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
3C9M	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Structure of a mutant bovine rhodopsin in hexagonal crystal form	X-Ray Diffraction	3.4	2008-08-05	Stenkamp et al. Alternative models for two crystal structures of bovine rhodopsin. Acta Crystallogr.,Sect.D. 2008, 64, 902.	18645239	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
5IU4	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with ZM241385 at 1.7A resolution	X-Ray Diffraction	1.72	2016-06-29	Segala et al. Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength. J.Med.Chem. 2016, 59, 6470.	27312113	ZMA	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, N154A, L202A, L235A, V239A, S277A, G318A	Soluble cytochrome b562 (P0ABE7)	N/A
5T1A	C-C chemokine receptor type 2	Class A	Chemokines and chemotactic factors receptors	P41597	Homo sapiens (Human)	Structure of CC Chemokine Receptor 2 with Orthosteric and Allosteric Antagonists	X-Ray Diffraction	2.81	2016-12-14	Zheng et al. Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists. Nature. 2016, 540, 458.	27926736	73R$$$$VT5	(3S)-1-{(1S,2R,4R)-4-[methyl(propan-2-yl)amino]-2-propylcyclohexyl}-3-{[6-(trifluoromethyl)quinazolin-4-yl]amino}pyrrolidin-2-one$$$$(2~{R})-1-(4-chloranyl-2-fluoranyl-phenyl)-2-cyclohexyl-3-ethanoyl-4-oxidanyl-2~{H}-pyrrol-5-one	InChI=1S/C26H36F3N5O/c1-5-6-17-13-19(33(4)16(2)3)8-10-23(17)34-12-11-22(25(34)35)32-24-20-14-18(26(27,28)29)7-9-21(20)30-15-31-24/h7,9,14-17,19,22-23H,5-6,8,10-13H2,1-4H3,(H,30,31,32)/t17-,19-,22+,23+/m1/s1$$$$InChI=1S/C18H19ClFNO3/c1-10(22)15-16(11-5-3-2-4-6-11)21(18(24)17(15)23)14-8-7-12(19)9-13(14)20/h7-9,11,16,23H,2-6H2,1H3/t16-/m1/s1	NUJWKQSEJDYCDB-GNRVTEMESA-N$$$$VQNLJXWZGVRLBA-MRXNPFEDSA-N	L226S, K227R, T228A, L229S, L230K, R231S, C232R, R233I, N234P, E235P, K236S, K237R, R238E, H239K, R240K	Lysozyme (P00720)	N/A
3VGA	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Crystal structure of human adenosine A2A receptor with an allosteric inverse-agonist antibody at 3.1 A resolution	X-Ray Diffraction	3.1	2012-02-01	Hino et al. G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody. Nature. 2012, 482, 237.	22286059	ZMA	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N	N154Q	N/A	Antibody Fab Fragment Light Chain, Antibody Fab Fragment Heavy Chain
5CXV	Muscarinic acetylcholine receptor M1	Class A	Acetylcholine (muscarinic) receptors	P11229	Homo sapiens (Human)	Structure of the human M1 muscarinic acetylcholine receptor bound to antagonist Tiotropium	X-Ray Diffraction	2.7	2016-03-09	Thal et al. Crystal structures of the M1 and M4 muscarinic acetylcholine receptors. Nature. 2016, 531, 335.	26958838	0HK	(1R,2R,4S,5S,7S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane	InChI=1S/C19H22NO4S2/c1-20(2)12-9-11(10-13(20)17-16(12)24-17)23-18(21)19(22,14-5-3-7-25-14)15-6-4-8-26-15/h3-8,11-13,16-17,22H,9-10H2,1-2H3/q+1/t11-,12-,13+,16-,17+	LERNTVKEWCAPOY-DZZGSBJMSA-N	N2Q, N12Q, N110Q	Lysozyme (P00720)	N/A
6H7J	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST ISOPRENALINE AND NANOBODY Nb80	X-Ray Diffraction	2.8	2018-10-17	Warne et al. Molecular basis for high affinity agonist binding in GPCRs. Biorxiv. 2018.	N/A	5FW	ISOPRENALINE	InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8/h3-5,7,11-15H,6H2,1-2H3/t11-/m0/s1	JWZZKOKVBUJMES-NSHDSACASA-N	R68S, M90V, C116L, F327A, F338M, C358A	N/A	Camelid Antibody Fragment Nb80, Thioredoxin 1 (P0AA25)
5UIG	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Crystal structure of adenosine A2A receptor bound to a novel triazole-carboximidamide antagonist	X-Ray Diffraction	3.5	2017-02-08	Sun et al. Crystal structure of the adenosine A2A receptor bound to an antagonist reveals a potential allosteric pocket. Proc. Natl. Acad. Sci. U.S.A. 2017, 114, 2066.	28167788	8D1	5-amino-N-[(2-methoxyphenyl)methyl]-2-(3-methylphenyl)-2H-1,2,3-triazole-4-carboximidamide	InChI=1S/C18H20N6O/c1-12-6-5-8-14(10-12)24-22-16(18(20)23-24)17(19)21-11-13-7-3-4-9-15(13)25-2/h3-10H,11H2,1-2H3,(H2,19,21)(H2,20,23)	UJHUYWLZLDBDSR-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
3UZA	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Thermostabilised Adenosine A2A receptor in complex with 6-(2,6-Dimethylpyridin-4-yl)-5-phenyl-1,2,4-triazin-3-amine	X-Ray Diffraction	3.27	2012-03-21	Congreve et al. Discovery of 1,2,4-Triazine Derivatives as Adenosine A(2A) Antagonists using Structure Based Drug Design. J.Med.Chem. 2012, 55, 1898.	22220592	T4G	6-(2,6-dimethylpyridin-4-yl)-5-phenyl-1,2,4-triazin-3-amine	InChI=1S/C16H15N5/c1-10-8-13(9-11(2)18-10)15-14(19-16(17)21-20-15)12-6-4-3-5-7-12/h3-9H,1-2H3,(H2,17,19,21)	SORFNYWLKDSNNF-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, L202A, L235A, V239A, S277A	N/A	N/A
3PQR	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of Metarhodopsin II in complex with a C-terminal peptide derived from the Galpha subunit of transducin	X-Ray Diffraction	2.85	2011-03-09	Choe et al. Crystal structure of metarhodopsin II. Nature. 2011, 471, 651.	21389988	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
5DSG	Muscarinic acetylcholine receptor M4	Class A	Acetylcholine (muscarinic) receptors	P08173	Homo sapiens (Human)	Structure of the M4 muscarinic acetylcholine receptor (M4-mT4L) bound to tiotropium	X-Ray Diffraction	2.6	2016-03-16	Thal et al. Crystal structures of the M1 and M4 muscarinic acetylcholine receptors. Nature. 2016, 531, 335.	26958838	0HK	(1R,2R,4S,5S,7S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane	InChI=1S/C19H22NO4S2/c1-20(2)12-9-11(10-13(20)17-16(12)24-17)23-18(21)19(22,14-5-3-7-25-14)15-6-4-8-26-15/h3-8,11-13,16-17,22H,9-10H2,1-2H3/q+1/t11-,12-,13+,16-,17+	LERNTVKEWCAPOY-DZZGSBJMSA-N	N/A	Lysozyme (P00720)	N/A
1U19	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal Structure of Bovine Rhodopsin at 2.2 Angstroms Resolution	X-Ray Diffraction	2.2	2004-10-12	Okada et al. The retinal conformation and its environment in rhodopsin in light of a new 22 A crystal structure. J.Mol.Biol. 2004, 342, 571.	15327956	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
5ZKQ	Platelet-activating factor receptor	Class A	Platelet-activating factor receptors	P25105	Homo sapiens (Human)	Crystal structure of the human platelet-activating factor receptor in complex with ABT-491	X-Ray Diffraction	2.9	2018-06-20	Cao et al. Structural basis for signal recognition and transduction by platelet-activating-factor receptor. Nat. Struct. Mol. Biol. 2018, 25, 488.	29808000	9EU	4-ethynyl-3-{3-fluoro-4-[(2-methyl-1H-imidazo[4,5-c]pyridin-1-yl)methyl]benzene-1-carbonyl}-N,N-dimethyl-1H-indole-1-carboxamide	InChI=1S/C28H22FN5O2/c1-5-18-7-6-8-25-26(18)21(16-34(25)28(36)32(3)4)27(35)19-9-10-20(22(29)13-19)15-33-17(2)31-23-14-30-12-11-24(23)33/h1,6-14,16H,15H2,2-4H3	GDLNHSUSOZEAOR-UHFFFAOYSA-N	F116Y, N169D, A230D, V234A, D289N	Lysozyme (P00720)	N/A
4MQT	Muscarinic acetylcholine receptor M2	Class A	Acetylcholine (muscarinic) receptors	P08172	Homo sapiens (Human)	Structure of active human M2 muscarinic acetylcholine receptor bound to the agonist iperoxo and allosteric modulator LY2119620	X-Ray Diffraction	3.7	2013-11-27	Kruse et al. Activation and allosteric modulation of a muscarinic acetylcholine receptor. Nature. 2013, 504, 101.	24256733	2CU$$$$IXO	3-amino-5-chloro-N-cyclopropyl-4-methyl-6-[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]thieno[2,3-b]pyridine-2-carboxamide$$$$4-(4,5-dihydro-1,2-oxazol-3-yloxy)-N,N,N-trimethylbut-2-yn-1-aminium	InChI=1S/C19H24ClN5O3S/c1-10-13-15(21)16(17(27)22-11-3-4-11)29-19(13)23-18(14(10)20)28-9-12(26)25-7-5-24(2)6-8-25/h11H,3-9,21H2,1-2H3,(H,22,27)$$$$InChI=1S/C10H17N2O2/c1-12(2,3)7-4-5-8-13-10-6-9-14-11-10/h6-9H2,1-3H3/q+1	TYTGOXSAAQWLPJ-UHFFFAOYSA-N$$$$WXXOCGISBCTWPW-UHFFFAOYSA-N	N0D, N1D, N4D, N7D, A373T, K374R	N/A	Nanobody 9-8
5VBL	Apelin receptor	Class A	Apelin receptors	P35414	Homo sapiens (Human)	Structure of apelin receptor in complex with agonist peptide	X-Ray Diffraction	2.6	2017-05-31	Ma et al. Structural Basis for Apelin Control of the Human Apelin Receptor. Structure. 2017, 25, 858.	28528775	N/A	N/A	N/A	N/A	V117A, T177N, W261K, C325L, C326M	Rubredoxin (P00268)	N/A
5ZK8	Muscarinic acetylcholine receptor M2	Class A	Acetylcholine (muscarinic) receptors	P08172	Homo sapiens (Human)	Crystal structure of M2 muscarinic acetylcholine receptor bound with NMS	X-Ray Diffraction	3.0	2018-11-21	Suno et al. Structural insights into the subtype-selective antagonist binding to the M2muscarinic receptor. Nat. Chem. Biol. 2018, 14, 1150.	30420692	3C0	N-methyl scopolamine	InChI=1S/C18H24NO4/c1-19(2)14-8-12(9-15(19)17-16(14)23-17)22-18(21)13(10-20)11-6-4-3-5-7-11/h3-7,12-17,20H,8-10H2,1-2H3/q+1/t12-,13-,14-,15+,16-,17+/m1/s1	LZCOQTDXKCNBEE-IKIFYQGPSA-N	N/A	N/A	N/A
5TZR	Free fatty acid receptor 1	Class A	Free fatty acid receptors	O14842	Homo sapiens (Human)	GPR40 in complex with partial agonist MK-8666	X-Ray Diffraction	2.2	2017-06-07	Lu et al. Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40. Nat. Struct. Mol. Biol. 2017, 24, 570.	28581512	MK6	(5aR,6S,6aS)-3-({2',6'-dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl}methoxy)-5,5a,6,6a-tetrahydrocyclopropa[4,5]cyclopenta[1,2-c]pyridine-6-carboxylic acid	InChI=1S/C29H31NO6S/c1-17-10-22(35-8-5-9-37(3,33)34)11-18(2)26(17)20-7-4-6-19(12-20)16-36-25-14-21-13-23-27(24(21)15-30-25)28(23)29(31)32/h4,6-7,10-12,14-15,23,27-28H,5,8-9,13,16H2,1-3H3,(H,31,32)/t23-,27-,28+/m1/s1	CODQKEMYZZKQAE-QPVYNBJUSA-N	L42A, F88A, G103A, Y202F	Lysozyme (P00720)	N/A
5OLV	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Structure of the A2A-StaR2-bRIL562-LUAA47070 complex at 2.0A obtained from in meso soaking experiments.	X-Ray Diffraction	2.0	2018-01-17	Rucktooa et al. Towards high throughput GPCR crystallography: In Meso soaking of Adenosine A2A Receptor crystals. Sci Rep. 2018, 8, 41.	29311713	9Y2	4-(3,3-dimethylbutanoylamino)-3,5-bis(fluoranyl)-~{N}-(1,3-thiazol-2-yl)benzamide	InChI=1S/C16H17F2N3O2S/c1-16(2,3)8-12(22)20-13-10(17)6-9(7-11(13)18)14(23)21-15-19-4-5-24-15/h4-7H,8H2,1-3H3,(H,20,22)(H,19,21,23)	KEUJAGGJGBWRFC-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, N154A, L202A, L235A, V239A, S277A	Soluble cytochrome b562 (P0ABE7)	N/A
3OAX	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of bovine rhodopsin with beta-ionone	X-Ray Diffraction	2.6	2011-01-19	Makino et al. Binding of more than one retinoid to visual opsins. Biophys.J. 2010, 99, 2366.	20923672	ID3$$$$RET	(3E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-one$$$$RETINAL	InChI=1S/C13H20O/c1-10-6-5-9-13(3,4)12(10)8-7-11(2)14/h7-8H,5-6,9H2,1-4H3/b8-7+$$$$InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	PSQYTAPXSHCGMF-BQYQJAHWSA-N$$$$NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
4ZWJ	Rhodopsin	Class A	Opsins	P08100	Homo sapiens (Human)	Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser	X-Ray Diffraction	3.3	2015-07-29	Kang et al. Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser. Nature. 2015, 523, 561.	26200343	N/A	N/A	N/A	N/A	N2C, E113Q, M257Y, N282C	Lysozyme (P00720), S-arrestin (P20443)	N/A
4XES	Neurotensin receptor type 1	Class A	Neurotensin receptors	P20789	Rattus norvegicus (Rat)	Structure of active-like neurotensin receptor	X-Ray Diffraction	2.6	2015-07-29	Krumm et al. Structural prerequisites for G-protein activation by the neurotensin receptor. Nat Commun. 2015, 6, 7895.	26205105	N/A	N/A	N/A	N/A	A86L, E166A, G215A, V360A	Lysozyme (P00720)	N/A
6AKX	C-C chemokine receptor type 5	Class A	Chemokines and chemotactic factors receptors	P51681	Homo sapiens (Human)	The Crystal structure of Human Chemokine Receptor CCR5 in complex with compound 21	X-Ray Diffraction	2.8	2018-10-24	Peng et al. Structure-Based Design of 1-Heteroaryl-1,3-propanediamine Derivatives as a Novel Series of CC-Chemokine Receptor 5 Antagonists. J. Med. Chem. 2018, 61, 9621.	30234300	A4R	N-[(1S)-3-{(3-exo)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl}-1-(thiophen-2-yl)propyl]cyclopentanecarboxamide	InChI=1S/C26H39N5OS/c1-17(2)25-29-28-18(3)31(25)22-15-20-10-11-21(16-22)30(20)13-12-23(24-9-6-14-33-24)27-26(32)19-7-4-5-8-19/h6,9,14,17,19-23H,4-5,7-8,10-13,15-16H2,1-3H3,(H,27,32)/t20-,21+,22-,23-/m0/s1	FKHCEPANSGYZPM-BJESRGMDSA-N	C58Y, G163N, A233D, K303E	Rubredoxin (P00268)	N/A
4UHR	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Thermostabilised HUMAN A2a Receptor with CGS21680 bound	X-Ray Diffraction	2.6	2015-04-08	Lebon et al. Molecular Determinants of Cgs21680 Binding to the Human Adenosine A2A Receptor. Mol.Pharmacol. 2015, 87, 907.	25762024	NGI	2-[P-(2-CARBOXYETHYL)PHENYLETHYL-AMINO]-5'-N-ETHYLCARBOXAMIDO ADENOSINE	InChI=1S/C23H29N7O6/c1-2-25-21(35)18-16(33)17(34)22(36-18)30-11-27-15-19(24)28-23(29-20(15)30)26-10-9-13-5-3-12(4-6-13)7-8-14(31)32/h3-6,11,16-18,22,33-34H,2,7-10H2,1H3,(H,25,35)(H,31,32)(H3,24,26,28,29)/t16-,17+,18-,22+/m0/s1	PAOANWZGLPPROA-RQXXJAGISA-N	L48A, A54L, T65A, Q89A, N154A	N/A	N/A
6DRZ	5-hydroxytryptamine receptor 2B	Class A	Serotonin receptors	P41595	Homo sapiens (Human)	Structural Determinants of Activation and Biased Agonism at the 5-HT2B Receptor	X-Ray Diffraction	3.1	2018-08-29	McCorvy et al. Structural determinants of 5-HT2Breceptor activation and biased agonism. Nat. Struct. Mol. Biol. 2018.	30127358	H8J	(8alpha)-N-[(2S)-1-hydroxybutan-2-yl]-1,6-dimethyl-9,10-didehydroergoline-8-carboxamide	InChI=1S/C21H27N3O2/c1-4-15(12-25)22-21(26)14-8-17-16-6-5-7-18-20(16)13(10-23(18)2)9-19(17)24(3)11-14/h5-8,10,14-15,19,25H,4,9,11-12H2,1-3H3,(H,22,26)/t14-,15+,19-/m1/s1	KPJZHOPZRAFDTN-ZRGWGRIASA-N	M144W, A225G	Soluble cytochrome b562 (P0ABE7)	N/A
6MXT	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	Crystal structure of human beta2 adrenergic receptor bound to salmeterol and Nb71	X-Ray Diffraction	2.96	2018-11-14	Masureel et al. Structural insights into binding specificity, efficacy and bias of a beta2AR partial agonist. Nat. Chem. Biol. 2018, 14, 1059.	30327561	K5Y	salmeterol	InChI=1S/C25H37NO4/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2/t25-/m0/s1	GIIZNNXWQWCKIB-VWLOTQADSA-N	M1096T, M1098T, N1187E	Lysozyme (D9IEF7)	Nanobody Nb71
5DGY	Rhodopsin	Class A	Opsins	P08100	Homo sapiens (Human)	Crystal structure of rhodopsin bound to visual arrestin	X-Ray Diffraction	7.7	2016-03-23	Zhou et al. X-ray laser diffraction for structure determination of the rhodopsin-arrestin complex. Sci Data. 2016, 3, 160021.	27070998	N/A	N/A	N/A	N/A	N2C, E113Q, M257Y, N282C	Lysozyme (P00720), S-arrestin (P20443)	N/A
5WIU	D(4) dopamine receptor	Class A	Dopamine receptors	P21917	Homo sapiens (Human)	Structure of the human D4 Dopamine receptor in complex with Nemonapride	X-Ray Diffraction	1.96	2017-10-18	Wang et al. D4 dopamine receptor high-resolution structures enable the discovery of selective agonists. Science. 2017, 358, 381.	29051383	AQD	Nemonapride	InChI=1S/C21H26ClN3O2/c1-14-18(9-10-25(14)13-15-7-5-4-6-8-15)24-21(26)16-11-17(22)19(23-2)12-20(16)27-3/h4-8,11-12,14,18,23H,9-10,13H2,1-3H3,(H,24,26)/t14-,18-/m1/s1	KRVOJOCLBAAKSJ-RDTXWAMCSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
6CMO	Rhodopsin	Class A	Opsins	P08100	Homo sapiens (Human)	Rhodopsin-Gi complex	Electron Microscopy	4.5	2018-06-20	Kang et al. Cryo-EM structure of human rhodopsin bound to an inhibitory G protein. Nature. 2018, 558, 553.	29899450	N/A	N/A	N/A	N/A	N/A	Soluble cytochrome b562 (P0ABE7)	Guanine nucleotide-binding protein G(i) subunit alpha-1 (P63096), Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (P54311), Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 (P63212), Fab Heavy Chain, Fab Light Chain
4N4W	Smoothened homolog	Class F	N/A	Q99835	Homo sapiens (Human)	Structure of the human smoothened receptor in complex with SANT-1.	X-Ray Diffraction	2.8	2014-01-22	Wang et al. Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs. Nat Commun. 2014, 5, 4355.	25008467	SNT	(E)-N-(4-benzylpiperazin-1-yl)-1-(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)methanimine	InChI=1S/C23H27N5/c1-19-23(20(2)28(25-19)22-11-7-4-8-12-22)17-24-27-15-13-26(14-16-27)18-21-9-5-3-6-10-21/h3-12,17H,13-16,18H2,1-2H3/b24-17+	FOORCIAZMIWALX-JJIBRWJFSA-N	N/A	Cytochrome b(562) {ECO:0000313|EMBL:ABF06237.1} (Q0SXH8)	N/A
4GRV	Neurotensin receptor type 1	Class A	Neurotensin receptors	P20789	Rattus norvegicus (Rat)	The crystal structure of the neurotensin receptor NTS1 in complex with neurotensin (8-13)	X-Ray Diffraction	2.8	2012-10-17	White et al. Structure of the agonist-bound neurotensin receptor. Nature. 2012, 490, 508.	23051748	N/A	N/A	N/A	N/A	A86L, E166A, G215A, L310A, F358A, V360A	Lysozyme (P00720)	N/A
5DHH	Nociceptin receptor	Class A	Opioid peptides receptors	P41146	Homo sapiens (Human)	The crystal structure of nociceptin/orphanin FQ peptide receptor (NOP) in complex with SB-612111 (PSI Community Target)	X-Ray Diffraction	3.0	2015-10-21	Miller et al. The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor. Structure. 2015, 23, 2291.	26526853	DGW	(5S,7S)-7-{[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl}-1-methyl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-ol	InChI=1S/C24H29Cl2NO/c1-16-4-2-5-20-19(16)9-8-17(14-23(20)28)15-27-12-10-18(11-13-27)24-21(25)6-3-7-22(24)26/h2-7,17-18,23,28H,8-15H2,1H3/t17-,23-/m0/s1	OHRDCQFCAWLDBP-SBUREZEXSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
5GLH	Endothelin receptor type B	Class A	Endothelin receptors	P24530	Homo sapiens (Human)	Human endothelin receptor type-B in complex with ET-1	X-Ray Diffraction	2.8	2016-09-07	Shihoya et al. Activation mechanism of endothelin ETB receptor by endothelin-1. Nature. 2016, 537, 363.	27595334	N/A	N/A	N/A	N/A	N/A	Lysozyme (P00720)	N/A
2I37	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of a photoactivated rhodopsin	X-Ray Diffraction	4.15	2006-10-17	Salom et al. Crystal structure of a photoactivated deprotonated intermediate of rhodopsin. Proc.Natl.Acad.Sci.Usa. 2006, 103, 16123.	17060607	N/A	N/A	N/A	N/A	N/A	N/A	N/A
3DQB	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of the active G-protein-coupled receptor opsin in complex with a C-terminal peptide derived from the Galpha subunit of transducin	X-Ray Diffraction	3.2	2008-09-23	Scheerer et al. Crystal structure of opsin in its G-protein-interacting conformation. Nature. 2008, 455, 497.	18818650	N/A	N/A	N/A	N/A	N/A	N/A	N/A
6B3J	Glucagon-like peptide 1 receptor	Class B	N/A	P43220	Homo sapiens (Human)	3.3 angstrom phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex	Electron Microscopy	3.3	2018-02-21	Liang et al. Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex. Nature. 2018, 555, 121.	29466332	N/A	N/A	N/A	N/A	N/A	N/A	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (P63092), Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (P62873), Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 (P59768), Nanobody 35
6IIV	Thromboxane A2 receptor	Class A	Prostanoids receptors	P21731	Homo sapiens (Human)	Crystal structure of the human thromboxane A2 receptor bound to daltroban	X-Ray Diffraction	3.0	2018-12-19	Fan et al. Structural basis for ligand recognition of the human thromboxane A2receptor. Nat. Chem. Biol. 2019, 15, 27.	30510189	A90	2-[4-[2-[(4-chlorophenyl)sulfonylamino]ethyl]phenyl]ethanoic acid	InChI=1S/C16H16ClNO4S/c17-14-5-7-15(8-6-14)23(21,22)18-10-9-12-1-3-13(4-2-12)11-16(19)20/h1-8,18H,9-11H2,(H,19,20)	IULOBWFWYDMECP-UHFFFAOYSA-N	L247A	Soluble cytochrome b562 (P0ABE7), Rubredoxin (P00268)	N/A
4BUO	Neurotensin receptor type 1	Class A	Neurotensin receptors	P20789	Rattus norvegicus (Rat)	High Resolution Structure of Thermostable Agonist-bound Neurotensin Receptor 1 Mutant without Lysozyme Fusion	X-Ray Diffraction	2.75	2014-01-29	Egloff et al. Structure of Signaling-Competent Neurotensin Receptor 1 Obtained by Directed Evolution in Escherichia Coli. Proc.Natl.Acad.Sci.USA. 2014, 111, E655.	24453215	N/A	N/A	N/A	N/A	A86L, H103D, H105Y, A161V, R167L, R213L, V234L, I253A, H305R, F358V, S362A	N/A	N/A
5XEZ	Glucagon receptor	Class B	N/A	P47871	Homo sapiens (Human)	Structure of the Full-length glucagon class B G protein-coupled receptor	X-Ray Diffraction	3.0	2017-05-24	Zhang et al. Structure of the full-length glucagon class B G-protein-coupled receptor. Nature. 2017, 546, 259.	28514451	97V	4-{[(4-cyclohexylphenyl){[3-(methylsulfonyl)phenyl]carbamoyl}amino]methyl}-N-(1H-tetrazol-5-yl)benzamide	InChI=1S/C29H31N7O4S/c1-41(39,40)26-9-5-8-24(18-26)30-29(38)36(25-16-14-22(15-17-25)21-6-3-2-4-7-21)19-20-10-12-23(13-11-20)27(37)31-28-32-34-35-33-28/h5,8-18,21H,2-4,6-7,19H2,1H3,(H,30,38)(H2,31,32,33,34,35,37)	PPTKULJUDJWTSA-UHFFFAOYSA-N	N/A	Lysozyme (P00720)	Antibody, Mab1, Heavy Chain, Antibody, Mab1, Light Chain
1GZM	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Structure of Bovine Rhodopsin in a Trigonal Crystal Form	X-Ray Diffraction	2.65	2003-11-20	Li et al. Structure of Bovine Rhodopsin in a Trigonal Crystal Form. J.Mol.Biol. 2004, 343, 1409.	15491621	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
5WF5	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Agonist bound human A2a adenosine receptor with D52N mutation at 2.60 A resolution	X-Ray Diffraction	2.6	2018-02-21	White et al. Structural Connection between Activation Microswitch and Allosteric Sodium Site in GPCR Signaling. Structure. 2018, 26, 259.	29395784	UKA	6-(2,2-diphenylethylamino)-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]-N-[2-[(1-pyridin-2-ylpiperidin-4-yl)carbamoylamino]ethyl]purine-2-carboxamide	InChI=1S/C40H47N11O6/c1-2-41-37(54)33-31(52)32(53)39(57-33)51-24-46-30-34(45-23-28(25-11-5-3-6-12-25)26-13-7-4-8-14-26)48-35(49-36(30)51)38(55)43-19-20-44-40(56)47-27-16-21-50(22-17-27)29-15-9-10-18-42-29/h3-15,18,24,27-28,31-33,39,52-53H,2,16-17,19-23H2,1H3,(H,41,54)(H,43,55)(H2,44,47,56)(H,45,48,49)/t31-,32+,33-,39+/m0/s1	ZOTHAEBAWXWVID-HXEFRTELSA-N	D52N	Lysozyme (P00720)	N/A
2G87	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystallographic model of bathorhodopsin	X-Ray Diffraction	2.6	2006-09-02	Nakamichi et al. Crystallographic analysis of primary visual photochemistry. Angew.Chem.Int.Ed.Engl. 2006, 45, 4270.	16586416	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
6MET	C-C chemokine receptor type 5	Class A	Chemokines and chemotactic factors receptors	P51681	Homo sapiens (Human)	Structural basis of coreceptor recognition by HIV-1 envelope spike	Electron Microscopy	4.5	2018-12-12	Shaik et al. Structural basis of coreceptor recognition by HIV-1 envelope spike. Nature. 2018.	30542158	N/A	N/A	N/A	N/A	N/A	N/A	T-cell surface glycoprotein CD4 (P01730), Envelope glycoprotein gp160 {ECO:0000256|SAAS:SAAS01060177} (Q70145)
4S0V	Orexin receptor type 2	Class A	Orexins receptors	O43614	Homo sapiens (Human)	Crystal structure of the human OX2 orexin receptor bound to the insomnia drug Suvorexant	X-Ray Diffraction	2.5	2015-01-14	Yin et al. Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant. Nature. 2015, 519, 247.	25533960	SUV	[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone	InChI=1S/C23H23ClN6O2/c1-15-3-5-20(30-25-8-9-26-30)18(13-15)22(31)29-12-11-28(10-7-16(29)2)23-27-19-14-17(24)4-6-21(19)32-23/h3-6,8-9,13-14,16H,7,10-12H2,1-2H3/t16-/m1/s1	JYTNQNCOQXFQPK-MRXNPFEDSA-N	N/A	GlgA glycogen synthase (Q9V2J8)	N/A
3ODU	C-X-C chemokine receptor type 4	Class A	Chemokines and chemotactic factors receptors	P61073	Homo sapiens (Human)	The 2.5 A structure of the CXCR4 chemokine receptor in complex with small molecule antagonist IT1t	X-Ray Diffraction	2.5	2010-10-27	Wu et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science. 2010, 330, 1066.	20929726	ITD	(6,6-dimethyl-5,6-dihydroimidazo[2,1-b][1,3]thiazol-3-yl)methyl N,N'-dicyclohexylimidothiocarbamate	InChI=1S/C21H34N4S2/c1-21(2)15-25-18(14-27-20(25)24-21)13-26-19(22-16-9-5-3-6-10-16)23-17-11-7-4-8-12-17/h14,16-17H,3-13,15H2,1-2H3,(H,22,23)	OOSUDWRRWZVFEB-UHFFFAOYSA-N	N/A	Lysozyme (P00720)	N/A
6GDG	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Cryo-EM structure of the adenosine A2A receptor bound to a miniGs heterotrimer	Electron Microscopy	4.11	2018-05-16	Garcia-Nafria et al. Cryo-EM structure of the adenosine A2Areceptor coupled to an engineered heterotrimeric G protein. Elife. 2018, 7, .	29726815	NEC	N-ETHYL-5'-CARBOXAMIDO ADENOSINE	InChI=1S/C12H16N6O4/c1-2-14-11(21)8-6(19)7(20)12(22-8)18-4-17-5-9(13)15-3-16-10(5)18/h3-4,6-8,12,19-20H,2H2,1H3,(H,14,21)(H2,13,15,16)/t6-,7+,8-,12+/m0/s1	JADDQZYHOWSFJD-FLNNQWSLSA-N	N/A	TrxA {ECO:0000313|EMBL:AAY89720.1} (Q14F07)	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (P62873), Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 (P59768), Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (P63092), Nanobody Nb35
4QIN	Smoothened homolog	Class F	N/A	Q99835	Homo sapiens (Human)	Structure of the human smoothened receptor in complex with SAG1.5	X-Ray Diffraction	2.6	2014-07-23	Wang et al. Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs. Nat Commun. 2014, 5, 4355.	25008467	SG8	3-chloro-4,7-difluoro-N-[trans-4-(methylamino)cyclohexyl]-N-[3-(pyridin-4-yl)benzyl]-1-benzothiophene-2-carboxamide	InChI=1S/C28H26ClF2N3OS/c1-32-20-5-7-21(8-6-20)34(16-17-3-2-4-19(15-17)18-11-13-33-14-12-18)28(35)27-25(29)24-22(30)9-10-23(31)26(24)36-27/h2-4,9-15,20-21,32H,5-8,16H2,1H3/t20-,21-	RXZDWPYJFCAZCW-MEMLXQNLSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
4RWD	Delta-type opioid receptor	Class A	Opioid peptides receptors	P41143	Homo sapiens (Human)	XFEL structure of the human delta opioid receptor in complex with a bifunctional peptide	X-Ray Diffraction	2.7	2015-01-14	Fenalti et al. Structural basis for bifunctional peptide recognition at human delta-opioid receptor. Nat.Struct.Mol.Biol. 2015, 22, 265.	25686086	N/A	N/A	N/A	N/A	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
6E3Y	Calcitonin gene-related peptide type 1 receptor	Class B	N/A	Q16602	Homo sapiens (Human)	Cryo-EM structure of the active, Gs-protein complexed, human CGRP receptor	Electron Microscopy	3.3	2018-09-19	Liang et al. Cryo-EM structure of the active, Gs-protein complexed, human CGRP receptor. Nature. 2018, 561, 492.	30209400	N/A	N/A	N/A	N/A	N/A	N/A	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (P63092), Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (P62873), Receptor activity-modifying protein 1 (O60894), Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 (P59768), Nanobody 35
1L9H	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of bovine rhodopsin at 2.6 angstroms RESOLUTION	X-Ray Diffraction	2.6	2002-05-15	Okada et al. Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. Proc.Natl.Acad.Sci.USA. 2002, 99, 5982.	11972040	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
5TZY	Free fatty acid receptor 1	Class A	Free fatty acid receptors	O14842	Homo sapiens (Human)	GPR40 in complex with AgoPAM AP8 and partial agonist MK-8666	X-Ray Diffraction	3.22	2017-06-07	Lu et al. Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40. Nat. Struct. Mol. Biol. 2017, 24, 570.	28581512	7OS$$$$MK6	(2S,3R)-3-cyclopropyl-3-[(2R)-2-(1-{(1S)-1-[5-fluoro-2-(trifluoromethoxy)phenyl]ethyl}piperidin-4-yl)-3,4-dihydro-2H-1-benzopyran-7-yl]-2-methylpropanoic acid$$$$(5aR,6S,6aS)-3-({2',6'-dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl}methoxy)-5,5a,6,6a-tetrahydrocyclopropa[4,5]cyclopenta[1,2-c]pyridine-6-carboxylic acid	InChI=1S/C30H35F4NO4/c1-17(29(36)37)28(21-4-5-21)22-6-3-19-7-9-25(38-27(19)15-22)20-11-13-35(14-12-20)18(2)24-16-23(31)8-10-26(24)39-30(32,33)34/h3,6,8,10,15-18,20-21,25,28H,4-5,7,9,11-14H2,1-2H3,(H,36,37)/t17-,18-,25+,28-/m0/s1$$$$InChI=1S/C29H31NO6S/c1-17-10-22(35-8-5-9-37(3,33)34)11-18(2)26(17)20-7-4-6-19(12-20)16-36-25-14-21-13-23-27(24(21)15-30-25)28(23)29(31)32/h4,6-7,10-12,14-15,23,27-28H,5,8-9,13,16H2,1-3H3,(H,31,32)/t23-,27-,28+/m1/s1	ADYYYLTWZYYGNX-LJYIQKJHSA-N$$$$CODQKEMYZZKQAE-QPVYNBJUSA-N	L42A, G103A, Y202F	Lysozyme (P00720)	N/A
3PXO	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of Metarhodopsin II	X-Ray Diffraction	3.0	2011-03-09	Choe et al. Crystal structure of metarhodopsin II. Nature. 2011, 471, 651.	21389988	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
2I36	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of trigonal crystal form of ground-state rhodopsin	X-Ray Diffraction	4.1	2006-10-17	Salom et al. Crystal structure of a photoactivated deprotonated intermediate of rhodopsin. Proc.Natl.Acad.Sci.Usa. 2006, 103, 16123.	17060607	N/A	N/A	N/A	N/A	N/A	N/A	N/A
3AYM	Rhodopsin	Class A	Opsins	P31356	Todarodes pacificus (Japanese flying squid)	Crystal structure of the batho intermediate of squid rhodopsin	X-Ray Diffraction	2.8	2011-08-17	Murakami et al. Crystallographic Analysis of the Primary Photochemical Reaction of Squid Rhodopsin. J.Mol.Biol. 2011, 413, 615.	21906602	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
5F8U	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	Ligand occupancy in crystal structure of beta1-adrenergic receptor previously submitted by Huang et al	X-Ray Diffraction	3.35	2015-12-23	Leslie et al. Ligand occupancy in crystal structure of Beta1 adrenergic G protein coupled receptor. Nat.Struct.Mol.Biol. 2015, 22, 941.	26643842	P32	4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile	InChI=1S/C16H21N3O2/c1-16(2,3)18-9-12(20)10-21-15-6-4-5-14-13(15)7-11(8-17)19-14/h4-6,12,18,20H,7,9-10H2,1-3H3/t12-/m0/s1	CQEFAUFOQSCRMZ-LBPRGKRZSA-N	R68S, M90V, C116L, Y227A, A282L, F327A, F338M, C358A	N/A	N/A
2R4S	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	Crystal structure of the human beta2 adrenoceptor	X-Ray Diffraction	3.4	2007-11-06	Rasmussen et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature. 2007, 450, 383.	17952055	N/A	N/A	N/A	N/A	N/A	N/A	Antibody For Beta2 Adrenoceptor, Heavy Chain, Antibody For Beta2 Adrenoceptor, Light Chain
4U14	Muscarinic acetylcholine receptor M3	Class A	Acetylcholine (muscarinic) receptors	P08483	Rattus norvegicus (Rat)	Structure of the M3 muscarinic acetylcholine receptor bound to the antagonist tiotropium crystallized with disulfide-stabilized T4 lysozyme (dsT4L)	X-Ray Diffraction	3.57	2014-11-26	Thorsen et al. Modified T4 Lysozyme Fusion Proteins Facilitate G Protein-Coupled Receptor Crystallogenesis. Structure. 2014, 22, 1657.	25450769	0HK	(1R,2R,4S,5S,7S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane	InChI=1S/C19H22NO4S2/c1-20(2)12-9-11(10-13(20)17-16(12)24-17)23-18(21)19(22,14-5-3-7-25-14)15-6-4-8-26-15/h3-8,11-13,16-17,22H,9-10H2,1-2H3/q+1/t11-,12-,13+,16-,17+	LERNTVKEWCAPOY-DZZGSBJMSA-N	N/A	Lysozyme (P00720)	N/A
2ZIY	Rhodopsin	Class A	Opsins	P31356	Todarodes pacificus (Japanese flying squid)	Crystal structure of squid rhodopsin	X-Ray Diffraction	3.7	2008-05-06	Shimamura et al. Crystal structure of squid rhodopsin with intracellularly extended cytoplasmic region. J.Biol.Chem. 2008, 283, 17753.	18463093	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
4PXZ	P2Y purinoceptor 12	Class A	Adenosine and adenine nucleotide receptors	Q9H244	Homo sapiens (Human)	Crystal structure of P2Y12 receptor in complex with 2MeSADP	X-Ray Diffraction	2.5	2014-04-30	Zhang et al. Agonist-bound structure of the human P2Y12 receptor. Nature. 2014, 509, 119.	24784220	6AD	2-(methylsulfanyl)adenosine 5'-(trihydrogen diphosphate)	InChI=1S/C11H17N5O10P2S/c1-29-11-14-8(12)5-9(15-11)16(3-13-5)10-7(18)6(17)4(25-10)2-24-28(22,23)26-27(19,20)21/h3-4,6-7,10,17-18H,2H2,1H3,(H,22,23)(H2,12,14,15)(H2,19,20,21)/t4-,6-,7-,10-/m1/s1	WLMZTKAZJUWXCB-KQYNXXCUSA-N	D294N	Soluble cytochrome b562 (P0ABE7)	N/A
5V56	Smoothened homolog	Class F	N/A	Q99835	Homo sapiens (Human)	2.9A XFEL structure of the multi-domain human smoothened receptor (with E194M mutation) in complex with TC114	X-Ray Diffraction	2.9	2017-05-24	Zhang et al. Crystal structure of a multi-domain human smoothened receptor in complex with a super stabilizing ligand. Nat Commun. 2017, 8, 15383.	28513578	836	N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-4-nitro-2-(trifluoromethyl)benzamide	InChI=1S/C26H24F3N7O3/c1-33(25(37)20-8-7-17(36(38)39)15-21(20)26(27,28)29)16-10-13-35(14-11-16)24-19-6-4-3-5-18(19)23(31-32-24)22-9-12-30-34(22)2/h3-9,12,15-16H,10-11,13-14H2,1-2H3	ZDEZQXNVPSUJHK-UHFFFAOYSA-N	E194M	Flavodoxin (P00323)	N/A
4EA3	Nociceptin receptor	Class A	Opioid peptides receptors	P41146	Homo sapiens (Human)	Structure of the N/OFQ Opioid Receptor in Complex with a Peptide Mimetic	X-Ray Diffraction	3.01	2012-04-25	Thompson et al. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic. Nature. 2012, 485, 395.	22596163	0NN	1-benzyl-N-[3-(1'H,3H-spiro[2-benzofuran-1,4'-piperidin]-1'-yl)propyl]-D-prolinamide	InChI=1S/C27H35N3O2/c31-26(25-12-6-17-30(25)20-22-8-2-1-3-9-22)28-15-7-16-29-18-13-27(14-19-29)24-11-5-4-10-23(24)21-32-27/h1-5,8-11,25H,6-7,12-21H2,(H,28,31)/t25-/m1/s1	MAKMQGKJURAJEN-RUZDIDTESA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
5X93	Endothelin receptor type B	Class A	Endothelin receptors	P24530	Homo sapiens (Human)	Human endothelin receptor type-B in complex with antagonist K-8794	X-Ray Diffraction	2.2	2017-08-16	Shihoya et al. X-ray structures of endothelin ETB receptor bound to clinical antagonist bosentan and its analog. Nat. Struct. Mol. Biol. 2017, 24, 758.	28805809	K87	3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]oxy-N-(2,6-dimethylphenyl)propanamide	InChI=1S/C36H38N6O6S/c1-23-11-9-12-24(2)30(23)39-29(43)19-22-47-35-31(48-28-14-8-7-13-27(28)46-6)32(40-34(41-35)33-37-20-10-21-38-33)42-49(44,45)26-17-15-25(16-18-26)36(3,4)5/h7-18,20-21H,19,22H2,1-6H3,(H,39,43)(H,40,41,42)	MTNFANNLCUMCNB-UHFFFAOYSA-N	R124Y, D154A, K270A, S342A, I381A, C396A, C400A, C405A	Lysozyme (P00720)	N/A
2X72	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	CRYSTAL STRUCTURE OF THE CONSTITUTIVELY ACTIVE E113Q,D2C,D282C RHODOPSIN MUTANT WITH BOUND GALPHACT PEPTIDE.	X-Ray Diffraction	3.0	2011-03-16	Standfuss et al. The Structural Basis of Agonist Induced Activation in Constitutively Active Rhodopsin. Nature. 2011, 471, 656.	21389983	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N2C, E113Q, D282C	N/A	N/A
6C1R	C5a anaphylatoxin chemotactic receptor 1	Class A	Chemokines and chemotactic factors receptors	P21730	Homo sapiens (Human)	Crystal structure of human C5a receptor in complex with an orthosteric antagonist PMX53 and an allosteric antagonist avacopan	X-Ray Diffraction	2.2	2018-05-30	Liu et al. Orthosteric and allosteric action of the C5a receptor antagonists. Nat. Struct. Mol. Biol. 2018, 25, 472.	29867214	EFD	avacopan	InChI=1S/C33H35F4N3O2/c1-20-12-15-25(19-27(20)33(35,36)37)39-31(41)26-10-6-18-40(32(42)29-21(2)7-5-11-28(29)34)30(26)22-13-16-24(17-14-22)38-23-8-3-4-9-23/h5,7,11-17,19,23,26,30,38H,3-4,6,8-10,18H2,1-2H3,(H,39,41)/t26-,30-/m0/s1	PUKBOVABABRILL-YZNIXAGQSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
5D5A	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	In meso in situ serial X-ray crystallography structure of the Beta2-adrenergic receptor at 100 K	X-Ray Diffraction	2.48	2016-01-13	Huang et al. In meso in situ serial X-ray crystallography of soluble and membrane proteins at cryogenic temperatures. Acta Crystallogr D Struct Biol. 2016, 72, 93.	26894538	CAU	(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol	InChI=1S/C18H22N2O2/c1-12(2)19-10-13(21)11-22-17-9-5-8-16-18(17)14-6-3-4-7-15(14)20-16/h3-9,12-13,19-21H,10-11H2,1-2H3/t13-/m0/s1	BQXQGZPYHWWCEB-ZDUSSCGKSA-N	N187E	Lysozyme (P00720)	N/A
5IUB	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with compound 12x at 2.1A resolution	X-Ray Diffraction	2.1	2016-06-29	Segala et al. Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength. J.Med.Chem. 2016, 59, 6470.	27312113	6DV	N~5~-{2-[4-(2,4-difluorophenyl)piperazin-1-yl]ethyl}-2-(furan-2-yl)[1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine	InChI=1S/C20H21F2N9O/c21-13-3-4-15(14(22)12-13)30-9-7-29(8-10-30)6-5-24-19-26-18(23)31-20(27-19)25-17(28-31)16-2-1-11-32-16/h1-4,11-12H,5-10H2,(H3,23,24,25,26,27,28)	NJQVZARFMYPNOT-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, N154A, L202A, L235A, V239A, S277A	Soluble cytochrome b562 (P0ABE7)	N/A
6AKY	C-C chemokine receptor type 5	Class A	Chemokines and chemotactic factors receptors	P51681	Homo sapiens (Human)	The Crystal structure of Human Chemokine Receptor CCR5 in complex with compound 34	X-Ray Diffraction	2.8	2018-10-24	Peng et al. Structure-Based Design of 1-Heteroaryl-1,3-propanediamine Derivatives as a Novel Series of CC-Chemokine Receptor 5 Antagonists. J. Med. Chem. 2018, 61, 9621.	30234300	A4X	4,4-difluoro-N-[(1S)-3-{(3-exo)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl}-1-(thiophen-3-yl)propyl]cyclohexane-1-carboxamide	InChI=1S/C27H39F2N5OS/c1-17(2)25-32-31-18(3)34(25)23-14-21-4-5-22(15-23)33(21)12-8-24(20-9-13-36-16-20)30-26(35)19-6-10-27(28,29)11-7-19/h9,13,16-17,19,21-24H,4-8,10-12,14-15H2,1-3H3,(H,30,35)/t21-,22+,23-,24-/m0/s1	KESMRFWRGXZDEF-KIHHCIJBSA-N	C58Y, G163N, A233D, K303E	Rubredoxin (P00268)	N/A
4BV0	Neurotensin receptor type 1	Class A	Neurotensin receptors	P20789	Rattus norvegicus (Rat)	High Resolution Structure of Evolved Agonist-bound Neurotensin Receptor 1 Mutant without Lysozyme Fusion	X-Ray Diffraction	3.1	2014-01-29	Egloff et al. Structure of Signaling-Competent Neurotensin Receptor 1 Obtained by Directed Evolution in Escherichia Coli. Proc.Natl.Acad.Sci.USA. 2014, 111, E655.	24453215	N/A	N/A	N/A	N/A	S83G, A86L, T101R, H103D, H105Y, L119F, M121L, E124D, L125V, R143K, D150E, A161V, R167L, C172R, A177H, M208V, R213L, V234L, V240L, I253A, N262R, K263R, H305R, V313M, C332V, F342A, T354S, F358V, S362A	N/A	N/A
5ZHP	Muscarinic acetylcholine receptor M3	Class A	Acetylcholine (muscarinic) receptors	P08483	Rattus norvegicus (Rat)	M3 muscarinic acetylcholine receptor in complex with a selective antagonist	X-Ray Diffraction	3.1	2018-11-28	Liu et al. Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists. Proc. Natl. Acad. Sci. U.S.A. 2018, 115, 12046.	30404914	9EC	(1R,2R,4S,5S,7s)-7-({[4-fluoro-2-(thiophen-2-yl)phenyl]carbamoyl}oxy)-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]nonan-9-ium	InChI=1S/C20H21FN2O3S/c1-23(2)15-9-12(10-16(23)19-18(15)26-19)25-20(24)22-14-6-5-11(21)8-13(14)17-4-3-7-27-17/h3-8,12,15-16,18-19H,9-10H2,1-2H3/p+1/t12-,15-,16+,18-,19+	YBYUWXNCRPKGOH-ADYDWEGLSA-O	S154R	Lysozyme (D9IEF7)	N/A
5L7D	Smoothened homolog	Class F	N/A	Q99835	Homo sapiens (Human)	Structure of human Smoothened in complex with cholesterol	X-Ray Diffraction	3.2	2016-07-20	Byrne et al. Structural basis of Smoothened regulation by its extracellular domains. Nature. 2016, 535, 517.	27437577	N/A	N/A	N/A	N/A	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
5TVN	5-hydroxytryptamine receptor 2B	Class A	Serotonin receptors	P41595	Homo sapiens (Human)	Crystal structure of the LSD-bound 5-HT2B receptor	X-Ray Diffraction	2.9	2017-02-01	Wacker et al. Crystal Structure of an LSD-Bound Human Serotonin Receptor. Cell. 2017, 168, 377.	28129538	7LD	(8alpha)-N,N-diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide	InChI=1S/C20H25N3O/c1-4-23(5-2)20(24)14-9-16-15-7-6-8-17-19(15)13(11-21-17)10-18(16)22(3)12-14/h6-9,11,14,18,21H,4-5,10,12H2,1-3H3/t14-,18-/m1/s1	VAYOSLLFUXYJDT-RDTXWAMCSA-N	M144W	Soluble cytochrome b562 (P0ABE7)	N/A
6FKC	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of N2C/D282C stabilized opsin bound to RS15	X-Ray Diffraction	2.46	2018-04-04	Mattle et al. Ligand channel in pharmacologically stabilized rhodopsin. Proc. Natl. Acad. Sci. U.S.A. 2018, 115, 3640.	29555765	DLB	3-[1'-[(2~{S})-2-(4-chlorophenyl)-3-methyl-butanoyl]spiro[1,3-benzodioxole-2,4'-piperidine]-5-yl]propanoic acid	InChI=1S/C25H28ClNO5/c1-16(2)23(18-5-7-19(26)8-6-18)24(30)27-13-11-25(12-14-27)31-20-9-3-17(4-10-22(28)29)15-21(20)32-25/h3,5-9,15-16,23H,4,10-14H2,1-2H3,(H,28,29)/t23-/m0/s1	OHAKQPWAEANPAJ-QHCPKHFHSA-N	N/A	N/A	N/A
2KS9	Substance-P receptor	Class A	Tachykinin receptors	P25103	Homo sapiens (Human)	Solution conformation of substance P in water complexed with NK1R	Solution NMR	N/A	2010-11-03	Gayen et al. NMR evidence of GM1-induced conformational change of Substance P using isotropic bicelles. Biochim.Biophys.Acta. 2010.	20937248	N/A	N/A	N/A	N/A	N/A	N/A	N/A
4UG2	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Thermostabilised HUMAN A2a Receptor with CGS21680 bound	X-Ray Diffraction	2.6	2015-04-08	Lebon et al. Molecular Determinants of Cgs21680 Binding to the Human Adenosine A2A Receptor. Mol.Pharmacol. 2015, 87, 907.	25762024	NGI	2-[P-(2-CARBOXYETHYL)PHENYLETHYL-AMINO]-5'-N-ETHYLCARBOXAMIDO ADENOSINE	InChI=1S/C23H29N7O6/c1-2-25-21(35)18-16(33)17(34)22(36-18)30-11-27-15-19(24)28-23(29-20(15)30)26-10-9-13-5-3-12(4-6-13)7-8-14(31)32/h3-6,11,16-18,22,33-34H,2,7-10H2,1H3,(H,25,35)(H,31,32)(H3,24,26,28,29)/t16-,17+,18-,22+/m0/s1	PAOANWZGLPPROA-RQXXJAGISA-N	L48A, A54L, T65A, Q89A, N154A	N/A	N/A
5WB2	G-protein coupled receptor homolog US28	Class A	Viral receptors	P69333	Human cytomegalovirus (strain Towne) (HHV-5)	US28 bound to engineered chemokine CX3CL1.35 and nanobodies	X-Ray Diffraction	3.5	2018-06-13	Miles et al. Viral GPCR US28 can signal in response to chemokine agonists of nearly unlimited structural degeneracy. Elife. 2018, 7, .	29882741	N/A	N/A	N/A	N/A	N/A	N/A	Fractalkine (P78423), Nanobody B1
3PWH	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Thermostabilised Adenosine A2A Receptor	X-Ray Diffraction	3.3	2011-09-07	Dore et al. Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. Structure. 2011, 19, 1283.	21885291	ZMA	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, L202A, L235A, V239A, S277A	N/A	N/A
6FJ3	Parathyroid hormone-parathyroid hormone-related peptide receptor	Class B	N/A	Q03431	Homo sapiens (Human)	High resolution crystal structure of parathyroid hormone 1 receptor in complex with a peptide agonist.	X-Ray Diffraction	2.5	2018-11-21	Ehrenmann et al. High-resolution crystal structure of parathyroid hormone 1 receptor in complex with a peptide agonist. Nat. Struct. Mol. Biol. 2018, 25, 1086.	30455434	N/A	N/A	N/A	N/A	Y191C, K240M, L300A, M312K, V334I, K359N, L407A, A426L, Q440R, I458A	GlgA glycogen synthase (Q9V2J8)	N/A
3NYA	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	Crystal structure of the human beta2 adrenergic receptor in complex with the neutral antagonist alprenolol	X-Ray Diffraction	3.16	2010-08-11	Wacker et al. Conserved Binding Mode of Human beta(2) Adrenergic Receptor Inverse Agonists and Antagonist Revealed by X-ray Crystallography. J.Am.Chem.Soc. 2010, 132, 11443.	20669948	JTZ	(2S)-1-[(1-methylethyl)amino]-3-(2-prop-2-en-1-ylphenoxy)propan-2-ol	InChI=1S/C15H23NO2/c1-4-7-13-8-5-6-9-15(13)18-11-14(17)10-16-12(2)3/h4-6,8-9,12,14,16-17H,1,7,10-11H2,2-3H3/t14-/m0/s1	PAZJSJFMUHDSTF-AWEZNQCLSA-N	E122W, N187E	Lysozyme (P00720)	N/A
6IIU	Thromboxane A2 receptor	Class A	Prostanoids receptors	P21731	Homo sapiens (Human)	Crystal structure of the human thromboxane A2 receptor bound to ramatroban	X-Ray Diffraction	2.5	2018-12-19	Fan et al. Structural basis for ligand recognition of the human thromboxane A2receptor. Nat. Chem. Biol. 2019, 15, 27.	30510189	A8X	3-[(3R)-3-[(4-fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic acid	InChI=1S/C21H21FN2O4S/c22-14-5-8-16(9-6-14)29(27,28)23-15-7-10-20-18(13-15)17-3-1-2-4-19(17)24(20)12-11-21(25)26/h1-6,8-9,15,23H,7,10-13H2,(H,25,26)/t15-/m1/s1	LDXDSHIEDAPSSA-OAHLLOKOSA-N	L247A	Soluble cytochrome b562 (P0ABE7), Rubredoxin (P00268)	N/A
4ZJ8	Orexin receptor type 1	Class A	Orexins receptors	O43613	Homo sapiens (Human)	Structures of the human OX1 orexin receptor bound to selective and dual antagonists	X-Ray Diffraction	2.75	2016-03-09	Yin et al. Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors. Nat.Struct.Mol.Biol. 2016, 23, 293.	26950369	SUV	[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone	InChI=1S/C23H23ClN6O2/c1-15-3-5-20(30-25-8-9-26-30)18(13-15)22(31)29-12-11-28(10-7-16(29)2)23-27-19-14-17(24)4-6-21(19)32-23/h3-6,8-9,13-14,16H,7,10-12H2,1-2H3/t16-/m1/s1	JYTNQNCOQXFQPK-MRXNPFEDSA-N	V319I	GlgA glycogen synthase (Q9V2J8)	N/A
2RH1	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	High resolution crystal structure of human B2-adrenergic G protein-coupled receptor.	X-Ray Diffraction	2.4	2007-10-30	Cherezov et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science. 2007, 318, 1258.	17962520	CAU	(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol	InChI=1S/C18H22N2O2/c1-12(2)19-10-13(21)11-22-17-9-5-8-16-18(17)14-6-3-4-7-15(14)20-16/h3-9,12-13,19-21H,10-11H2,1-2H3/t13-/m0/s1	BQXQGZPYHWWCEB-ZDUSSCGKSA-N	N/A	Lysozyme (P00720)	N/A
5YWY	Prostaglandin E2 receptor EP4 subtype	Class A	Prostanoids receptors	P35408	Homo sapiens (Human)	Crystal structure of the human prostaglandin E receptor EP4 in complex with Fab and ONO-AE3-208	X-Ray Diffraction	3.2	2018-12-05	Toyoda et al. Ligand binding to human prostaglandin E receptor EP4at the lipid-bilayer interface. Nat. Chem. Biol. 2019, 15, 18.	30510193	7UR	4-[4-cyano-2-[[(2R)-2-(4-fluoranylnaphthalen-1-yl)propanoyl]amino]phenyl]butanoic acid	InChI=1S/C24H21FN2O3/c1-15(18-11-12-21(25)20-7-3-2-6-19(18)20)24(30)27-22-13-16(14-26)9-10-17(22)5-4-8-23(28)29/h2-3,6-7,9-13,15H,4-5,8H2,1H3,(H,27,30)(H,28,29)/t15-/m1/s1	MTDIMKNAJUQTIO-OAHLLOKOSA-N	N7Q, A62L, G106R, N177Q	N/A	Heavy Chain Of Fab Fragment, Light Chain Of Fab Fragment
5UEN	Adenosine receptor A1	Class A	Adenosine and adenine nucleotide receptors	P30542	Homo sapiens (Human)	Crystal structure of the human adenosine A1 receptor A1AR-bRIL in complex with the covalent antagonist DU172 at 3.2A resolution	X-Ray Diffraction	3.2	2017-03-01	Glukhova et al. Structure of the Adenosine A1 Receptor Reveals the Basis for Subtype Selectivity. Cell. 2017, 168, 867.	28235198	DU1	4-{[3-(8-cyclohexyl-2,6-dioxo-1-propyl-1,2,6,7-tetrahydro-3H-purin-3-yl)propyl]carbamoyl}benzene-1-sulfonyl fluoride	InChI=1S/C24H30FN5O5S/c1-2-14-30-23(32)19-21(28-20(27-19)16-7-4-3-5-8-16)29(24(30)33)15-6-13-26-22(31)17-9-11-18(12-10-17)36(25,34)35/h9-12,16H,2-8,13-15H2,1H3,(H,26,31)(H,27,28)	KAJVJPLKXGLLDA-UHFFFAOYSA-N	N159A	Soluble cytochrome b562 (P0ABE7)	N/A
4LDL	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	Structure of beta2 adrenoceptor bound to hydroxybenzylisoproterenol and an engineered nanobody	X-Ray Diffraction	3.1	2013-09-25	Ring et al. Adrenaline-activated structure of beta 2-adrenoceptor stabilized by an engineered nanobody. Nature. 2013, 502, 575.	24056936	XQC	4-[(1R)-1-hydroxy-2-{[1-(4-hydroxyphenyl)-2-methylpropan-2-yl]amino}ethyl]benzene-1,2-diol	InChI=1S/C18H23NO4/c1-18(2,10-12-3-6-14(20)7-4-12)19-11-17(23)13-5-8-15(21)16(22)9-13/h3-9,17,19-23H,10-11H2,1-2H3/t17-/m0/s1	CTXHFGIUMIBAFO-KRWDZBQOSA-N	M1096T, M1098T, N1187E, C1265A	Lysozyme (P00720)	Camelid Antibody Fragment
6DS0	5-hydroxytryptamine receptor 2B	Class A	Serotonin receptors	P41595	Homo sapiens (Human)	Structural Determinants of Activation and Biased Agonism at the 5-HT2B Receptor	X-Ray Diffraction	3.19	2018-08-29	McCorvy et al. Structural determinants of 5-HT2Breceptor activation and biased agonism. Nat. Struct. Mol. Biol. 2018.	30127358	H8M	(1S)-1-[(2-chloro-3,4-dimethoxyphenyl)methyl]-6-methyl-2,3,4,9-tetrahydro-1H-beta-carboline	InChI=1S/C21H23ClN2O2/c1-12-4-6-16-15(10-12)14-8-9-23-17(20(14)24-16)11-13-5-7-18(25-2)21(26-3)19(13)22/h4-7,10,17,23-24H,8-9,11H2,1-3H3/t17-/m0/s1	NJLHHCITDFZZSE-KRWDZBQOSA-N	M144W	Soluble cytochrome b562 (P0ABE7)	N/A
3ZPR	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	Thermostabilised turkey beta1 adrenergic receptor with 4-methyl-2-(piperazin-1-yl) quinoline bound	X-Ray Diffraction	2.7	2013-04-03	Christopher et al. Biophysical Fragment Screening of the Beta1-Adrenergic Receptor: Identification of High Affinity Aryl Piperazine Leads Using Structure-Based Drug Design. J.Med.Chem. 2013, 56, 3446.	23517028	3WC	4-METHYL-2-(PIPERAZIN-1-YL) QUINOLINE	InChI=1S/C14H17N3/c1-11-10-14(17-8-6-15-7-9-17)16-13-5-3-2-4-12(11)13/h2-5,10,15H,6-9H2,1H3	LCRABWZMGNEZJV-UHFFFAOYSA-N	R68S, M90V, C116L, Y227A, A282L, F327A, F338M, C358A	N/A	N/A
4OO9	Metabotropic glutamate receptor 5	Class C	N/A	P41594	Homo sapiens (Human)	Structure of the human class C GPCR metabotropic glutamate receptor 5 transmembrane domain in complex with the negative allosteric modulator mavoglurant	X-Ray Diffraction	2.6	2014-07-02	Dore et al. Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain. Nature. 2014, 511, 557.	25042998	2U8	Mavoglurant	InChI=1S/C19H23NO3/c1-14-5-3-6-15(13-14)8-11-19(22)10-4-7-17-16(19)9-12-20(17)18(21)23-2/h3,5-6,13,16-17,22H,4,7,9-10,12H2,1-2H3/t16-,17-,19-/m1/s1	ZFPZEYHRWGMJCV-ZHALLVOQSA-N	E579A, N667Y, I669A, G675M, T742A, S753A	Lysozyme (P00720)	N/A
6FKA	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of N2C/D282C stabilized opsin bound to RS11	X-Ray Diffraction	2.7	2018-04-04	Mattle et al. Ligand channel in pharmacologically stabilized rhodopsin. Proc. Natl. Acad. Sci. U.S.A. 2018, 115, 3640.	29555765	DN5	(2~{S})-2-(3,4-dichlorophenyl)-3-methyl-1-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl-butan-1-one	InChI=1S/C22H23Cl2NO3/c1-14(2)20(15-7-8-16(23)17(24)13-15)21(26)25-11-9-22(10-12-25)27-18-5-3-4-6-19(18)28-22/h3-8,13-14,20H,9-12H2,1-2H3/t20-/m0/s1	QFUKMLGGPINITQ-FQEVSTJZSA-N	N/A	N/A	N/A
5YQZ	Glucagon receptor	Class B	N/A	P47871	Homo sapiens (Human)	Structure of the glucagon receptor in complex with a glucagon analogue	X-Ray Diffraction	3.0	2018-01-17	Zhang et al. Structure of the glucagon receptor in complex with a glucagon analogue. Nature. 2018, 553, 106.	29300013	N/A	N/A	N/A	N/A	R173A	Lysozyme (P00720)	N/A
6M9T	Prostaglandin E2 receptor EP3 subtype	Class A	Prostanoids receptors	P43115	Homo sapiens (Human)	Crystal structure of EP3 receptor bound to misoprostol-FA	X-Ray Diffraction	2.5	2018-12-05	Audet et al. Crystal structure of misoprostol bound to the labor inducer prostaglandin E2receptor. Nat. Chem. Biol. 2019, 15, 11.	30510194	J9P	(11alpha,12alpha,13E,16S)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oic acid	InChI=1S/C21H36O5/c1-3-4-13-21(2,26)14-9-11-17-16(18(22)15-19(17)23)10-7-5-6-8-12-20(24)25/h9,11,16-17,19,23,26H,3-8,10,12-15H2,1-2H3,(H,24,25)/b11-9+/t16-,17-,19-,21+/m1/s1	CNWGPXZGIIOYDL-AGRNYGATSA-N	G286A	Lysozyme (P00720)	N/A
4AMI	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	Turkey beta1 adrenergic receptor with stabilising mutations and bound biased agonist bucindolol	X-Ray Diffraction	3.2	2012-05-23	Warne et al. Crystal Structures of a Stabilized Beta1-Adrenoceptor Bound to the Biased Agonists Bucindolol and Carvedilol. Structure. 2012, 20, 841.	22579251	G90	2-[(2S)-3-[[1-(1H-indol-3-yl)-2-methyl-propan-2-yl]amino]-2-oxidanyl-propoxy]benzenecarbonitrile	InChI=1S/C22H25N3O2/c1-22(2,11-17-13-24-20-9-5-4-8-19(17)20)25-14-18(26)15-27-21-10-6-3-7-16(21)12-23/h3-10,13,18,24-26H,11,14-15H2,1-2H3/t18-/m0/s1	FBMYKMYQHCBIGU-SFHVURJKSA-N	R68S, M90V, C116L, Y227A, A282L, F327A, F338M, C358A	N/A	N/A
5OM4	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Structure of the A2A-StaR2-bRIL562-Compound 4e complex at 1.86A obtained from in meso soaking experiments (24 hour soak).	X-Ray Diffraction	2.0	2018-01-17	Rucktooa et al. Towards high throughput GPCR crystallography: In Meso soaking of Adenosine A2A Receptor crystals. Sci Rep. 2018, 8, 41.	29311713	T4E	4-(3-amino-5-phenyl-1,2,4-triazin-6-yl)-2-chlorophenol	InChI=1S/C15H11ClN4O/c16-11-8-10(6-7-12(11)21)14-13(18-15(17)20-19-14)9-4-2-1-3-5-9/h1-8,21H,(H2,17,18,20)	ZHUZHTHIEMXLRA-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, N154A, L202A, L235A, V239A, S277A	Soluble cytochrome b562 (P0ABE7)	N/A
5NDD	Proteinase-activated receptor 2	Class A	Proteinase-activated receptors	P55085	Homo sapiens (Human)	Crystal structure of a thermostabilised human protease-activated receptor-2 (PAR2) in complex with AZ8838 at 2.8 angstrom resolution	X-Ray Diffraction	2.8	2017-05-03	Cheng et al. Structural insight into allosteric modulation of protease-activated receptor 2. Nature. 2017, 545, 112.	28445455	8TZ	(~{S})-(4-fluoranyl-2-propyl-phenyl)-(1~{H}-imidazol-2-yl)methanol	InChI=1S/C13H15FN2O/c1-2-3-9-8-10(14)4-5-11(9)12(17)13-15-6-7-16-13/h4-8,12,17H,2-3H2,1H3,(H,15,16)/t12-/m0/s1	IDFPQEHZYBXIFO-LBPRGKRZSA-N	G89A, H108A, G157A, M166L, Y174A, V176E, N222Q, M268A, I289A, L293A	Lysozyme (P00720), Soluble cytochrome b562 (P0ABE7)	N/A
6H7L	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND PARTIAL AGONIST DOBUTAMINE AND NANOBODY Nb6B9	X-Ray Diffraction	2.7	2018-10-17	Warne et al. Molecular basis for high affinity agonist binding in GPCRs. Biorxiv. 2018.	N/A	Y00	DOBUTAMINE	InChI=1S/C18H23NO3/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15/h4-9,12-13,19-22H,2-3,10-11H2,1H3/t13-/m1/s1	JRWZLRBJNMZMFE-CYBMUJFWSA-N	R68S, M90V, C116L, F327A, F338M, C358A	N/A	Camelid Antibody Fragment Nb6b9, Thioredoxin 1 (P0AA25)
6N4X	Metabotropic glutamate receptor 5	Class C	N/A	P41594	Homo sapiens (Human)	Metabotropic Glutamate Receptor 5 Apo Form Ligand Binding Domain	X-Ray Diffraction	4.0	2019-01-23	Koehl et al. Structural insights into the activation of metabotropic glutamate receptors. Nature. 2019.	30675062	N/A	N/A	N/A	N/A	N/A	N/A	N/A
6J21	Substance-P receptor	Class A	Tachykinin receptors	P25103	Homo sapiens (Human)	Crystal structure of the human NK1 substance P receptor	X-Ray Diffraction	3.2	2019-03-06	Chen et al. Human substance P receptor binding mode of the antagonist drug aprepitant by NMR and crystallography. Nat Commun. 2019, 10, 638.	30733446	GBQ	5-[[(2~{R},3~{S})-2-[(1~{R})-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one	InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1	ATALOFNDEOCMKK-OITMNORJSA-N	E78D, Y121W, Q165A, T222R	Lysozyme (D9IEF7)	N/A
6HLL	Substance-P receptor	Class A	Tachykinin receptors	P25103	Homo sapiens (Human)	Crystal structure of the Neurokinin 1 receptor in complex with the small molecule antagonist CP-99,994	X-Ray Diffraction	3.27	2019-01-16	Schoppe et al. Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists. Nat Commun. 2019, 10, 17.	30604743	GBK	(2~{S},3~{S})-~{N}-[(2-methoxyphenyl)methyl]-2-phenyl-piperidin-3-amine	InChI=1S/C19H24N2O/c1-22-18-12-6-5-10-16(18)14-21-17-11-7-13-20-19(17)15-8-3-2-4-9-15/h2-6,8-10,12,17,19-21H,7,11,13-14H2,1H3/t17-,19-/m0/s1	DTQNEFOKTXXQKV-HKUYNNGSSA-N	L74A, V116I, A144L, M181K, A215L, W224R, K243A	GlgA glycogen synthase (Q9V2J8)	N/A
2Y01	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND PARTIAL AGONIST DOBUTAMINE (CRYSTAL DOB102)	X-Ray Diffraction	2.6	2011-03-30	Warne et al. The Structural Basis for Agonist and Partial Agonist Action on a Beta1-Adrenergic Receptor. Nature. 2011, 469, 241.	21228877	Y00	DOBUTAMINE	InChI=1S/C18H23NO3/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15/h4-9,12-13,19-22H,2-3,10-11H2,1H3/t13-/m1/s1	JRWZLRBJNMZMFE-CYBMUJFWSA-N	R68S, M90V, C116L, Y227A, A282L, F327A, F338M, C358A	N/A	N/A
5XF1	Glucagon receptor	Class B	N/A	P47871	Homo sapiens (Human)	Structure of the Full-length glucagon class B G protein-coupled receptor	X-Ray Diffraction	3.19	2017-05-24	Zhang et al. Structure of the full-length glucagon class B G-protein-coupled receptor. Nature. 2017, 546, 259.	28514451	97V	4-{[(4-cyclohexylphenyl){[3-(methylsulfonyl)phenyl]carbamoyl}amino]methyl}-N-(1H-tetrazol-5-yl)benzamide	InChI=1S/C29H31N7O4S/c1-41(39,40)26-9-5-8-24(18-26)30-29(38)36(25-16-14-22(15-17-25)21-6-3-2-4-7-21)19-20-10-12-23(13-11-20)27(37)31-28-32-34-35-33-28/h5,8-18,21H,2-4,6-7,19H2,1H3,(H,30,38)(H2,31,32,33,34,35,37)	PPTKULJUDJWTSA-UHFFFAOYSA-N	N/A	Lysozyme (P00720)	Antibody Mab1 Heavy Chain, Antibody Mab1 Light Chain
5NDZ	Proteinase-activated receptor 2	Class A	Proteinase-activated receptors	P55085	Homo sapiens (Human)	Crystal structure of a thermostabilised human protease-activated receptor-2 (PAR2) in complex with AZ3451 at 3.6 angstrom resolution	X-Ray Diffraction	3.6	2017-05-03	Cheng et al. Structural insight into allosteric modulation of protease-activated receptor 2. Nature. 2017, 545, 112.	28445455	8UN	2-(6-bromanyl-1,3-benzodioxol-5-yl)-~{N}-(4-cyanophenyl)-1-[(1~{S})-1-cyclohexylethyl]benzimidazole-5-carboxamide	InChI=1S/C30H27BrN4O3/c1-18(20-5-3-2-4-6-20)35-26-12-9-21(30(36)33-22-10-7-19(16-32)8-11-22)13-25(26)34-29(35)23-14-27-28(15-24(23)31)38-17-37-27/h7-15,18,20H,2-6,17H2,1H3,(H,33,36)/t18-/m0/s1	FJAOGFGHTPYADT-SFHVURJKSA-N	G89A, H108A, G157A, M166L, Y174A, V176E, N222Q, M268A, I289A, L293A	Lysozyme (P00720), Soluble cytochrome b562 (P0ABE7)	N/A
6BQH	5-hydroxytryptamine receptor 2C	Class A	Serotonin receptors	P28335	Homo sapiens (Human)	Crystal structure of 5-HT2C in complex with ritanserin	X-Ray Diffraction	2.7	2018-02-14	Peng et al. 5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology. Cell. 2018, 172, 719.	29398112	E2J	6-(2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl)-7-methyl-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one	InChI=1S/C27H25F2N3OS/c1-18-24(26(33)32-16-17-34-27(32)30-18)12-15-31-13-10-21(11-14-31)25(19-2-6-22(28)7-3-19)20-4-8-23(29)9-5-20/h2-9,16-17H,10-15H2,1H3	JUQLTPCYUFPYKE-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
3C9L	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Structure of ground-state bovine rhodospin in a hexagonal crystal form	X-Ray Diffraction	2.65	2008-08-05	Stenkamp et al. Alternative models for two crystal structures of bovine rhodopsin. Acta Crystallogr.,Sect.D. 2008, 64, 902.	18645239	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
4N6H	Delta-type opioid receptor	Class A	Opioid peptides receptors	P41143	Homo sapiens (Human)	1.8 A Structure of the human delta opioid 7TM receptor (PSI Community Target)	X-Ray Diffraction	1.8	2013-12-25	Fenalti et al. Molecular control of delta-opioid receptor signalling. Nature. 2014, 506, 191.	24413399	EJ4	(4bS,8R,8aS,14bR)-7-(cyclopropylmethyl)-5,6,7,8,14,14b-hexahydro-4,8-methano[1]benzofuro[2,3-a]pyrido[4,3-b]carbazole-1,8a(9H)-diol	InChI=1S/C26H26N2O3/c29-19-8-7-15-11-20-26(30)12-17-16-3-1-2-4-18(16)27-22(17)24-25(26,21(15)23(19)31-24)9-10-28(20)13-14-5-6-14/h1-4,7-8,14,20,24,27,29-30H,5-6,9-13H2/t20-,24+,25+,26-/m1/s1	WIYUZYBFCWCCQJ-IFKAHUTRSA-N	P37S	Soluble cytochrome b562 (P0ABE7)	N/A
6AQF	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Crystal structure of A2AAR-BRIL in complex with the antagonist ZM241385 produced from Pichia pastoris	X-Ray Diffraction	2.51	2018-01-10	Eddy et al. Allosteric Coupling of Drug Binding and Intracellular Signaling in the A2A Adenosine Receptor. Cell. 2018, 172, 68.	29290469	ZMA	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
2Z73	Rhodopsin	Class A	Opsins	P31356	Todarodes pacificus (Japanese flying squid)	Crystal structure of squid rhodopsin	X-Ray Diffraction	2.5	2008-05-13	Murakami et al. Crystal structure of squid rhodopsin. Nature. 2008, 453, 363.	18480818	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
2YCW	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND ANTAGONIST CARAZOLOL	X-Ray Diffraction	3.0	2011-06-01	Moukhametzianov et al. Two Distinct Conformations of Helix 6 Observed in Antagonist-Bound Structures of a Beta-1- Adrenergic Receptor. Proc.Natl.Acad.Sci.USA. 2011, 108, 8228.	21540331	CAU	(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol	InChI=1S/C18H22N2O2/c1-12(2)19-10-13(21)11-22-17-9-5-8-16-18(17)14-6-3-4-7-15(14)20-16/h3-9,12-13,19-21H,10-11H2,1-2H3/t13-/m0/s1	BQXQGZPYHWWCEB-ZDUSSCGKSA-N	R68S, M90V, C116L, Y227A, A282L, F327A, F338M, C358A	N/A	N/A
4WW3	Rhodopsin	Class A	Opsins	P31356	Todarodes pacificus (Japanese flying squid)	Crystal structure of the lumi intermediate of squid rhodopsin	X-Ray Diffraction	2.8	2015-06-17	Murakami et al. Crystallographic Study of the LUMI Intermediate of Squid Rhodopsin. Plos One. 2015, 10, e0126970.	26024518	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
4QIM	Smoothened homolog	Class F	N/A	Q99835	Homo sapiens (Human)	Structure of the human smoothened receptor in complex with ANTA XV	X-Ray Diffraction	2.61	2014-07-23	Wang et al. Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs. Nat Commun. 2014, 5, 4355.	25008467	A8T	2-{6-[4-(4-benzylphthalazin-1-yl)piperazin-1-yl]pyridin-3-yl}propan-2-ol	InChI=1S/C27H29N5O/c1-27(2,33)21-12-13-25(28-19-21)31-14-16-32(17-15-31)26-23-11-7-6-10-22(23)24(29-30-26)18-20-8-4-3-5-9-20/h3-13,19,33H,14-18H2,1-2H3	KSWYJUIFHPSZOL-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
6E59	Substance-P receptor	Class A	Tachykinin receptors	P25103	Homo sapiens (Human)	Crystal structure of the human NK1 tachykinin receptor	X-Ray Diffraction	3.4	2018-12-12	Yin et al. Crystal structure of the human NK1tachykinin receptor. Proc. Natl. Acad. Sci. U.S.A. 2018, 115, 13264.	30538204	L76	1-(4-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-1H-1,2,3-triazol-5-yl)-N,N-dimethylmethanamine	InChI=1S/C26H28F7N5O2/c1-15(17-10-18(25(28,29)30)12-19(11-17)26(31,32)33)40-24-23(16-4-6-20(27)7-5-16)38(8-9-39-24)14-22-21(13-37(2)3)34-36-35-22/h4-7,10-12,15,23-24H,8-9,13-14H2,1-3H3,(H,34,35,36)/t15-,23+,24-/m1/s1	USRYEHHMJIRICK-ZNZBMKLDSA-N	N/A	GlgA glycogen synthase (Q9V2J8)	N/A
4YAY	Type-1 angiotensin II receptor	Class A	Angiotensin receptors	P30556	Homo sapiens (Human)	XFEL structure of human Angiotensin Receptor	X-Ray Diffraction	2.9	2015-04-22	Zhang et al. Structure of the Angiotensin receptor revealed by serial femtosecond crystallography. Cell. 2015, 161, 833.	25913193	ZD7	5,7-diethyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-3,4-dihydro-1,6-naphthyridin-2(1H)-one	InChI=1S/C26H26N6O/c1-3-19-15-24-22(23(4-2)27-19)13-14-25(33)32(24)16-17-9-11-18(12-10-17)20-7-5-6-8-21(20)26-28-30-31-29-26/h5-12,15H,3-4,13-14,16H2,1-2H3,(H,28,29,30,31)	BFVNEYDCFJNLGN-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
4DAJ	Muscarinic acetylcholine receptor M3	Class A	Acetylcholine (muscarinic) receptors	P08483	Rattus norvegicus (Rat)	Structure of the M3 Muscarinic Acetylcholine Receptor	X-Ray Diffraction	3.4	2012-02-22	Kruse et al. Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature. 2012, 482, 552.	22358844	0HK	(1R,2R,4S,5S,7S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane	InChI=1S/C19H22NO4S2/c1-20(2)12-9-11(10-13(20)17-16(12)24-17)23-18(21)19(22,14-5-3-7-25-14)15-6-4-8-26-15/h3-8,11-13,16-17,22H,9-10H2,1-2H3/q+1/t11-,12-,13+,16-,17+	LERNTVKEWCAPOY-DZZGSBJMSA-N	N/A	Lysozyme (P00720)	N/A
5NM2	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	A2A Adenosine receptor cryo structure	X-Ray Diffraction	1.95	2017-09-27	Weinert et al. Serial millisecond crystallography for routine room-temperature structure determination at synchrotrons. Nat Commun. 2017, 8, 542.	28912485	ZMA	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, N154A, L202A, L235A, V239A, S277A	Soluble cytochrome b562 (P0ABE7)	N/A
2I35	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of rhombohedral crystal form of ground-state rhodopsin	X-Ray Diffraction	3.8	2006-10-17	Salom et al. Crystal structure of a photoactivated deprotonated intermediate of rhodopsin. Proc.Natl.Acad.Sci.Usa. 2006, 103, 16123.	17060607	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
5W0P	Rhodopsin	Class A	Opsins	P08100	Homo sapiens (Human)	Crystal structure of rhodopsin bound to visual arrestin determined by X-ray free electron laser	X-Ray Diffraction	3.01	2017-08-09	Zhou et al. Identification of Phosphorylation Codes for Arrestin Recruitment by G Protein-Coupled Receptors. Cell. 2017, 170, 457.	28753425	N/A	N/A	N/A	N/A	N2C, E113Q, M257Y, N282C	Lysozyme (P00720), S-arrestin (P20443)	N/A
3V2Y	Sphingosine 1-phosphate receptor 1	Class A	Lysolipids receptors	P21453	Homo sapiens (Human)	Crystal Structure of a Lipid G protein-Coupled Receptor at 2.80A	X-Ray Diffraction	2.8	2012-02-15	Hanson et al. Crystal structure of a lipid G protein-coupled receptor. Science. 2012, 335, 851.	22344443	ML5	{(3R)-3-amino-4-[(3-hexylphenyl)amino]-4-oxobutyl}phosphonic acid	InChI=1S/C16H27N2O4P/c1-2-3-4-5-7-13-8-6-9-14(12-13)18-16(19)15(17)10-11-23(20,21)22/h6,8-9,12,15H,2-5,7,10-11,17H2,1H3,(H,18,19)(H2,20,21,22)/t15-/m1/s1	FWJRVGZWNDOOFH-OAHLLOKOSA-N	N/A	Lysozyme (P00720)	N/A
5N2S	Adenosine receptor A1	Class A	Adenosine and adenine nucleotide receptors	P30542	Homo sapiens (Human)	Crystal structure of stabilized A1 receptor in complex with PSB36 at 3.3A resolution	X-Ray Diffraction	3.3	2017-07-26	Cheng et al. Structures of Human A1 and A2A Adenosine Receptors with Xanthines Reveal Determinants of Selectivity. Structure. 2017, 25, 1275.	28712806	8K8	1-butyl-3-(3-oxidanylpropyl)-8-[(1~{R},5~{S})-3-tricyclo[3.3.1.0^{3,7}]nonanyl]-7~{H}-purine-2,6-dione	InChI=1S/C21H30N4O3/c1-2-3-5-25-18(27)16-17(24(20(25)28)6-4-7-26)23-19(22-16)21-11-13-8-14(12-21)10-15(21)9-13/h13-15,26H,2-12H2,1H3,(H,22,23)/t13-,14+,15-,21-	CIBIXJYFYPFMTN-FZUGUKJMSA-N	A1162L, T1196A, N1264A, Y1310A, L1341A, L1345A, T1382A, C1414S	Soluble cytochrome b562 (P0ABE7)	N/A
5TGZ	Cannabinoid receptor 1	Class A	Cannabinoids receptors	P21554	Homo sapiens (Human)	Crystal Structure of the Human Cannabinoid Receptor CB1	X-Ray Diffraction	2.8	2016-11-02	Hua et al. Crystal Structure of the Human Cannabinoid Receptor CB1. Cell. 2016, 167, 750.	27768894	ZDG	4-[4-[2-(2,4-dichlorophenyl)-4-methyl-5-(piperidin-1-ylcarbamoyl)pyrazol-3-yl]phenyl]but-3-ynyl nitrate	InChI=1S/C26H25Cl2N5O4/c1-18-24(26(34)30-31-14-4-2-5-15-31)29-32(23-13-12-21(27)17-22(23)28)25(18)20-10-8-19(9-11-20)7-3-6-16-37-33(35)36/h8-13,17H,2,4-6,14-16H2,1H3,(H,30,34)	KXXKUWQMQUYUSE-UHFFFAOYSA-N	T210A, E273K, T283V, R340E	Flavodoxin (P00323)	N/A
3QAK	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Agonist bound structure of the human adenosine A2a receptor	X-Ray Diffraction	2.71	2011-03-09	Xu et al. Structure of an agonist-bound human A2A adenosine receptor. Science. 2011, 332, 322.	21393508	UKA	6-(2,2-diphenylethylamino)-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]-N-[2-[(1-pyridin-2-ylpiperidin-4-yl)carbamoylamino]ethyl]purine-2-carboxamide	InChI=1S/C40H47N11O6/c1-2-41-37(54)33-31(52)32(53)39(57-33)51-24-46-30-34(45-23-28(25-11-5-3-6-12-25)26-13-7-4-8-14-26)48-35(49-36(30)51)38(55)43-19-20-44-40(56)47-27-16-21-50(22-17-27)29-15-9-10-18-42-29/h3-15,18,24,27-28,31-33,39,52-53H,2,16-17,19-23H2,1H3,(H,41,54)(H,43,55)(H2,44,47,56)(H,45,48,49)/t31-,32+,33-,39+/m0/s1	ZOTHAEBAWXWVID-HXEFRTELSA-N	N/A	Lysozyme (P00720)	N/A
2Y03	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND AGONIST ISOPRENALINE	X-Ray Diffraction	2.85	2011-01-12	Warne et al. The Structural Basis for Agonist and Partial Agonist Action on a Beta1-Adrenergic Receptor. Nature. 2011, 469, 241.	21228877	5FW	ISOPRENALINE	InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8/h3-5,7,11-15H,6H2,1-2H3/t11-/m0/s1	JWZZKOKVBUJMES-NSHDSACASA-N	R68S, M90V, C116L, Y227A, A282L, F327A, F338M, C358A	N/A	N/A
2YCX	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND ANTAGONIST CYANOPINDOLOL	X-Ray Diffraction	3.25	2011-06-01	Moukhametzianov et al. Two Distinct Conformations of Helix 6 Observed in Antagonist-Bound Structures of a Beta-1- Adrenergic Receptor. Proc.Natl.Acad.Sci.USA. 2011, 108, 8228.	21540331	P32	4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile	InChI=1S/C16H21N3O2/c1-16(2,3)18-9-12(20)10-21-15-6-4-5-14-13(15)7-11(8-17)19-14/h4-6,12,18,20H,7,9-10H2,1-3H3/t12-/m0/s1	CQEFAUFOQSCRMZ-LBPRGKRZSA-N	R68S, M90V, C116L, Y227A, A282L, F327A, F338M, C358A	N/A	N/A
5ZK3	Muscarinic acetylcholine receptor M2	Class A	Acetylcholine (muscarinic) receptors	P08172	Homo sapiens (Human)	Crystal structure of rationally thermostabilized M2 muscarinic acetylcholine receptor bound with QNB	X-Ray Diffraction	2.6	2018-11-21	Suno et al. Structural insights into the subtype-selective antagonist binding to the M2muscarinic receptor. Nat. Chem. Biol. 2018, 14, 1150.	30420692	QNB	(3R)-1-azabicyclo[2.2.2]oct-3-yl hydroxy(diphenyl)acetate	InChI=1S/C21H23NO3/c23-20(25-19-15-22-13-11-16(19)12-14-22)21(24,17-7-3-1-4-8-17)18-9-5-2-6-10-18/h1-10,16,19,24H,11-15H2/t19-/m0/s1	HGMITUYOCPPQLE-IBGZPJMESA-N	S110R	N/A	N/A
4NC3	5-hydroxytryptamine receptor 2B	Class A	Serotonin receptors	P41595	Homo sapiens (Human)	Crystal structure of the 5-HT2B receptor solved using serial femtosecond crystallography in lipidic cubic phase.	X-Ray Diffraction	2.8	2013-12-18	Liu et al. Serial femtosecond crystallography of G protein-coupled receptors. Science. 2013, 342, 1521.	24357322	ERM	Ergotamine	InChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1	XCGSFFUVFURLIX-VFGNJEKYSA-N	M144W	Soluble cytochrome b562 (P0ABE7)	N/A
5MZP	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with caffeine at 2.1A resolution	X-Ray Diffraction	2.1	2017-07-26	Cheng et al. Structures of Human A1 and A2A Adenosine Receptors with Xanthines Reveal Determinants of Selectivity. Structure. 2017, 25, 1275.	28712806	CFF	CAFFEINE	InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3	RYYVLZVUVIJVGH-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, N154A, L202A, L235A, V239A, S277A	Soluble cytochrome b562 (P0ABE7)	N/A
5G53	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Structure of the adenosine A2A receptor bound to an engineered G protein	X-Ray Diffraction	3.4	2016-08-03	Carpenter et al. Structure of the Adenosine A2A Receptor Bound to an Engineered G Protein. Nature. 2016, 536, 104.	27462812	NEC	N-ETHYL-5'-CARBOXAMIDO ADENOSINE	InChI=1S/C12H16N6O4/c1-2-14-11(21)8-6(19)7(20)12(22-8)18-4-17-5-9(13)15-3-16-10(5)18/h3-4,6-8,12,19-20H,2H2,1H3,(H,14,21)(H2,13,15,16)/t6-,7+,8-,12+/m0/s1	JADDQZYHOWSFJD-FLNNQWSLSA-N	N154A	N/A	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (P63092)
3ZPQ	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	Thermostabilised turkey beta1 adrenergic receptor with 4-(piperazin-1- yl)-1H-indole bound (compound 19)	X-Ray Diffraction	2.8	2013-04-03	Christopher et al. Biophysical Fragment Screening of the Beta1-Adrenergic Receptor: Identification of High Affinity Aryl Piperazine Leads Using Structure-Based Drug Design. J.Med.Chem. 2013, 56, 3446.	23517028	XF5	4-(PIPERAZIN-1-YL)-1H-INDOLE	InChI=1S/C12H15N3/c1-2-11-10(4-5-14-11)12(3-1)15-8-6-13-7-9-15/h1-5,13-14H,6-9H2	YZKSXUIOKWQABW-UHFFFAOYSA-N	R68S, M90V, C116L, Y227A, A282L, F327A, F338M, C358A	N/A	N/A
6BQG	5-hydroxytryptamine receptor 2C	Class A	Serotonin receptors	P28335	Homo sapiens (Human)	Crystal structure of 5-HT2C in complex with ergotamine	X-Ray Diffraction	3.0	2018-02-14	Peng et al. 5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology. Cell. 2018, 172, 719.	29398112	ERM	Ergotamine	InChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1	XCGSFFUVFURLIX-VFGNJEKYSA-N	C360N	Soluble cytochrome b562 (P0ABE7)	N/A
5NX2	Glucagon-like peptide 1 receptor	Class B	N/A	P43220	Homo sapiens (Human)	Crystal structure of thermostabilised full-length GLP-1R in complex with a truncated peptide agonist at 3.7 A resolution	X-Ray Diffraction	3.7	2017-06-14	Jazayeri et al. Crystal structure of the GLP-1 receptor bound to a peptide agonist. Nature. 2017, 546, 254.	28562585	N/A	N/A	N/A	N/A	T207E, Q211A, D215R, L232F, G295A, T298A, C329A, P358A, G361A, H363V, V405A	N/A	N/A
2PED	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystallographic model of 9-cis-rhodopsin	X-Ray Diffraction	2.95	2007-10-30	Nakamichi et al. Photoisomerization mechanism of rhodopsin and 9-cis-rhodopsin revealed by x-ray crystallography. Biophys.J. 2007, 92, L106.	17449675	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
5VAI	Glucagon-like peptide 1 receptor	Class B	N/A	G1SGD4	Oryctolagus cuniculus (Rabbit)	Cryo-EM structure of the activated Glucagon-like peptide-1 receptor in complex with G protein	Electron Microscopy	4.1	2017-05-24	Zhang et al. Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein. Nature. 2017, 546, 248.	28538729	N/A	N/A	N/A	N/A	N/A	N/A	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (P63092), Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (P54311), Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 (P63212), Nanobody 35
6D26	Prostaglandin D2 receptor 2	Class A	Orphan receptors	Q9Y5Y4	Homo sapiens (Human)	Crystal structure of the prostaglandin D2 receptor CRTH2 with fevipiprant	X-Ray Diffraction	2.8	2018-10-03	Wang et al. Structures of the prostaglandin D2 receptor CRTH2 with antagonists. To be Published. .	N/A	FSY	fevipiprant	InChI=1S/C19H17F3N2O4S/c1-11-15(9-17(25)26)14-4-3-7-23-18(14)24(11)10-12-5-6-13(29(2,27)28)8-16(12)19(20,21)22/h3-8H,9-10H2,1-2H3,(H,25,26)	GFPPXZDRVCSVNR-UHFFFAOYSA-N	N25A	Lysozyme (D9IEF7)	N/A
6FKD	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of N2C/D282C stabilized opsin bound to RS16	X-Ray Diffraction	2.49	2018-04-04	Mattle et al. Ligand channel in pharmacologically stabilized rhodopsin. Proc. Natl. Acad. Sci. U.S.A. 2018, 115, 3640.	29555765	DL2	5-chloranyl-2-(2-oxidanylidene-2-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl-ethyl)-3~{H}-pyridin-6-one	InChI=1S/C18H17ClN2O4/c19-13-6-5-12(20-17(13)23)11-16(22)21-9-7-18(8-10-21)24-14-3-1-2-4-15(14)25-18/h1-4,6H,5,7-11H2	PBLFEEIOVIDZSW-UHFFFAOYSA-N	N/A	N/A	N/A
4U16	Muscarinic acetylcholine receptor M3	Class A	Acetylcholine (muscarinic) receptors	P08483	Rattus norvegicus (Rat)	M3-mT4L receptor bound to NMS	X-Ray Diffraction	3.7	2014-11-26	Thorsen et al. Modified T4 Lysozyme Fusion Proteins Facilitate G Protein-Coupled Receptor Crystallogenesis. Structure. 2014, 22, 1657.	25450769	3C0	N-methyl scopolamine	InChI=1S/C18H24NO4/c1-19(2)14-8-12(9-15(19)17-16(14)23-17)22-18(21)13(10-20)11-6-4-3-5-7-11/h3-7,12-17,20H,8-10H2,1-2H3/q+1/t12-,13-,14-,15+,16-,17+/m1/s1	LZCOQTDXKCNBEE-IKIFYQGPSA-N	N/A	Lysozyme (D9IEF7)	N/A
5DHG	Nociceptin receptor	Class A	Opioid peptides receptors	P41146	Homo sapiens (Human)	The crystal structure of nociceptin/orphanin FQ peptide receptor (NOP) in complex with C-35 (PSI Community Target)	X-Ray Diffraction	3.0	2015-10-21	Miller et al. The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor. Structure. 2015, 23, 2291.	26526853	DGV	1-benzyl-N-{3-[4-(2,6-dichlorophenyl)piperidin-1-yl]propyl}-D-prolinamide	InChI=1S/C26H33Cl2N3O/c27-22-9-4-10-23(28)25(22)21-12-17-30(18-13-21)15-6-14-29-26(32)24-11-5-16-31(24)19-20-7-2-1-3-8-20/h1-4,7-10,21,24H,5-6,11-19H2,(H,29,32)/t24-/m1/s1	UWHDLFOAIARROU-XMMPIXPASA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
4ZUD	Type-1 angiotensin II receptor	Class A	Angiotensin receptors	P30556	Homo sapiens (Human)	Crystal Structure of Human Angiotensin Receptor in Complex with Inverse Agonist Olmesartan at 2.8A resolution.	X-Ray Diffraction	2.8	2015-10-07	Zhang et al. Structural Basis for Ligand Recognition and Functional Selectivity at Angiotensin Receptor. J.Biol.Chem. 2015, 290, 29127.	26420482	OLM	Olmesartan	InChI=1S/C24H26N6O3/c1-4-7-19-25-21(24(2,3)33)20(23(31)32)30(19)14-15-10-12-16(13-11-15)17-8-5-6-9-18(17)22-26-28-29-27-22/h5-6,8-13,33H,4,7,14H2,1-3H3,(H,31,32)(H,26,27,28,29)	VTRAEEWXHOVJFV-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
6CM4	D(2) dopamine receptor	Class A	Dopamine receptors	P14416	Homo sapiens (Human)	Structure of the D2 Dopamine Receptor Bound to the Atypical Antipsychotic Drug Risperidone	X-Ray Diffraction	2.87	2018-03-14	Wang et al. Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone. Nature. 2018, 555, 269.	29466326	8NU	3-[2-[4-(6-fluoranyl-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one	InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3	RAPZEAPATHNIPO-UHFFFAOYSA-N	N/A	Lysozyme (D9IEF7)	N/A
5K2C	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	1.9 angstrom A2a adenosine receptor structure with sulfur SAD phasing and phase extension using XFEL data	X-Ray Diffraction	1.9	2016-09-21	Batyuk et al. Native phasing of x-ray free-electron laser data for a G protein-coupled receptor. Sci Adv. 2016, 2, e1600292.	27679816	ZMA	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
6NIY	Calcitonin receptor	Class B	N/A	P30988	Homo sapiens (Human)	A high-resolution cryo-electron microscopy structure of a calcitonin receptor-heterotrimeric Gs protein complex	Electron Microscopy	3.34	2019-01-23	dal Maso et al. The molecular control of calcitonin receptor (CTR) signaling. to be published. .	N/A	N/A	N/A	N/A	N/A	N/A	N/A	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (P63092), Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (P62873), Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 (P59768), Nanobody35
4GPO	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	Oligomeic Turkey Beta1-Adrenergic G Protein-Coupled Receptor	X-Ray Diffraction	3.5	2013-02-27	Huang et al. Crystal structure of oligomeric beta-1-adrenergic G protein-coupled receptors in ligand-free basal state. Nat.Struct.Mol.Biol. 2013, 20, 419.	23435379	N/A	N/A	N/A	N/A	N/A	N/A	N/A
1LN6	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	STRUCTURE OF BOVINE RHODOPSIN (Metarhodopsin II)	Solution NMR	N/A	2002-07-10	Choi et al. Structural studies of metarhodopsin II, the activated form of the G-protein coupled receptor, rhodopsin. Biochemistry. 2002, 41, 7318.	12044163	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
1HZX	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	CRYSTAL STRUCTURE OF BOVINE RHODOPSIN	X-Ray Diffraction	2.8	2001-07-04	Teller et al. Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry. 2001, 40, 7761.	11425302	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
5UNF	Type-2 angiotensin II receptor	Class A	Angiotensin receptors	P50052	Homo sapiens (Human)	XFEL structure of human angiotensin II type 2 receptor (Monoclinic form) in complex with compound 1 (N-benzyl-N-(2-ethyl-4-oxo-3-{[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl])	X-Ray Diffraction	2.8	2017-04-05	Zhang et al. Structural basis for selectivity and diversity in angiotensin II receptors. Nature. 2017, 544, 327.	28379944	8ES	N-benzyl-N-(2-ethyl-4-oxo-3-{[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-3,4-dihydroquinazolin-6-yl)thiophene-2-carboxamide	InChI=1S/C36H29N7O2S/c1-2-33-37-31-19-18-27(42(22-24-9-4-3-5-10-24)36(45)32-13-8-20-46-32)21-30(31)35(44)43(33)23-25-14-16-26(17-15-25)28-11-6-7-12-29(28)34-38-40-41-39-34/h3-21H,2,22-23H2,1H3,(H,38,39,40,41)	KDPHUUTUDFDLBT-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
4PY0	P2Y purinoceptor 12	Class A	Adenosine and adenine nucleotide receptors	Q9H244	Homo sapiens (Human)	Crystal structure of P2Y12 receptor in complex with 2MeSATP	X-Ray Diffraction	3.1	2014-04-30	Zhang et al. Agonist-bound structure of the human P2Y12 receptor. Nature. 2014, 509, 119.	24784220	6AT	2-(methylsulfanyl)adenosine 5'-(tetrahydrogen triphosphate)	InChI=1S/C11H18N5O13P3S/c1-33-11-14-8(12)5-9(15-11)16(3-13-5)10-7(18)6(17)4(27-10)2-26-31(22,23)29-32(24,25)28-30(19,20)21/h3-4,6-7,10,17-18H,2H2,1H3,(H,22,23)(H,24,25)(H2,12,14,15)(H2,19,20,21)/t4-,6-,7-,10-/m1/s1	XNOBOKJVOTYSJV-KQYNXXCUSA-N	D294N	Soluble cytochrome b562 (P0ABE7)	N/A
6J20	Substance-P receptor	Class A	Tachykinin receptors	P25103	Homo sapiens (Human)	Crystal structure of the human NK1 substance P receptor	X-Ray Diffraction	2.7	2019-03-06	Chen et al. Human substance P receptor binding mode of the antagonist drug aprepitant by NMR and crystallography. Nat Commun. 2019, 10, 638.	30733446	GBQ	5-[[(2~{R},3~{S})-2-[(1~{R})-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one	InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1	ATALOFNDEOCMKK-OITMNORJSA-N	E78N, Y121W, T222R	Lysozyme (D9IEF7)	N/A
4X1H	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Opsin/G(alpha) peptide complex stabilized by nonyl-glucoside	X-Ray Diffraction	2.29	2015-11-04	Blankenship et al. The High-Resolution Structure of Activated Opsin Reveals a Conserved Solvent Network in the Transmembrane Region Essential for Activation. Structure. 2015, 23, 2358.	26526852	N/A	N/A	N/A	N/A	N/A	N/A	N/A
6N4B	Cannabinoid receptor 1	Class A	Cannabinoids receptors	P21554	Homo sapiens (Human)	Cannabinoid Receptor 1-G Protein Complex	Electron Microscopy	3.0	2019-01-30	Krishna Kumar et al. Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex. Cell. 2018.	30639101	KCA	methyl N-{1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}-3-methyl-L-valinate	InChI=1S/C22H24FN3O3/c1-22(2,3)19(21(28)29-4)24-20(27)18-16-7-5-6-8-17(16)26(25-18)13-14-9-11-15(23)12-10-14/h5-12,19H,13H2,1-4H3,(H,24,27)/t19-/m1/s1	RFCDVEHNYDVCMU-LJQANCHMSA-N	N/A	N/A	Guanine nucleotide-binding protein G(i) subunit alpha-1 (P63096), Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (P62873), Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 (P59768), Scfv16
2LNL	C-X-C chemokine receptor type 1	Class A	Chemokines and chemotactic factors receptors	P25024	Homo sapiens (Human)	Structure of human CXCR1 in phospholipid bilayers	Solid-State NMR	N/A	2012-10-17	Park et al. Structure of the chemokine receptor CXCR1 in phospholipid bilayers. Nature. 2012, 491, 779.	23086146	N/A	N/A	N/A	N/A	N/A	N/A	N/A
5ZKP	Platelet-activating factor receptor	Class A	Platelet-activating factor receptors	P25105	Homo sapiens (Human)	Crystal structure of the human platelet-activating factor receptor in complex with SR 27417	X-Ray Diffraction	2.81	2018-06-20	Cao et al. Structural basis for signal recognition and transduction by platelet-activating-factor receptor. Nat. Struct. Mol. Biol. 2018, 25, 488.	29808000	9ER	N1,N1-dimethyl-N2-[(pyridin-3-yl)methyl]-N2-{4-[2,4,6-tri(propan-2-yl)phenyl]-1,3-thiazol-2-yl}ethane-1,2-diamine	InChI=1S/C28H40N4S/c1-19(2)23-14-24(20(3)4)27(25(15-23)21(5)6)26-18-33-28(30-26)32(13-12-31(7)8)17-22-10-9-11-29-16-22/h9-11,14-16,18-21H,12-13,17H2,1-8H3	VVBFISAUNSXQGZ-UHFFFAOYSA-N	F116Y, N169D, A230D, V234A, D289N	Flavodoxin (P00323)	N/A
5TUD	5-hydroxytryptamine receptor 2B	Class A	Serotonin receptors	P41595	Homo sapiens (Human)	Structural Insights into the Extracellular Recognition of the Human Serotonin 2B Receptor by an Antibody	X-Ray Diffraction	3.0	2017-07-26	Ishchenko et al. Structural insights into the extracellular recognition of the human serotonin 2B receptor by an antibody. Proc. Natl. Acad. Sci. U.S.A. 2017, 114, 8223.	28716900	ERM	Ergotamine	InChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1	XCGSFFUVFURLIX-VFGNJEKYSA-N	M144W	Soluble cytochrome b562 (P0ABE7)	Anti-5-ht2b Fab Light Chain, Anti-5-ht2b Fab Heavy Chain
5DYS	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal Structure of T94I rhodopsin mutant	X-Ray Diffraction	2.3	2016-08-10	Singhal et al. Structural role of the T94I rhodopsin mutation in congenital stationary night blindness. Embo Rep. 2016, 17, 1431.	27458239	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N2C, T94I, D282C	N/A	N/A
4IAQ	5-hydroxytryptamine receptor 1B	Class A	Serotonin receptors	P28222	Homo sapiens (Human)	Crystal structure of the chimeric protein of 5-HT1B-BRIL in complex with dihydroergotamine (PSI Community Target)	X-Ray Diffraction	2.8	2013-03-13	Wang et al. Structural basis for molecular recognition at serotonin receptors. Science. 2013, 340, 610.	23519210	2GM	Dihydroergotamine	InChI=1S/C33H37N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,17,21,23,25-27,34,42H,7,12-16,18H2,1-2H3,(H,35,39)/t21-,23-,25-,26+,27+,32-,33+/m1/s1	LUZRJRNZXALNLM-JGRZULCMSA-N	L138W	Soluble cytochrome b562 (P0ABE7)	N/A
3KJ6	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	Crystal structure of a Methylated beta2 Adrenergic Receptor-Fab complex	X-Ray Diffraction	3.4	2010-02-16	Bokoch et al. Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor. Nature. 2010, 463, 108.	20054398	N/A	N/A	N/A	N/A	N/A	N/A	Fab Heavy Chain, Fab Light Chain
5LWE	C-C chemokine receptor type 9	Class A	Chemokines and chemotactic factors receptors	P51686	Homo sapiens (Human)	Crystal structure of the human CC chemokine receptor type 9 (CCR9) in complex with vercirnon	X-Ray Diffraction	2.8	2016-12-07	Oswald et al. Intracellular allosteric antagonism of the CCR9 receptor. Nature. 2016, 540, 462.	27926729	79K	Vercirnon	InChI=1S/C22H21ClN2O4S/c1-22(2,3)16-4-7-18(8-5-16)30(28,29)24-20-9-6-17(23)14-19(20)21(26)15-10-12-25(27)13-11-15/h4-14,24H,1-3H3	JRWROCIMSDXGOZ-UHFFFAOYSA-N	N/A	N/A	N/A
2Y00	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND PARTIAL AGONIST DOBUTAMINE (CRYSTAL DOB92)	X-Ray Diffraction	2.5	2011-01-12	Warne et al. The Structural Basis for Agonist and Partial Agonist Action on a Beta1-Adrenergic Receptor. Nature. 2011, 469, 241.	21228877	Y00	DOBUTAMINE	InChI=1S/C18H23NO3/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15/h4-9,12-13,19-22H,2-3,10-11H2,1H3/t13-/m1/s1	JRWZLRBJNMZMFE-CYBMUJFWSA-N	R68S, M90V, C116L, Y227A, A282L, F327A, F338M, C358A	N/A	N/A
4K5Y	Corticotropin-releasing factor receptor 1	Class B	N/A	P34998	Homo sapiens (Human)	Crystal structure of human corticotropin-releasing factor receptor 1 (CRF1R) in complex with the antagonist CP-376395	X-Ray Diffraction	2.98	2013-07-17	Hollenstein et al. Structure of class B GPCR corticotropin-releasing factor receptor 1. Nature. 2013, 499, 438.	23863939	1Q5	3,6-dimethyl-N-(pentan-3-yl)-2-(2,4,6-trimethylphenoxy)pyridin-4-amine	InChI=1S/C21H30N2O/c1-8-18(9-2)23-19-12-16(6)22-21(17(19)7)24-20-14(4)10-13(3)11-15(20)5/h10-12,18H,8-9H2,1-7H3,(H,22,23)	VIZBSVDBNLAVAW-UHFFFAOYSA-N	V120A, L144A, W156A, S160A, K228A, F260A, I277A, Y309A, F330A, S349A, Y363A	Lysozyme (P00720)	N/A
5UNH	Type-2 angiotensin II receptor	Class A	Angiotensin receptors	P50052	Homo sapiens (Human)	Synchrotron structure of human angiotensin II type 2 receptor in complex with compound 2 (N-[(furan-2-yl)methyl]-N-(4-oxo-2-propyl-3-{[2'-(2H-tetrazol-5-yl)[1,1'- biphenyl]-4-yl]methyl}-3,4-dihydroquinazolin-6-yl)benzamide)	X-Ray Diffraction	2.9	2017-04-05	Zhang et al. Structural basis for selectivity and diversity in angiotensin II receptors. Nature. 2017, 544, 327.	28379944	8EM	N-[(furan-2-yl)methyl]-N-(4-oxo-2-propyl-3-{[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-3,4-dihydroquinazolin-6-yl)benzamide	InChI=1S/C37H31N7O3/c1-2-9-34-38-33-20-19-28(43(24-29-12-8-21-47-29)36(45)27-10-4-3-5-11-27)22-32(33)37(46)44(34)23-25-15-17-26(18-16-25)30-13-6-7-14-31(30)35-39-41-42-40-35/h3-8,10-22H,2,9,23-24H2,1H3,(H,39,40,41,42)	SYDVEZUPFQXMSM-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
6FK8	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of N2C/D282C stabilized opsin bound to RS08	X-Ray Diffraction	2.87	2018-04-04	Mattle et al. Ligand channel in pharmacologically stabilized rhodopsin. Proc. Natl. Acad. Sci. U.S.A. 2018, 115, 3640.	29555765	DNZ	(2~{R},3~{S})-3-azanyl-2-(4-chlorophenyl)-1-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl-butan-1-one	InChI=1S/C21H23ClN2O3/c1-14(23)19(15-6-8-16(22)9-7-15)20(25)24-12-10-21(11-13-24)26-17-4-2-3-5-18(17)27-21/h2-9,14,19H,10-13,23H2,1H3/t14-,19-/m0/s1	WRVOICVPIQQYTO-LIRRHRJNSA-N	N/A	N/A	N/A
6D27	Prostaglandin D2 receptor 2	Class A	Orphan receptors	Q9Y5Y4	Homo sapiens (Human)	Crystal structure of the prostaglandin D2 receptor CRTH2 with CAY10471	X-Ray Diffraction	2.74	2018-10-03	Wang et al. Structures of the prostaglandin D2 receptor CRTH2 with antagonists. To be Published. .	N/A	FT4	[(3R)-3-{[(4-fluorophenyl)sulfonyl](methyl)amino}-1,2,3,4-tetrahydro-9H-carbazol-9-yl]acetic acid	InChI=1S/C21H21FN2O4S/c1-23(29(27,28)16-9-6-14(22)7-10-16)15-8-11-20-18(12-15)17-4-2-3-5-19(17)24(20)13-21(25)26/h2-7,9-10,15H,8,11-13H2,1H3,(H,25,26)/t15-/m1/s1	CANCTKXGRVNXFP-OAHLLOKOSA-N	N25A	Lysozyme (D9IEF7)	N/A
5N2R	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with PSB36 at 2.8A resolution	X-Ray Diffraction	2.8	2017-07-26	Cheng et al. Structures of Human A1 and A2A Adenosine Receptors with Xanthines Reveal Determinants of Selectivity. Structure. 2017, 25, 1275.	28712806	8JN	1-butyl-3-[(~{E})-3-oxidanylprop-1-enyl]-8-[(1~{R},5~{S})-3-tricyclo[3.3.1.0^{3,7}]nonanyl]-7~{H}-purine-2,6-dione	InChI=1S/C21H28N4O3/c1-2-3-5-25-18(27)16-17(24(20(25)28)6-4-7-26)23-19(22-16)21-11-13-8-14(12-21)10-15(21)9-13/h4,6,13-15,26H,2-3,5,7-12H2,1H3,(H,22,23)/b6-4+/t13-,14+,15-,21-	BPTHCTUXQADTJT-ZKQWZTGNSA-N	A54L, T88A, R107A, K122A, N154A, L202A, L235A, V239A, S277A, G318A	Soluble cytochrome b562 (P0ABE7)	N/A
3VW7	Proteinase-activated receptor 1	Class A	Proteinase-activated receptors	P25116	Homo sapiens (Human)	Crystal structure of human protease-activated receptor 1 (PAR1) bound with antagonist vorapaxar at 2.2 angstrom	X-Ray Diffraction	2.2	2012-12-12	Zhang et al. High-resolution crystal structure of human protease-activated receptor 1. Nature. 2012, 492, 387.	23222541	VPX	ethyl [(1R,3aR,4aR,6R,8aR,9S,9aS)-9-{(E)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethenyl}-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl]carbamate	InChI=1S/C29H33FN2O4/c1-3-35-29(34)32-23-10-11-24-20(14-23)15-26-27(17(2)36-28(26)33)25(24)12-9-22-8-7-19(16-31-22)18-5-4-6-21(30)13-18/h4-9,12-13,16-17,20,23-27H,3,10-11,14-15H2,1-2H3,(H,32,34)/b12-9+/t17-,20+,23-,24-,25+,26-,27+/m1/s1	ZBGXUVOIWDMMJE-QHNZEKIYSA-N	N250G, N259S	Lysozyme (P00720)	N/A
5OLO	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Structure of the A2A-StaR2-bRIL562-Tozadenant complex at 3.1A obtained from in meso soaking experiments.	X-Ray Diffraction	3.1	2018-01-17	Rucktooa et al. Towards high throughput GPCR crystallography: In Meso soaking of Adenosine A2A Receptor crystals. Sci Rep. 2018, 8, 41.	29311713	9XW	~{N}-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-methyl-4-oxidanyl-piperidine-1-carboxamide	InChI=1S/C19H26N4O4S/c1-19(25)5-7-23(8-6-19)18(24)21-17-20-15-14(26-2)4-3-13(16(15)28-17)22-9-11-27-12-10-22/h3-4,25H,5-12H2,1-2H3,(H,20,21,24)	XNBRWUQWSKXMPW-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, N154A, L202A, L235A, V239A, S277A, G318A	Soluble cytochrome b562 (P0ABE7)	N/A
5K2A	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	2.5 angstrom A2a adenosine receptor structure with sulfur SAD phasing using XFEL data	X-Ray Diffraction	2.5	2016-09-21	Batyuk et al. Native phasing of x-ray free-electron laser data for a G protein-coupled receptor. Sci Adv. 2016, 2, e1600292.	27679816	ZMA	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
4Z35	Lysophosphatidic acid receptor 1	Class A	Lysolipids receptors	Q92633	Homo sapiens (Human)	Crystal Structure of Human Lysophosphatidic Acid Receptor 1 in complex with ONO-9910539	X-Ray Diffraction	2.9	2015-06-03	Chrencik et al. Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1. Cell. 2015, 161, 1633.	26091040	ON9	3-{1-[(2S,3S)-3-(4-acetyl-3,5-dimethoxyphenyl)-2-(2,3-dihydro-1H-inden-2-ylmethyl)-3-hydroxypropyl]-4-(methoxycarbonyl)-1H-pyrrol-3-yl}propanoic acid	InChI=1S/C32H37NO8/c1-19(34)30-27(39-2)14-24(15-28(30)40-3)31(37)25(13-20-11-21-7-5-6-8-22(21)12-20)17-33-16-23(9-10-29(35)36)26(18-33)32(38)41-4/h5-8,14-16,18,20,25,31,37H,9-13,17H2,1-4H3,(H,35,36)/t25-,31+/m0/s1	URHZQBASTULQKJ-VVFBEHOQSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
4BWB	Neurotensin receptor type 1	Class A	Neurotensin receptors	P20789	Rattus norvegicus (Rat)	Structure of Evolved Agonist-bound Neurotensin Receptor 1 Mutant without Lysozyme Fusion	X-Ray Diffraction	3.57	2014-01-29	Egloff et al. Structure of Signaling-Competent Neurotensin Receptor 1 Obtained by Directed Evolution in Escherichia Coli. Proc.Natl.Acad.Sci.USA. 2014, 111, E655.	24453215	N/A	N/A	N/A	N/A	S83G, A86L, T101R, H103D, H105Y, L119F, M121L, E124D, R143K, D150E, A161V, R167L, R213L, V234L, K235R, V240L, I253A, I260A, N262R, K263R, H305R, C332V, F342A, T354S, F358V, S362A	N/A	N/A
3OE6	C-X-C chemokine receptor type 4	Class A	Chemokines and chemotactic factors receptors	P61073	Homo sapiens (Human)	Crystal structure of the CXCR4 chemokine receptor in complex with a small molecule antagonist IT1t in I222 spacegroup	X-Ray Diffraction	3.2	2010-10-27	Wu et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science. 2010, 330, 1066.	20929726	ITD	(6,6-dimethyl-5,6-dihydroimidazo[2,1-b][1,3]thiazol-3-yl)methyl N,N'-dicyclohexylimidothiocarbamate	InChI=1S/C21H34N4S2/c1-21(2)15-25-18(14-27-20(25)24-21)13-26-19(22-16-9-5-3-6-10-16)23-17-11-7-4-8-12-17/h14,16-17H,3-13,15H2,1-2H3,(H,22,23)	OOSUDWRRWZVFEB-UHFFFAOYSA-N	N/A	Lysozyme (P00720)	N/A
4MQS	Muscarinic acetylcholine receptor M2	Class A	Acetylcholine (muscarinic) receptors	P08172	Homo sapiens (Human)	Structure of active human M2 muscarinic acetylcholine receptor bound to the agonist iperoxo	X-Ray Diffraction	3.5	2013-11-27	Kruse et al. Activation and allosteric modulation of a muscarinic acetylcholine receptor. Nature. 2013, 504, 101.	24256733	IXO	4-(4,5-dihydro-1,2-oxazol-3-yloxy)-N,N,N-trimethylbut-2-yn-1-aminium	InChI=1S/C10H17N2O2/c1-12(2,3)7-4-5-8-13-10-6-9-14-11-10/h6-9H2,1-3H3/q+1	WXXOCGISBCTWPW-UHFFFAOYSA-N	N0D, N1D, N4D, N7D, A373T, K374R	N/A	Nanobody 9-8
5L7I	Smoothened homolog	Class F	N/A	Q99835	Homo sapiens (Human)	Structure of human Smoothened in complex with Vismodegib	X-Ray Diffraction	3.3	2016-07-20	Byrne et al. Structural basis of Smoothened regulation by its extracellular domains. Nature. 2016, 535, 517.	27437577	VIS	2-chloranyl-~{N}-(4-chloranyl-3-pyridin-2-yl-phenyl)-4-methylsulfonyl-benzamide	InChI=1S/C19H14Cl2N2O3S/c1-27(25,26)13-6-7-14(17(21)11-13)19(24)23-12-5-8-16(20)15(10-12)18-4-2-3-9-22-18/h2-11H,1H3,(H,23,24)	BPQMGSKTAYIVFO-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
4EIY	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Crystal structure of the chimeric protein of A2aAR-BRIL in complex with ZM241385 at 1.8A resolution	X-Ray Diffraction	1.8	2012-07-25	Liu et al. Structural basis for allosteric regulation of GPCRs by sodium ions. Science. 2012, 337, 232.	22798613	ZMA	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
6FFH	Metabotropic glutamate receptor 5	Class C	N/A	P41594	Homo sapiens (Human)	Crystal Structure of mGluR5 in complex with Fenobam at 2.65 A	X-Ray Diffraction	2.65	2018-03-07	Christopher et al. Structure-Based Optimization Strategies for G Protein-Coupled Receptor (GPCR) Allosteric Modulators: A Case Study from Analyses of New Metabotropic Glutamate Receptor 5 (mGlu5) X-ray Structures. J. Med. Chem. 2018.	29455526	D7W	1-(3-chlorophenyl)-3-(3-methyl-5-oxidanylidene-4~{H}-imidazol-2-yl)urea	InChI=1S/C11H11ClN4O2/c1-16-6-9(17)14-10(16)15-11(18)13-8-4-2-3-7(12)5-8/h2-5H,6H2,1H3,(H2,13,14,15,17,18)	DWPQODZAOSWNHB-UHFFFAOYSA-N	E579A, N667Y, I669A, G675M, T1742A, S1753A	Lysozyme (P00720)	N/A
5NM4	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	A2A Adenosine receptor room-temperature structure determined by serial femtosecond crystallography	X-Ray Diffraction	1.7	2017-09-27	Weinert et al. Serial millisecond crystallography for routine room-temperature structure determination at synchrotrons. Nat Commun. 2017, 8, 542.	28912485	ZMA	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N	A63L, T97A, R116A, K131A, N163A, L211A, L340A, V344A, S382A	Soluble cytochrome b562 (P0ABE7)	N/A
5IU8	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with compound 12f at 2.0A resolution	X-Ray Diffraction	2.0	2016-06-29	Segala et al. Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength. J.Med.Chem. 2016, 59, 6470.	27312113	6DZ	2-(furan-2-yl)-N~5~-[2-(4-methylpiperazin-1-yl)ethyl][1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine	InChI=1S/C15H21N9O/c1-22-6-8-23(9-7-22)5-4-17-14-19-13(16)24-15(20-14)18-12(21-24)11-3-2-10-25-11/h2-3,10H,4-9H2,1H3,(H3,16,17,18,19,20,21)	NLHRMBTYEDTOKC-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, N154A, L202A, L235A, V239A, S277A	Soluble cytochrome b562 (P0ABE7)	N/A
5IU7	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with compound 12c at 1.9A resolution	X-Ray Diffraction	1.9	2016-06-29	Segala et al. Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength. J.Med.Chem. 2016, 59, 6470.	27312113	6DY	2-(furan-2-yl)-N~5~-[2-(4-phenylpiperidin-1-yl)ethyl][1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine	InChI=1S/C21H24N8O/c22-19-25-20(26-21-24-18(27-29(19)21)17-7-4-14-30-17)23-10-13-28-11-8-16(9-12-28)15-5-2-1-3-6-15/h1-7,14,16H,8-13H2,(H3,22,23,24,25,26,27)	WUOOFKSGLYZAKD-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, N154A, L202A, L235A, V239A, S277A	Soluble cytochrome b562 (P0ABE7)	N/A
2KSB	Substance-P receptor	Class A	Tachykinin receptors	P25103	Homo sapiens (Human)	Substance P in isotropic q=0.25 DMPC/CHAPS/GM1 bicelles as a ligand for NK1R	Solution NMR	N/A	2010-11-03	Gayen et al. NMR evidence of GM1-induced conformational change of Substance P using isotropic bicelles. Biochim.Biophys.Acta. 2010.	20937248	N/A	N/A	N/A	N/A	N/A	N/A	N/A
5JTB	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Crystal structure of the chimeric protein of A2aAR-BRIL with bound iodide ions	X-Ray Diffraction	2.8	2017-05-31	Melnikov et al. Fast iodide-SAD phasing for high-throughput membrane protein structure determination. Sci Adv. 2017, 3, e1602952.	28508075	ZMA	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
5XRA	Cannabinoid receptor 1	Class A	Cannabinoids receptors	P21554	Homo sapiens (Human)	Crystal structure of the human CB1 in complex with agonist AM11542	X-Ray Diffraction	2.8	2017-07-12	Hua et al. Crystal structures of agonist-bound human cannabinoid receptor CB1. Nature. 2017, 547, 468.	28678776	8D3	(6aR,10aR)-3-(8-bromanyl-2-methyl-octan-2-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol	InChI=1S/C25H37BrO2/c1-17-10-11-20-19(14-17)23-21(27)15-18(16-22(23)28-25(20,4)5)24(2,3)12-8-6-7-9-13-26/h10,15-16,19-20,27H,6-9,11-14H2,1-5H3/t19-,20-/m1/s1	SZDVFUZKFPGYEK-WOJBJXKFSA-N	T210A, E273K, T283V, R340E	Flavodoxin (P00323)	N/A
5VEW	Glucagon-like peptide 1 receptor	Class B	N/A	P43220	Homo sapiens (Human)	Structure of the human GLP-1 receptor complex with PF-06372222	X-Ray Diffraction	2.7	2017-05-24	Song et al. Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators. Nature. 2017, 546, 312.	28514449	97Y	N-{4-[(R)-(3,3-dimethylcyclobutyl)({6-[4-(trifluoromethyl)-1H-imidazol-1-yl]pyridin-3-yl}amino)methyl]benzene-1-carbonyl}-beta-alanine	InChI=1S/C26H28F3N5O3/c1-25(2)11-18(12-25)23(16-3-5-17(6-4-16)24(37)30-10-9-22(35)36)33-19-7-8-21(31-13-19)34-14-20(32-15-34)26(27,28)29/h3-8,13-15,18,23,33H,9-12H2,1-2H3,(H,30,37)(H,35,36)/t23-/m0/s1	MYZIDYJMNWEJMC-QHCPKHFHSA-N	S193C, I196F, S225A, S271A, I317C, G318I, K346A, C347F, G361C	Lysozyme (P00720)	N/A
2YDV	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Thermostabilised HUMAN A2a Receptor with NECA bound	X-Ray Diffraction	2.6	2011-05-18	Lebon et al. Agonist-Bound Adenosine A(2A) Receptor Structures Reveal Common Features of Gpcr Activation. Nature. 2011, 474, 521.	21593763	NEC	N-ETHYL-5'-CARBOXAMIDO ADENOSINE	InChI=1S/C12H16N6O4/c1-2-14-11(21)8-6(19)7(20)12(22-8)18-4-17-5-9(13)15-3-16-10(5)18/h3-4,6-8,12,19-20H,2H2,1H3,(H,14,21)(H2,13,15,16)/t6-,7+,8-,12+/m0/s1	JADDQZYHOWSFJD-FLNNQWSLSA-N	L48A, A54L, T65A, Q89A, N154A	N/A	N/A
4IAR	5-hydroxytryptamine receptor 1B	Class A	Serotonin receptors	P28222	Homo sapiens (Human)	Crystal structure of the chimeric protein of 5-HT1B-BRIL in complex with ergotamine (PSI Community Target)	X-Ray Diffraction	2.7	2013-03-13	Wang et al. Structural basis for molecular recognition at serotonin receptors. Science. 2013, 340, 610.	23519210	ERM	Ergotamine	InChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1	XCGSFFUVFURLIX-VFGNJEKYSA-N	L138W	Soluble cytochrome b562 (P0ABE7)	N/A
4U15	Muscarinic acetylcholine receptor M3	Class A	Acetylcholine (muscarinic) receptors	P08483	Rattus norvegicus (Rat)	M3-mT4L receptor bound to tiotropium	X-Ray Diffraction	2.8	2014-11-26	Thorsen et al. Modified T4 Lysozyme Fusion Proteins Facilitate G Protein-Coupled Receptor Crystallogenesis. Structure. 2014, 22, 1657.	25450769	0HK	(1R,2R,4S,5S,7S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane	InChI=1S/C19H22NO4S2/c1-20(2)12-9-11(10-13(20)17-16(12)24-17)23-18(21)19(22,14-5-3-7-25-14)15-6-4-8-26-15/h3-8,11-13,16-17,22H,9-10H2,1-2H3/q+1/t11-,12-,13+,16-,17+	LERNTVKEWCAPOY-DZZGSBJMSA-N	N/A	Lysozyme (D9IEF7)	N/A
6MEO	C-C chemokine receptor type 5	Class A	Chemokines and chemotactic factors receptors	P51681	Homo sapiens (Human)	Structural basis of coreceptor recognition by HIV-1 envelope spike	Electron Microscopy	3.9	2018-12-12	Shaik et al. Structural basis of coreceptor recognition by HIV-1 envelope spike. Nature. 2018.	30542158	N/A	N/A	N/A	N/A	N/A	N/A	T-cell surface glycoprotein CD4 (P01730), Envelope glycoprotein gp160 {ECO:0000256|SAAS:SAAS01060177} (Q70145)
5CGD	Metabotropic glutamate receptor 5	Class C	N/A	P41594	Homo sapiens (Human)	Structure of the human class C GPCR metabotropic glutamate receptor 5 transmembrane domain in complex with the negative allosteric modulator 3-chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile - (HTL14242)	X-Ray Diffraction	2.6	2015-08-12	Christopher et al. Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile). J.Med.Chem. 2015, 58, 6653.	26225459	51E	3-chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile	InChI=1S/C16H8ClFN4/c17-12-4-10(7-19)3-11(5-12)15-6-16(22-9-21-15)14-2-1-13(18)8-20-14/h1-6,8-9H	FQAXDSVNYVVQSE-UHFFFAOYSA-N	E579A, N667Y, I669A, G675M, T742A, S753A	Lysozyme (P00720)	N/A
4PHU	Free fatty acid receptor 1	Class A	Free fatty acid receptors	O14842	Homo sapiens (Human)	Crystal structure of Human GPR40 bound to allosteric agonist TAK-875	X-Ray Diffraction	2.33	2014-07-16	Srivastava et al. High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875. Nature. 2014, 513, 124.	25043059	2YB	[(3S)-6-({2',6'-dimethyl-4'-[3-(methylsulfonyl)propoxy]biphenyl-3-yl}methoxy)-2,3-dihydro-1-benzofuran-3-yl]acetic acid	InChI=1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21(14-22)17-35-24-8-9-26-23(15-28(30)31)18-36-27(26)16-24/h4,6-9,12-14,16,23H,5,10-11,15,17-18H2,1-3H3,(H,30,31)/t23-/m1/s1	BZCALJIHZVNMGJ-HSZRJFAPSA-N	L42A, F88A, G103A, Y202F	Lysozyme (P00720)	N/A
3RZE	Histamine H1 receptor	Class A	Histamine receptors	P35367	Homo sapiens (Human)	Structure of the human histamine H1 receptor in complex with doxepin	X-Ray Diffraction	3.1	2011-06-15	Shimamura et al. Structure of the human histamine H1 receptor complex with doxepin. Nature. 2011, 475, 65.	21697825	5EH$$$$D7V	(3E)-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine$$$$(3Z)-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine	InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3/b17-11+$$$$InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3/b17-11-	ODQWQRRAPPTVAG-GZTJUZNOSA-N$$$$ODQWQRRAPPTVAG-BOPFTXTBSA-N	N/A	Lysozyme (P00720)	N/A
3SN6	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	Crystal structure of the beta2 adrenergic receptor-Gs protein complex	X-Ray Diffraction	3.2	2011-07-20	Rasmussen et al. Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature. 2011, 477, 549.	21772288	P0G	8-[(1R)-2-{[1,1-dimethyl-2-(2-methylphenyl)ethyl]amino}-1-hydroxyethyl]-5-hydroxy-2H-1,4-benzoxazin-3(4H)-one	InChI=1S/C21H26N2O4/c1-13-6-4-5-7-14(13)10-21(2,3)22-11-17(25)15-8-9-16(24)19-20(15)27-12-18(26)23-19/h4-9,17,22,24-25H,10-12H2,1-3H3,(H,23,26)/t17-/m0/s1	NWQXBEWHTDRJIP-KRWDZBQOSA-N	M96T, M98T, N187E	Lysozyme (P00720)	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (P04896), Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (P54311), Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 (P63212), Camelid Antibody Vhh Fragment
5WB1	G-protein coupled receptor homolog US28	Class A	Viral receptors	P69333	Human cytomegalovirus (strain Towne) (HHV-5)	Ligand-free US28 with stabilizing intracellular nanobody	X-Ray Diffraction	3.51	2018-06-13	Miles et al. Viral GPCR US28 can signal in response to chemokine agonists of nearly unlimited structural degeneracy. Elife. 2018, 7, .	29882741	N/A	N/A	N/A	N/A	N/A	N/A	N/A
3V2W	Sphingosine 1-phosphate receptor 1	Class A	Lysolipids receptors	P21453	Homo sapiens (Human)	Crystal Structure of a Lipid G protein-Coupled Receptor at 3.35A	X-Ray Diffraction	3.35	2012-02-15	Hanson et al. Crystal structure of a lipid G protein-coupled receptor. Science. 2012, 335, 851.	22344443	ML5	{(3R)-3-amino-4-[(3-hexylphenyl)amino]-4-oxobutyl}phosphonic acid	InChI=1S/C16H27N2O4P/c1-2-3-4-5-7-13-8-6-9-14(12-13)18-16(19)15(17)10-11-23(20,21)22/h6,8-9,12,15H,2-5,7,10-11,17H2,1H3,(H,18,19)(H2,20,21,22)/t15-/m1/s1	FWJRVGZWNDOOFH-OAHLLOKOSA-N	N/A	Lysozyme (P00720)	N/A
3NY9	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	Crystal structure of the human beta2 adrenergic receptor in complex with a novel inverse agonist	X-Ray Diffraction	2.84	2010-08-11	Wacker et al. Conserved Binding Mode of Human beta(2) Adrenergic Receptor Inverse Agonists and Antagonist Revealed by X-ray Crystallography. J.Am.Chem.Soc. 2010, 132, 11443.	20669948	JSZ	ethyl 4-({(2S)-2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)-3-methyl-1-benzofuran-2-carboxylate	InChI=1S/C18H25NO5/c1-5-22-18(21)17-12(4)16-14(7-6-8-15(16)24-17)23-10-13(20)9-19-11(2)3/h6-8,11,13,19-20H,5,9-10H2,1-4H3/t13-/m0/s1	QVJVMNUTCGTBCH-ZDUSSCGKSA-N	E122W, N187E	Lysozyme (P00720)	N/A
5WQC	Orexin receptor type 2	Class A	Orexins receptors	O43614	Homo sapiens (Human)	Crystal structure of human orexin 2 receptor bound to the selective antagonist EMPA determined by the synchrotron light source at SPring-8.	X-Ray Diffraction	1.96	2017-11-29	Suno et al. Crystal Structures of Human Orexin 2 Receptor Bound to the Subtype-Selective Antagonist EMPA. Structure. 2018, 26, 7.	29225076	7MA	N-ethyl-2-[(6-methoxypyridin-3-yl)-(2-methylphenyl)sulfonyl-amino]-N-(pyridin-3-ylmethyl)ethanamide	InChI=1S/C23H26N4O4S/c1-4-26(16-19-9-7-13-24-14-19)23(28)17-27(20-11-12-22(31-3)25-15-20)32(29,30)21-10-6-5-8-18(21)2/h5-15H,4,16-17H2,1-3H3	KJPHTXTWFHVJIG-UHFFFAOYSA-N	N/A	GlgA glycogen synthase (Q9V2J8)	N/A
6H7N	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND PARTIAL AGONIST XAMOTEROL AND NANOBODY Nb6B9	X-Ray Diffraction	2.5	2018-10-17	Warne et al. Molecular basis for high affinity agonist binding in GPCRs. Biorxiv. 2018.	N/A	FVK	~{N}-[2-[[(2~{S})-2-oxidanyl-3-(4-oxidanylphenoxy)propyl]amino]ethyl]morpholine-4-carboxamide	InChI=1S/C16H25N3O5/c20-13-1-3-15(4-2-13)24-12-14(21)11-17-5-6-18-16(22)19-7-9-23-10-8-19/h1-4,14,17,20-21H,5-12H2,(H,18,22)/t14-/m0/s1	DXPOSRCHIDYWHW-AWEZNQCLSA-N	R68S, M90V, C116L, F327A, F338M, C358A	N/A	Camelid Antibody Fragment Nb6b9, Thioredoxin 1 (P0AA25)
3CAP	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal Structure of Native Opsin: the G Protein-Coupled Receptor Rhodopsin in its Ligand-free State	X-Ray Diffraction	2.9	2008-06-24	Park et al. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature. 2008, 454, 183.	18563085	N/A	N/A	N/A	N/A	N/A	N/A	N/A
2Y02	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND AGONIST CARMOTEROL	X-Ray Diffraction	2.6	2011-01-12	Warne et al. The Structural Basis for Agonist and Partial Agonist Action on a Beta1-Adrenergic Receptor. Nature. 2011, 469, 241.	21228877	WHJ	CARMOTEROL	InChI=1S/C21H24N2O4/c1-13(11-14-3-5-15(27-2)6-4-14)22-12-19(25)16-7-9-18(24)21-17(16)8-10-20(26)23-21/h3-10,13,19,22,24-25H,11-12H2,1-2H3,(H,23,26)/t13-,19+/m1/s1	IHOXNOQMRZISPV-YJYMSZOUSA-N	R68S, M90V, C116L, Y227A, A282L, F327A, F338M, C358A	N/A	N/A
6FFI	Metabotropic glutamate receptor 5	Class C	N/A	P41594	Homo sapiens (Human)	Crystal Structure of mGluR5 in complex with MMPEP at 2.2 A	X-Ray Diffraction	2.2	2018-03-07	Christopher et al. Structure-Based Optimization Strategies for G Protein-Coupled Receptor (GPCR) Allosteric Modulators: A Case Study from Analyses of New Metabotropic Glutamate Receptor 5 (mGlu5) X-ray Structures. J. Med. Chem. 2018.	29455526	D8B	2-[2-(3-methoxyphenyl)ethynyl]-6-methyl-pyridine	InChI=1S/C15H13NO/c1-12-5-3-7-14(16-12)10-9-13-6-4-8-15(11-13)17-2/h3-8,11H,1-2H3	STDHINPODVHROK-UHFFFAOYSA-N	E579A, N667Y, I669A, G675M, T902A, S913A	Lysozyme (P00720)	N/A
6FK9	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of N2C/D282C stabilized opsin bound to RS09	X-Ray Diffraction	2.63	2018-04-04	Mattle et al. Ligand channel in pharmacologically stabilized rhodopsin. Proc. Natl. Acad. Sci. U.S.A. 2018, 115, 3640.	29555765	DNK	(2~{S})-3-methyl-2-phenyl-1-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl-butan-1-one	InChI=1S/C22H25NO3/c1-16(2)20(17-8-4-3-5-9-17)21(24)23-14-12-22(13-15-23)25-18-10-6-7-11-19(18)26-22/h3-11,16,20H,12-15H2,1-2H3/t20-/m0/s1	RWIUNGUJHWADDD-FQEVSTJZSA-N	N/A	N/A	N/A
1F88	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	CRYSTAL STRUCTURE OF BOVINE RHODOPSIN	X-Ray Diffraction	2.8	2000-08-04	Palczewski et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science. 2000, 289, 739.	10926528	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N/A	N/A	N/A
5WS3	Orexin receptor type 2	Class A	Orexins receptors	O43614	Homo sapiens (Human)	Crystal structures of human orexin 2 receptor bound to the selective antagonist EMPA determined by serial femtosecond crystallography at SACLA	X-Ray Diffraction	2.3	2017-12-13	Suno et al. Crystal Structures of Human Orexin 2 Receptor Bound to the Subtype-Selective Antagonist EMPA. Structure. 2018, 26, 7.	29225076	7MA	N-ethyl-2-[(6-methoxypyridin-3-yl)-(2-methylphenyl)sulfonyl-amino]-N-(pyridin-3-ylmethyl)ethanamide	InChI=1S/C23H26N4O4S/c1-4-26(16-19-9-7-13-24-14-19)23(28)17-27(20-11-12-22(31-3)25-15-20)32(29,30)21-10-6-5-8-18(21)2/h5-15H,4,16-17H2,1-3H3	KJPHTXTWFHVJIG-UHFFFAOYSA-N	N/A	GlgA glycogen synthase (Q9V2J8)	N/A
5ZBQ	Neuropeptide Y receptor type 1	Class A	Neuropeptide Y receptors	P25929	Homo sapiens (Human)	The Crystal Structure of human neuropeptide Y Y1 receptor with UR-MK299	X-Ray Diffraction	2.7	2018-04-25	Yang et al. Structural basis of ligand binding modes at the neuropeptide Y Y1receptor. Nature. 2018, 556, 520.	29670288	9AO	N~2~-(diphenylacetyl)-N-[(4-hydroxyphenyl)methyl]-N~5~-(N'-{[2-(propanoylamino)ethyl]carbamoyl}carbamimidoyl)-D-ornithinamide	InChI=1S/C33H41N7O5/c1-2-28(42)35-20-21-37-33(45)40-32(34)36-19-9-14-27(30(43)38-22-23-15-17-26(41)18-16-23)39-31(44)29(24-10-5-3-6-11-24)25-12-7-4-8-13-25/h3-8,10-13,15-18,27,29,41H,2,9,14,19-22H2,1H3,(H,35,42)(H,38,43)(H,39,44)(H4,34,36,37,40,45)/t27-/m1/s1	VQHNWOOVOKYJNL-HHHXNRCGSA-N	F129W	Thymosin beta {ECO:0000256|PIRNR:PIRNR001828} (A0A097)	N/A
4XNV	P2Y purinoceptor 1	Class A	Adenosine and adenine nucleotide receptors	P47900	Homo sapiens (Human)	The human P2Y1 receptor in complex with BPTU	X-Ray Diffraction	2.2	2015-04-01	Zhang et al. Two disparate ligand-binding sites in the human P2Y1 receptor. Nature. 2015, 520, 317.	25822790	BUR	1-[2-(2-tert-butylphenoxy)pyridin-3-yl]-3-[4-(trifluoromethoxy)phenyl]urea	InChI=1S/C23H22F3N3O3/c1-22(2,3)17-7-4-5-9-19(17)31-20-18(8-6-14-27-20)29-21(30)28-15-10-12-16(13-11-15)32-23(24,25)26/h4-14H,1-3H3,(H2,28,29,30)	AHFLGPTXSIRAQK-UHFFFAOYSA-N	D320N	Rubredoxin (P00268)	N/A
5X7D	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	Structure of beta2 adrenoceptor bound to carazolol and an intracellular allosteric antagonist	X-Ray Diffraction	2.7	2017-08-16	Liu et al. Mechanism of intracellular allosteric beta 2AR antagonist revealed by X-ray crystal structure. Nature. 2017, 548, 480.	28813418	8VS$$$$CAU	4-carbamoyl-N-[(2R)-2-cyclohexyl-2-phenylacetyl]-L-phenylalanyl-3-bromo-N-methyl-L-phenylalaninamide$$$$(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol	InChI=1S/C34H39BrN4O4/c1-37-32(41)28(21-23-9-8-14-27(35)19-23)38-33(42)29(20-22-15-17-26(18-16-22)31(36)40)39-34(43)30(24-10-4-2-5-11-24)25-12-6-3-7-13-25/h2,4-5,8-11,14-19,25,28-30H,3,6-7,12-13,20-21H2,1H3,(H2,36,40)(H,37,41)(H,38,42)(H,39,43)/t28-,29-,30-/m0/s1$$$$InChI=1S/C18H22N2O2/c1-12(2)19-10-13(21)11-22-17-9-5-8-16-18(17)14-6-3-4-7-15(14)20-16/h3-9,12-13,19-21H,10-11H2,1-2H3/t13-/m0/s1	MZHSBVCCCRUZKX-DTXPUJKBSA-N$$$$BQXQGZPYHWWCEB-ZDUSSCGKSA-N	N187E	Lysozyme (P00720)	N/A
5WIV	D(4) dopamine receptor	Class A	Dopamine receptors	P21917	Homo sapiens (Human)	Structure of the sodium-bound human D4 Dopamine receptor in complex with Nemonapride	X-Ray Diffraction	2.14	2017-10-18	Wang et al. D4 dopamine receptor high-resolution structures enable the discovery of selective agonists. Science. 2017, 358, 381.	29051383	AQD	Nemonapride	InChI=1S/C21H26ClN3O2/c1-14-18(9-10-25(14)13-15-7-5-4-6-8-15)24-21(26)16-11-17(22)19(23-2)12-20(16)27-3/h4-8,11-12,14,18,23H,9-10,13H2,1-3H3,(H,24,26)/t14-,18-/m1/s1	KRVOJOCLBAAKSJ-RDTXWAMCSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
5XPR	Endothelin receptor type B	Class A	Endothelin receptors	P24530	Homo sapiens (Human)	Human endothelin receptor type-B in complex with antagonist bosentan	X-Ray Diffraction	3.6	2017-08-16	Shihoya et al. X-ray structures of endothelin ETB receptor bound to clinical antagonist bosentan and its analog. Nat. Struct. Mol. Biol. 2017, 24, 758.	28805809	K86	4-tert-butyl-N-[6-(2-hydroxyethyloxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]benzenesulfonamide	InChI=1S/C27H29N5O6S/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24/h5-15,33H,16-17H2,1-4H3,(H,30,31,32)	GJPICJJJRGTNOD-UHFFFAOYSA-N	R124Y, K270A, S342A, I381A, C396A, C400A, C405A	Lysozyme (P00720)	N/A
5U09	Cannabinoid receptor 1	Class A	Cannabinoids receptors	P21554	Homo sapiens (Human)	High-resolution crystal structure of the human CB1 cannabinoid receptor	X-Ray Diffraction	2.6	2016-12-07	Shao et al. High-resolution crystal structure of the human CB1 cannabinoid receptor. Nature. 2016.	27851727	7DY	N-[(2S,3S)-4-(4-chlorophenyl)-3-(3-cyanophenyl)butan-2-yl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide	InChI=1S/C27H25ClF3N3O2/c1-17(34-25(35)26(2,3)36-24-12-9-21(16-33-24)27(29,30)31)23(14-18-7-10-22(28)11-8-18)20-6-4-5-19(13-20)15-32/h4-13,16-17,23H,14H2,1-3H3,(H,34,35)/t17-,23+/m0/s1	QLYKJCMUNUWAGO-GAJHUEQPSA-N	T210A	GlgA glycogen synthase (Q9V2J8)	N/A
5ZKC	Muscarinic acetylcholine receptor M2	Class A	Acetylcholine (muscarinic) receptors	P08172	Homo sapiens (Human)	Crystal structure of rationally thermostabilized M2 muscarinic acetylcholine receptor bound with NMS	X-Ray Diffraction	2.3	2018-11-21	Suno et al. Structural insights into the subtype-selective antagonist binding to the M2muscarinic receptor. Nat. Chem. Biol. 2018, 14, 1150.	30420692	3C0	N-methyl scopolamine	InChI=1S/C18H24NO4/c1-19(2)14-8-12(9-15(19)17-16(14)23-17)22-18(21)13(10-20)11-6-4-3-5-7-11/h3-7,12-17,20H,8-10H2,1-2H3/q+1/t12-,13-,14-,15+,16-,17+/m1/s1	LZCOQTDXKCNBEE-IKIFYQGPSA-N	S110R	N/A	N/A
5YHL	Prostaglandin E2 receptor EP4 subtype	Class A	Prostanoids receptors	P35408	Homo sapiens (Human)	Anomalous bromine signal of the human prostaglandin E receptor EP4 in complex with Fab and ONO-AE3-208-Br derivative	X-Ray Diffraction	4.2	2018-12-05	Toyoda et al. Ligand binding to human prostaglandin E receptor EP4at the lipid-bilayer interface. Nat. Chem. Biol. 2019, 15, 18.	30510193	8VL	4-[2-[[(2R)-2-(4-bromanylnaphthalen-1-yl)propanoyl]amino]-4-cyano-phenyl]butanoic acid	InChI=1S/C24H21BrN2O3/c1-15(18-11-12-21(25)20-7-3-2-6-19(18)20)24(30)27-22-13-16(14-26)9-10-17(22)5-4-8-23(28)29/h2-3,6-7,9-13,15H,4-5,8H2,1H3,(H,27,30)(H,28,29)/t15-/m1/s1	MCJIJRUBPRBSIT-OAHLLOKOSA-N	N7Q, A62L, G106R, N177Q	N/A	Heavy Chain Of Fab Fragment, Light Chain Of Fab Fragment
6FKB	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of N2C/D282C stabilized opsin bound to RS13	X-Ray Diffraction	3.03	2018-04-04	Mattle et al. Ligand channel in pharmacologically stabilized rhodopsin. Proc. Natl. Acad. Sci. U.S.A. 2018, 115, 3640.	29555765	DLH	2-(4-chlorophenyl)-1-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl-ethanone	InChI=1S/C19H18ClNO3/c20-15-7-5-14(6-8-15)13-18(22)21-11-9-19(10-12-21)23-16-3-1-2-4-17(16)24-19/h1-8H,9-13H2	FYEGABNDKDAYPJ-UHFFFAOYSA-N	N/A	N/A	N/A
5K2B	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	2.5 angstrom A2a adenosine receptor structure with MR phasing using XFEL data	X-Ray Diffraction	2.5	2016-09-21	Batyuk et al. Native phasing of x-ray free-electron laser data for a G protein-coupled receptor. Sci Adv. 2016, 2, e1600292.	27679816	ZMA	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
3UON	Muscarinic acetylcholine receptor M2	Class A	Acetylcholine (muscarinic) receptors	P08172	Homo sapiens (Human)	Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist	X-Ray Diffraction	3.0	2012-02-01	Haga et al. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature. 2012, 482, 547.	22278061	QNB	(3R)-1-azabicyclo[2.2.2]oct-3-yl hydroxy(diphenyl)acetate	InChI=1S/C21H23NO3/c23-20(25-19-15-22-13-11-16(19)12-14-22)21(24,17-7-3-1-4-8-17)18-9-5-2-6-10-18/h1-10,16,19,24H,11-15H2/t19-/m0/s1	HGMITUYOCPPQLE-IBGZPJMESA-N	N2D, N3D, N6D, N9D	Lysozyme (P00720)	N/A
5OM1	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Structure of the A2A-StaR2-bRIL562-Compound 4e complex at 2.1A obtained from in meso soaking experiments (1 hour soak).	X-Ray Diffraction	2.1	2018-01-17	Rucktooa et al. Towards high throughput GPCR crystallography: In Meso soaking of Adenosine A2A Receptor crystals. Sci Rep. 2018, 8, 41.	29311713	T4E	4-(3-amino-5-phenyl-1,2,4-triazin-6-yl)-2-chlorophenol	InChI=1S/C15H11ClN4O/c16-11-8-10(6-7-12(11)21)14-13(18-15(17)20-19-14)9-4-2-1-3-5-9/h1-8,21H,(H2,17,18,20)	ZHUZHTHIEMXLRA-UHFFFAOYSA-N	A54L, T88A, R107A, K122A, N154A, L202A, L235A, V239A, S277A	Soluble cytochrome b562 (P0ABE7)	N/A
3D4S	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	Cholesterol bound form of human beta2 adrenergic receptor.	X-Ray Diffraction	2.8	2008-06-17	Hanson et al. A specific cholesterol binding site is established by the 28 A structure of the human beta2-adrenergic receptor. Structure. 2008, 16, 897.	18547522	TIM	(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol	InChI=1S/C13H24N4O3S/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17/h10,14,18H,4-9H2,1-3H3/t10-/m0/s1	BLJRIMJGRPQVNF-JTQLQIEISA-N	N/A	Lysozyme (P00720)	N/A
5EE7	Glucagon receptor	Class B	N/A	P47871	Homo sapiens (Human)	Crystal structure of the human glucagon receptor (GCGR) in complex with the antagonist MK-0893	X-Ray Diffraction	2.5	2016-04-20	Jazayeri et al. Extra-helical binding site of a glucagon receptor antagonist. Nature. 2016, 533, 274.	27111510	5MV	3-[[4-[(1~{S})-1-[3-[3,5-bis(chloranyl)phenyl]-5-(6-methoxynaphthalen-2-yl)pyrazol-1-yl]ethyl]phenyl]carbonylamino]propanoic acid	InChI=1S/C32H27Cl2N3O4/c1-19(20-3-5-21(6-4-20)32(40)35-12-11-31(38)39)37-30(18-29(36-37)25-14-26(33)17-27(34)15-25)24-8-7-23-16-28(41-2)10-9-22(23)13-24/h3-10,13-19H,11-12H2,1-2H3,(H,35,40)(H,38,39)/t19-/m0/s1	DNTVJEMGHBIUMW-IBGZPJMESA-N	M137G, G154A, R173A, A182L, S190A, V193F, G207E, G223A, M276A, K344A, E362F, F387A	Lysozyme (P00720)	N/A
4DKL	Mu-type opioid receptor	Class A	Opioid peptides receptors	P42866	Mus musculus (Mouse)	Crystal structure of the mu-opioid receptor bound to a morphinan antagonist	X-Ray Diffraction	2.8	2012-03-21	Manglik et al. Crystal structure of the {mu}-opioid receptor bound to a morphinan antagonist. Nature. 2012, 485, 321.	22437502	BF0	methyl 4-{[(5beta,6alpha)-17-(cyclopropylmethyl)-3,14-dihydroxy-4,5-epoxymorphinan-6-yl]amino}-4-oxobutanoate	InChI=1S/C25H32N2O6/c1-32-20(30)7-6-19(29)26-16-8-9-25(31)18-12-15-4-5-17(28)22-21(15)24(25,23(16)33-22)10-11-27(18)13-14-2-3-14/h4-5,14,16,18,23,28,31H,2-3,6-13H2,1H3,(H,26,29)/t16-,18-,23+,24+,25-/m1/s1	PGIBGSVRAVGQMY-OIUZVZFJSA-N	N/A	Lysozyme (P00720)	N/A
5VEX	Glucagon-like peptide 1 receptor	Class B	N/A	P43220	Homo sapiens (Human)	Structure of the human GLP-1 receptor complex with NNC0640	X-Ray Diffraction	3.0	2017-05-17	Song et al. Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators. Nature. 2017, 546, 312.	28514449	97V	4-{[(4-cyclohexylphenyl){[3-(methylsulfonyl)phenyl]carbamoyl}amino]methyl}-N-(1H-tetrazol-5-yl)benzamide	InChI=1S/C29H31N7O4S/c1-41(39,40)26-9-5-8-24(18-26)30-29(38)36(25-16-14-22(15-17-25)21-6-3-2-4-7-21)19-20-10-12-23(13-11-20)27(37)31-28-32-34-35-33-28/h5,8-18,21H,2-4,6-7,19H2,1H3,(H,30,38)(H2,31,32,33,34,35,37)	PPTKULJUDJWTSA-UHFFFAOYSA-N	S193C, I196F, S225A, S271A, I317C, G318I, K346A, C347F, G361C	Lysozyme (P00720)	N/A
5UNG	Type-2 angiotensin II receptor	Class A	Angiotensin receptors	P50052	Homo sapiens (Human)	XFEL structure of human angiotensin II type 2 receptor (Orthorhombic form) in complex with compound 1 (N-benzyl-N-(2-ethyl-4-oxo-3-{[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl] methyl}-3,4-dihydroquinazolin-6-yl)thiophene-2-carboxamide)	X-Ray Diffraction	2.8	2017-04-05	Zhang et al. Structural basis for selectivity and diversity in angiotensin II receptors. Nature. 2017, 544, 327.	28379944	8ES	N-benzyl-N-(2-ethyl-4-oxo-3-{[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-3,4-dihydroquinazolin-6-yl)thiophene-2-carboxamide	InChI=1S/C36H29N7O2S/c1-2-33-37-31-19-18-27(42(22-24-9-4-3-5-10-24)36(45)32-13-8-20-46-32)21-30(31)35(44)43(33)23-25-14-16-26(17-15-25)28-11-6-7-12-29(28)34-38-40-41-39-34/h3-21H,2,22-23H2,1H3,(H,38,39,40,41)	KDPHUUTUDFDLBT-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
4J4Q	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of active conformation of GPCR opsin stabilized by octylglucoside	X-Ray Diffraction	2.65	2013-10-30	Park et al. Opsin, a structural model for olfactory receptors?. Angew.Chem.Int.Ed.Engl. 2013, 52, 11021.	24038729	N/A	N/A	N/A	N/A	N/A	N/A	N/A
4Z34	Lysophosphatidic acid receptor 1	Class A	Lysolipids receptors	Q92633	Homo sapiens (Human)	Crystal Structure of Human Lysophosphatidic Acid Receptor 1 in complex with ONO9780307	X-Ray Diffraction	3.0	2015-06-03	Chrencik et al. Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1. Cell. 2015, 161, 1633.	26091040	ON7	{1-[(2S,3S)-2-(2,3-dihydro-1H-inden-2-ylmethyl)-3-(3,5-dimethoxy-4-methylphenyl)-3-hydroxypropyl]-4-(methoxycarbonyl)-1H-pyrrol-3-yl}acetic acid	InChI=1S/C30H35NO7/c1-18-26(36-2)12-22(13-27(18)37-3)29(34)24(11-19-9-20-7-5-6-8-21(20)10-19)16-31-15-23(14-28(32)33)25(17-31)30(35)38-4/h5-8,12-13,15,17,19,24,29,34H,9-11,14,16H2,1-4H3,(H,32,33)/t24-,29+/m0/s1	PMPFDANPLYTSTM-PWUYWRBVSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
6GPX	C-C chemokine receptor type 2	Class A	Chemokines and chemotactic factors receptors	P41597	Homo sapiens (Human)	CRYSTAL STRUCTURE OF CCR2A IN COMPLEX WITH MK-0812	X-Ray Diffraction	2.7	2019-01-02	Apel et al. Crystal Structure of CC Chemokine Receptor 2A in Complex with an Orthosteric Antagonist Provides Insights for the Design of Selective Antagonists. Structure. 2018.	30581043	F7N	[(3~{S},4~{S})-3-methoxyoxan-4-yl]-[(1~{R},3~{S})-3-propan-2-yl-3-[[3-(trifluoromethyl)-7,8-dihydro-5~{H}-1,6-naphthyridin-6-yl]carbonyl]cyclopentyl]azanium	InChI=1S/C24H34F3N3O3/c1-15(2)23(7-4-18(11-23)29-20-6-9-33-14-21(20)32-3)22(31)30-8-5-19-16(13-30)10-17(12-28-19)24(25,26)27/h10,12,15,18,20-21,29H,4-9,11,13-14H2,1-3H3/p+1/t18-,20+,21-,23+/m1/s1	MTMDXAIUENDNDL-RJSMDTJLSA-O	N/A	Rubredoxin (P00268)	N/A
5ZBH	Neuropeptide Y receptor type 1	Class A	Neuropeptide Y receptors	P25929	Homo sapiens (Human)	The Crystal Structure of Human Neuropeptide Y Y1 Receptor with BMS-193885	X-Ray Diffraction	3.0	2018-04-25	Yang et al. Structural basis of ligand binding modes at the neuropeptide Y Y1receptor. Nature. 2018, 556, 520.	29670288	9AF	dimethyl 4-{3-[({3-[4-(3-methoxyphenyl)piperidin-1-yl]propyl}carbamoyl)amino]phenyl}-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate	InChI=1S/C33H42N4O6/c1-21-28(31(38)42-4)30(29(22(2)35-21)32(39)43-5)25-10-6-11-26(19-25)36-33(40)34-15-8-16-37-17-13-23(14-18-37)24-9-7-12-27(20-24)41-3/h6-7,9-12,19-20,23,30,35H,8,13-18H2,1-5H3,(H2,34,36,40)	WMYSXJSJXZFODY-UHFFFAOYSA-N	F129W	Lysozyme (D9IEF7)	N/A
4RWA	Delta-type opioid receptor	Class A	Opioid peptides receptors	P41143	Homo sapiens (Human)	Synchrotron structure of the human delta opioid receptor in complex with a bifunctional peptide (PSI community target)	X-Ray Diffraction	3.28	2015-01-14	Fenalti et al. Structural basis for bifunctional peptide recognition at human delta-opioid receptor. Nat.Struct.Mol.Biol. 2015, 22, 265.	25686086	N/A	N/A	N/A	N/A	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
4ZJC	Orexin receptor type 1	Class A	Orexins receptors	O43613	Homo sapiens (Human)	Structures of the human OX1 orexin receptor bound to selective and dual antagonists	X-Ray Diffraction	2.83	2016-03-09	Yin et al. Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors. Nat.Struct.Mol.Biol. 2016, 23, 293.	26950369	4OT	[5-(2-fluorophenyl)-2-methyl-1,3-thiazol-4-yl]{(2S)-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]pyrrolidin-1-yl}methanone	InChI=1S/C24H21FN4O2S/c1-15-26-21(22(32-15)18-11-5-6-12-19(18)25)24(30)29-13-7-10-17(29)14-20-27-28-23(31-20)16-8-3-2-4-9-16/h2-6,8-9,11-12,17H,7,10,13-14H2,1H3/t17-/m0/s1	HYBZWVLPALMACV-KRWDZBQOSA-N	V319I	GlgA glycogen synthase (Q9V2J8)	N/A
3ZEV	Neurotensin receptor type 1	Class A	Neurotensin receptors	P20789	Rattus norvegicus (Rat)	Structure of Thermostable Agonist-bound Neurotensin Receptor 1 Mutant without Lysozyme Fusion	X-Ray Diffraction	3.0	2014-01-29	Egloff et al. Structure of Signaling-Competent Neurotensin Receptor 1 Obtained by Directed Evolution in Escherichia Coli. Proc.Natl.Acad.Sci.USA. 2014, 111, E655.	24453215	N/A	N/A	N/A	N/A	A86L, H103D, H105Y, A161V, R167L, R213L, V234L, I253A, H305R, F358V, S362A	N/A	N/A
6GPS	C-C chemokine receptor type 2	Class A	Chemokines and chemotactic factors receptors	P41597	Homo sapiens (Human)	CRYSTAL STRUCTURE OF CCR2A IN COMPLEX WITH MK-0812	X-Ray Diffraction	3.3	2019-01-02	Apel et al. Crystal Structure of CC Chemokine Receptor 2A in Complex with an Orthosteric Antagonist Provides Insights for the Design of Selective Antagonists. Structure. 2018.	30581043	F7N	[(3~{S},4~{S})-3-methoxyoxan-4-yl]-[(1~{R},3~{S})-3-propan-2-yl-3-[[3-(trifluoromethyl)-7,8-dihydro-5~{H}-1,6-naphthyridin-6-yl]carbonyl]cyclopentyl]azanium	InChI=1S/C24H34F3N3O3/c1-15(2)23(7-4-18(11-23)29-20-6-9-33-14-21(20)32-3)22(31)30-8-5-19-16(13-30)10-17(12-28-19)24(25,26)27/h10,12,15,18,20-21,29H,4-9,11,13-14H2,1-3H3/p+1/t18-,20+,21-,23+/m1/s1	MTMDXAIUENDNDL-RJSMDTJLSA-O	N14Q, C70Y, G175N, A241D, K311E	Rubredoxin (P00268)	N/A
4Z36	Lysophosphatidic acid receptor 1	Class A	Lysolipids receptors	Q92633	Homo sapiens (Human)	Crystal Structure of Human Lysophosphatidic Acid Receptor 1 in complex with ONO-3080573	X-Ray Diffraction	2.9	2015-06-03	Chrencik et al. Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1. Cell. 2015, 161, 1633.	26091040	ON3	1-(4-{[(2S,3R)-2-(2,3-dihydro-1H-inden-2-yloxy)-3-(3,5-dimethoxy-4-methylphenyl)-3-hydroxypropyl]oxy}phenyl)cyclopropanecarboxylic acid	InChI=1S/C31H34O7/c1-19-26(35-2)16-22(17-27(19)36-3)29(32)28(38-25-14-20-6-4-5-7-21(20)15-25)18-37-24-10-8-23(9-11-24)31(12-13-31)30(33)34/h4-11,16-17,25,28-29,32H,12-15,18H2,1-3H3,(H,33,34)/t28-,29+/m0/s1	FVESDCZDESZGHA-URLMMPGGSA-N	D204C	Soluble cytochrome b562 (P0ABE7)	N/A
4A4M	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of the light-activated constitutively active N2C, M257Y,D282C rhodopsin mutant in complex with a peptide resembling the C-terminus of the Galpha-protein subunit (GaCT)	X-Ray Diffraction	3.3	2012-01-25	Deupi et al. Stabilized G Protein Binding Site in the Structure of Constitutively Active Metarhodopsin-II. Proc.Natl.Acad.Sci.USA. 2012, 109, 119.	22198838	RET	RETINAL	InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+	NCYCYZXNIZJOKI-OVSJKPMPSA-N	N2C, M257Y, D282C	N/A	N/A
5ZTY	Cannabinoid receptor 2	Class A	Cannabinoids receptors	P34972	Homo sapiens (Human)	Crystal structure of human G protein coupled receptor	X-Ray Diffraction	2.8	2019-01-30	Li et al. Crystal Structure of the Human Cannabinoid Receptor CB2. Cell. 2019.	30639103	9JU	N-(adamantan-1-yl)-1-(5-hydroxypentyl)-4-methyl-5-phenyl-1H-pyrazole-3-carboxamide	InChI=1S/C26H35N3O2/c1-18-23(25(31)27-26-15-19-12-20(16-26)14-21(13-19)17-26)28-29(10-6-3-7-11-30)24(18)22-8-4-2-5-9-22/h2,4-5,8-9,19-21,30H,3,6-7,10-17H2,1H3,(H,27,31)/t19-,20+,21-,26-	FMJXYCCDMAGPLE-AFJPGINASA-N	G78L, T127A, T153L, R242E, G304E	Lysozyme (D9IEF7)	N/A
2YCY	Beta-1 adrenergic receptor	Class A	Adrenergic receptors	P07700	Meleagris gallopavo (Wild turkey)	TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND ANTAGONIST CYANOPINDOLOL	X-Ray Diffraction	3.15	2011-06-08	Moukhametzianov et al. Two Distinct Conformations of Helix 6 Observed in Antagonist-Bound Structures of a {Beta}1- Adrenergic Receptor. Proc.Natl.Acad.Sci.USA. 2011, 108, 8228.	21540331	P32	4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile	InChI=1S/C16H21N3O2/c1-16(2,3)18-9-12(20)10-21-15-6-4-5-14-13(15)7-11(8-17)19-14/h4-6,12,18,20H,7,9-10H2,1-3H3/t12-/m0/s1	CQEFAUFOQSCRMZ-LBPRGKRZSA-N	R68S, M90V, C116L, Y227A, A282L, F327A, F338M, C358A	N/A	N/A
3PBL	D(3) dopamine receptor	Class A	Dopamine receptors	P35462	Homo sapiens (Human)	Structure of the human dopamine D3 receptor in complex with eticlopride	X-Ray Diffraction	2.89	2010-11-03	Chien et al. Structure of the human dopamine d3 receptor in complex with a d2/d3 selective antagonist. Science. 2010, 330, 1091.	21097933	ETQ	3-chloro-5-ethyl-N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-6-hydroxy-2-methoxybenzamide	InChI=1S/C17H25ClN2O3/c1-4-11-9-13(18)16(23-3)14(15(11)21)17(22)19-10-12-7-6-8-20(12)5-2/h9,12,21H,4-8,10H2,1-3H3,(H,19,22)/t12-/m0/s1	AADCDMQTJNYOSS-LBPRGKRZSA-N	L119W	Lysozyme (P00720)	N/A
2YDO	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	Thermostabilised HUMAN A2a Receptor with adenosine bound	X-Ray Diffraction	3.0	2011-05-18	Lebon et al. Agonist-Bound Adenosine A(2A) Receptor Structures Reveal Common Features of Gpcr Activation. Nature. 2011, 474, 521.	21593763	ADN	ADENOSINE	InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1	OIRDTQYFTABQOQ-KQYNXXCUSA-N	L48A, A54L, T65A, Q89A, N154A	N/A	N/A
3EML	Adenosine receptor A2a	Class A	Adenosine and adenine nucleotide receptors	P29274	Homo sapiens (Human)	The 2.6 A Crystal Structure of a Human A2A Adenosine Receptor bound to ZM241385.	X-Ray Diffraction	2.6	2008-10-14	Jaakola et al. The 26 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist. Science. 2008, 322, 1211.	18832607	ZMA	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N	N/A	Lysozyme (P00720)	N/A
6IGK	Endothelin receptor type B	Class A	Endothelin receptors	P24530	Homo sapiens (Human)	Crystal Structure of human ETB receptor in complex with Endothelin-3	X-Ray Diffraction	2.0	2018-11-21	Shihoya et al. Crystal structures of human ETBreceptor provide mechanistic insight into receptor activation and partial activation. Nat Commun. 2018, 9, 4711.	30413709	N/A	N/A	N/A	N/A	R124Y, D154A, K270A, S342A, I381A, C396A, C400A, C405A	Thymosin beta {ECO:0000256|PIRNR:PIRNR001828} (A0A097)	N/A
4JKV	Smoothened homolog	Class F	N/A	Q99835	Homo sapiens (Human)	Structure of the human smoothened 7TM receptor in complex with an antitumor agent	X-Ray Diffraction	2.45	2013-04-24	Wang et al. Structure of the human smoothened receptor bound to an antitumour agent. Nature. 2013, 497, 338.	23636324	1KS	4-fluoro-N-methyl-N-{1-[4-(1-methyl-1H-pyrazol-5-yl)phthalazin-1-yl]piperidin-4-yl}-2-(trifluoromethyl)benzamide	InChI=1S/C26H24F4N6O/c1-34(25(37)20-8-7-16(27)15-21(20)26(28,29)30)17-10-13-36(14-11-17)24-19-6-4-3-5-18(19)23(32-33-24)22-9-12-31-35(22)2/h3-9,12,15,17H,10-11,13-14H2,1-2H3	SZBGQDXLNMELTB-UHFFFAOYSA-N	N/A	Soluble cytochrome b562 (P0ABE7)	N/A
5JQH	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	Structure of beta2 adrenoceptor bound to carazolol and inactive-state stabilizing nanobody, Nb60	X-Ray Diffraction	3.2	2016-07-13	Staus et al. Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation. Nature. 2016, 535, 448.	27409812	CAU	(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol	InChI=1S/C18H22N2O2/c1-12(2)19-10-13(21)11-22-17-9-5-8-16-18(17)14-6-3-4-7-15(14)20-16/h3-9,12-13,19-21H,10-11H2,1-2H3/t13-/m0/s1	BQXQGZPYHWWCEB-ZDUSSCGKSA-N	M1096T, M1098T, N1187E, C1265A	Lysozyme (P00720)	Nanobody60, Nb60
6A94	5-hydroxytryptamine receptor 2A	Class A	Serotonin receptors	P28223	Homo sapiens (Human)	Crystal structure of 5-HT2AR in complex with zotepine	X-Ray Diffraction	2.9	2019-02-13	Kimura et al. Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepin. Nat.Struct.Mol.Biol. 2019, 26, 121.	N/A	ZOT	2-(3-chloranylbenzo[b][1]benzothiepin-5-yl)oxy-N,N-dimethyl-ethanamine	InChI=1S/C18H18ClNOS/c1-20(2)9-10-21-16-11-13-5-3-4-6-17(13)22-18-8-7-14(19)12-15(16)18/h3-8,11-12H,9-10H2,1-2H3	HDOZVRUNCMBHFH-UHFFFAOYSA-N	S162K, M164W	Soluble cytochrome b562 (P0ABE7)	N/A
4LDE	Beta-2 adrenergic receptor	Class A	Adrenergic receptors	P07550	Homo sapiens (Human)	Structure of beta2 adrenoceptor bound to BI167107 and an engineered nanobody	X-Ray Diffraction	2.79	2013-09-25	Ring et al. Adrenaline-activated structure of beta 2-adrenoceptor stabilized by an engineered nanobody. Nature. 2013, 502, 575.	24056936	P0G	8-[(1R)-2-{[1,1-dimethyl-2-(2-methylphenyl)ethyl]amino}-1-hydroxyethyl]-5-hydroxy-2H-1,4-benzoxazin-3(4H)-one	InChI=1S/C21H26N2O4/c1-13-6-4-5-7-14(13)10-21(2,3)22-11-17(25)15-8-9-16(24)19-20(15)27-12-18(26)23-19/h4-9,17,22,24-25H,10-12H2,1-3H3,(H,23,26)/t17-/m0/s1	NWQXBEWHTDRJIP-KRWDZBQOSA-N	M1096T, M1098T, N1187E, C1265A	Lysozyme (P00720)	Camelid Antibody Fragment
4XNW	P2Y purinoceptor 1	Class A	Adenosine and adenine nucleotide receptors	P47900	Homo sapiens (Human)	The human P2Y1 receptor in complex with MRS2500	X-Ray Diffraction	2.7	2015-04-01	Zhang et al. Two disparate ligand-binding sites in the human P2Y1 receptor. Nature. 2015, 520, 317.	25822790	2ID	[(1R,2S,4S,5S)-4-[2-iodo-6-(methylamino)-9H-purin-9-yl]-2-(phosphonooxy)bicyclo[3.1.0]hex-1-yl]methyl dihydrogen phosphate	InChI=1S/C13H18IN5O8P2/c1-15-10-9-11(18-12(14)17-10)19(5-16-9)7-2-8(27-29(23,24)25)13(3-6(7)13)4-26-28(20,21)22/h5-8H,2-4H2,1H3,(H,15,17,18)(H2,20,21,22)(H2,23,24,25)/t6-,7+,8+,13+/m1/s1	NMVWLEUONAKGCD-SMWKGLLFSA-N	D320N	Rubredoxin (P00268)	N/A
6N52	Metabotropic glutamate receptor 5	Class C	N/A	P41594	Homo sapiens (Human)	Metabotropic Glutamate Receptor 5 Apo Form	Electron Microscopy	4.0	2019-01-23	Koehl et al. Structural insights into the activation of metabotropic glutamate receptors. Nature. 2019.	30675062	N/A	N/A	N/A	N/A	N/A	N/A	N/A
5TE5	Rhodopsin	Class A	Opsins	P02699	Bos taurus (Bovine)	Crystal structure of Bos taurus opsin regenerated with 6-carbon ring retinal chromophore	X-Ray Diffraction	4.01	2017-03-15	Gulati et al. Photocyclic behavior of rhodopsin induced by an atypical isomerization mechanism. Proc. Natl. Acad. Sci. U.S.A. 2017, 114, E2608.	28289214	7AB	(2E)-{(4E)-4-[(3E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-ylidene]cyclohex-2-en-1-ylidene}acetaldehyde	InChI=1S/C21H28O/c1-16(19-10-8-18(9-11-19)13-15-22)7-12-20-17(2)6-5-14-21(20,3)4/h7-8,10,12-13,15H,5-6,9,11,14H2,1-4H3/b12-7+,18-13-,19-16-	QLEXUFWJSPRFOP-LCYNHIKNSA-N	N/A	N/A	N/A
5ZKB	Muscarinic acetylcholine receptor M2	Class A	Acetylcholine (muscarinic) receptors	P08172	Homo sapiens (Human)	Crystal structure of rationally thermostabilized M2 muscarinic acetylcholine receptor bound with AF-DX 384	X-Ray Diffraction	2.95	2018-11-21	Suno et al. Structural insights into the subtype-selective antagonist binding to the M2muscarinic receptor. Nat. Chem. Biol. 2018, 14, 1150.	30420692	82F	N-[2-[(2S)-2-[(dipropylamino)methyl]piperidin-1-yl]ethyl]-6-oxidanylidene-5H-pyrido[2,3-b][1,4]benzodiazepine-11-carboxamide	InChI=1S/C27H38N6O2/c1-3-16-31(17-4-2)20-21-10-7-8-18-32(21)19-15-29-27(35)33-24-13-6-5-11-22(24)26(34)30-23-12-9-14-28-25(23)33/h5-6,9,11-14,21H,3-4,7-8,10,15-20H2,1-2H3,(H,29,35)(H,30,34)/t21-/m0/s1	MZDYABXXPZNUCT-NRFANRHFSA-N	S110R	N/A	N/A
